Yaya tsawon lokacin da waɗannan alamun suka bayyana?
kuma za a iya magance ciwon kirji ta wannan hanyar musamman a cikin shekarunku
da kuma samun wuta
kuma kuna buƙatar a gwada hawan jini na cholesterol
Shin kuna da wuta a yanzu?
Shin kana jin zafi a kirji a wannan lokacin?
kuma a saman wannan kuna da matsalar numfashi
Za ka iya gaya mini ƙarin alamun da kake nunawa da kuma wannan?
Yaya girman wutar yake?
kuma ina da wani abu da zai sa ni baƙin ciki
kuma ina da wani girgizar da zan yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta yi ta ta yi ta yi ta yi ta ta yi ta ta yi ta yi ta ta yi ta ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta da ta
Lalle ne, ina da baƙin ciki ƙwarai a cikin kirji.
kuma wannan lokaci ne na kamuwa da zazzabin cizon sauro da kuma sanadin da ke sa tsire-tsire su yi sanyi.
kuma yana haifar da ciwo a kirjinka
kuma ina ganin ina da kadan wuta
kuma ina so ka bayyana a fili inda kake jin zafi a cikin kirji
kuma suna da ƙananan wutar lantarki
da kuma ciwon sukari
kuma ka san ina jin kirji na kamar zai karye
kuma ka san mutanen da suke bauta mini kullum
kuma kuna fama da ciwon kirji
kuma ka ce wannan yana sa ka sanyin gwiwa
ko wani a cikin iyalinka yana da ciwon zuciya, ciwon zuciya, ciwon zuciya, ciwon zuciya, ciwon jini, da kuma ciwon zuciya
Shin akwai wasu alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Don me ba a sami sauran marasa lafiya a gida suna nuna irin waɗannan alamun ba?
Shin akwai wasu alamun cutar da kake nunawa?
kana jin cewa kana da wani yanayi mai wuya?
har yanzu kuna jin zafi a kirji
domin wannan shine lokacin da mutane ke kamuwa da cutar mura
Amma kuma ba za mu iya watsi da ciwon kirji na zuciya ba
amma matsalar da ta fi muhimmanci a yanzu ita ce ciwon kirji
amma ina da matsalar numfashi
amma na san mutane da yawa suna yin tawaye da ni
amma muna bukatar mu magance kowane irin ciwon kirji ba tare da wani motsi ba
amma kuna numfashi sosai a yanzu?
'don na manta da dukan wannan ciwon ciki
kana jin kamar wani yana matsa maka a kirji
har yanzu kana jin kamar ruhun yana rayuwa kadan
Shin, suna gunaguni ne da irin waɗannan alamu domin suna rashin lafiya?
kuna da wani cututtukan cututtuka kamar hawan jini ko kuma irin wannan cututtuka?
kuna da wasu cututtuka na kiwon lafiya da suka shafi cututtukan da kuka riga kuka kamu da su, kamar su ciwon sukari?
Shin, akwai wani ɗan gajeren lokaci da za a iya yi tare da wannan ciwon kirji?
Shin, kuna da hauhawar jini?
Shin, ba za a iya yin haka ba?
Shin ka san alamun da yake nunawa?
Za ka ga hoton nan?
sha da yawa yau
amma ina shan siginan ciwon sukari
Amma yana da alamun da suka yi daidai da na kaina.
Yaya girman wutarka?
Yaya jini yake?
idan ka ci gaba da samun wuta mai yawa
idan kuna da zafi mai zafi na digiri talatin da takwas da rabi ko sama da haka
idan kana ganin alamun da kake nunawa da kuma matsalolin da kake da su sun nuna cewa kana da kyau
na yi wuta jiya
na yi ɗan wuta tare da ni
jiya ina da wuta
ina da zafi sosai a cikin kirji
Ina da matsalar numfashi
Zan aiko maka da hoto
yau ina da ciwon kirji
yau kawai ina da ciwon kai da kuma ciwon zafin jiki
ina ganin shi girpi ne
ina ganin girpi ne mai sauki
Kamar wani mutum mai nauyi yana zaune a ƙirjinsa?
Dukkanin sun fara ne da ciwon kai da kuma ciwon daji a lokaci guda
ina jin zafi a tsakiyar kirji
Yana da zafi kamar ciwon kirji.
a cikin kirji na
a tsakiyar kirji na
a tsakiyar kirji na
ina da ciwo a kirji
Ina da shakku mai yawa a yanzu ciwon kirji
Ina so ka gaya mini kuma ka bayyana min wannan ciwon kirji
irin su hawan jini ko ciwon sukari
kamar tsakiyar kirji
Yanzu kuna da wuta da za ta ƙone wani parasitoma na asali
Mary, ka san alamun cutar tun daga lokacin da ka fara aiki?
yanzu ka ce kana da ciwon kirji
Wani lokaci ina jin zafi a kirji
To, akwai wasu alamun da kake nunawa da kuma wadannan ban da kawai zafi
ko kuma kana jin kamar wani ne da yake zaune a kan ƙirjinka?
da za ka ce yana da kyau kamar wuta idan na yi ta ta girgiza kaina kuma na sha wahala a jijiyoyin
a cikin tsakiyar ƙirjin
nuna min a wannan hoton inda kake jin zafi
tun lokacin da aka kashe wuta
Saboda haka, kuna ganin cewa wasu daga cikin waɗannan alamun suna da alaƙa da ciki?
Shin yaranku suna da irin wannan alamun?
Faɗa mini game da ciwon kirjinka
wuta ta ƙaru da dare
wuta da na samu kwanaki biyu da suka gabata
wuta ta fara ƙaruwa a daren jiya
wannan shi ne Dr. Porter wanda ke aiki a wani cibiyar da ke zabar marasa lafiya zuwa dakin asibiti
Za ka iya gaya mini ƙarin bayani game da ciwon kirjinka?
shi ne abin da nake ji zafi a ciki na jiki a cikin kirji
shi ne abin da na yi lokacin da ciwo mai tsanani a kirji
shi ne lokacin da nake da wannan ciwon kirji
"To, me ya sa kake shan wahala a cikin ƙirjinka?
Yaushe ne wannan ciwon na ciki ya fara?
Wanene ke da ciwon kirji?
ina ka saurari wannan adadi na kirji wanda yake ɓoye a cikin kirji t
kana jin kamar a kirjinka ne aka haɗa
ka san ina da ciwon sukari da sauran cututtuka
ka ce kana jin wannan ciwon a kirjinka
Yawan kamuwa da cutar coronavirus (COVID-19) ya karu da sauri a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan kamuwa da cutar coronavirus (COVID-19) a cikin ƙasashen EU / Yankin Tattalin Arziki na Turai da Burtaniya ya nuna cewa, duk da cewa matakin ya bambanta daga ƙasa zuwa ƙasa, cutar COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Bisa ga abin da ya faru a Italiya, ƙasashe, asibitoci da wuraren gaggawa suna buƙatar haɓaka shirye-shiryen karɓar adadin COVID-19 da za a buƙata, musamman a cikin kulawar marasa lafiya.
A ranar 31 ga Disamba, 2019, an samu wani kamuwa da cutar ta ciwon kumburi a birnin Wuhan, lardin Hubei, kasar Sin, sakamakon wani abu da ba a sani ba.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta ba da sanarwar cewa sabon coronavirus ne wanda yanzu ake kira Coronavirus na 2 wanda ke haifar da cutar huhu mai tsanani (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 ana kiranta cutar coronavirus (COVID-19).
A halin yanzu, alamun sun nuna cewa kusan 80% na mutanen da ke da cutar COVID-19 suna da ƙananan cututtukan cututtukan numfashi tare da ko ba tare da cutar ba, kuma yawancin suna warkewa.
A cikin kashi 14 cikin dari na marasa lafiya, COVID-19 ya zama mummunan cuta wanda ke buƙatar asibiti yayin da kashi 6 cikin dari na sauran marasa lafiya ke rashin lafiya kuma suna buƙatar kulawar gaggawa.
Yawan mutuwar asibiti na COVID-19 kusan kashi 4%.
A cikin wannan binciken, muna nazarin jimlar adadin kamuwa da COVID-19 a kowace ƙasa ta Tarayyar Turai / Yankin Tattalin Arziki na Turai (EU/EEA) da Burtaniya (UK) kuma muna kwatanta shi da na lardin Hubei, China.
Muna kuma kwatanta yawan adadin masu kamuwa da COVID-19 a cikin EU/EEA da Burtaniya da na Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Rashin kamuwa da COVID-19 a cikin EU / EEA da UK
Bayan China, COVID-19 ya ci gaba da yaduwa zuwa wasu ƙasashe kuma yaduwar COVID-19 a sauran sassan duniya tana da tasiri iri ɗaya a cikin ƙasar.
A ranar 11 ga Maris, 2020, Babban Jami'in Hukumar Lafiya ta Duniya (WHO) ya bayyana COVID-19 a matsayin annoba.
A cikin batun Eurosurveillance 2020 na 5 ga Maris, Spiteri da abokan aikinsa sun ba da rahoton ƙididdigar farko na COVID-19 a Turai bisa ga ƙididdigar haƙuri ta WHO.
A cikin EU/EEA, Faransa ta fara gano mutum uku da suka kamu da cutar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, Lardin Hubei, China.
Tun daga 15 ga Maris, 2020, an sami kamuwa da COVID-19 a cikin ƙasashe 30 na EU / EEA da Burtaniya (UK), wanda ya ba da rahoton kamuwa da cutar 39,768 da mutuwar 1,727, daga cikinsu 17,750 da mutuwar 1,441 a Italiya kadai.
Gano yawan masu kamuwa da COVID-19 da kuma yadda ake yada su gaba ɗaya
A Cibiyar Tarayyar Turai don Yin Rigakafi da Rigakafin Cututtuka (ECDC), an ba da rahoton adadin COVID-19 ta kowace ƙasa a duniya, wanda aka bayar ta hanyar amintattun wurare kamar Ma'aikatar Lafiya, hukumomin kiwon lafiya na ƙasa da yanki da WHO, ana sabunta su kowace rana da karfe 8:00.
An yi amfani da wannan bayanan don nazarin halin da ake ciki na COVID-19 a cikin EU/EEA da Burtaniya, da kuma kwatanta shi da na Italiya.
Don nuna halin da ake ciki na COVID-19, mun tattara adadin kamuwa da COVID-19 a cikin kwanaki 14, don haka muna mai da hankali kan yadda COVID-19 ke yaduwa a cikin al'ada, a cikin kowace ƙasa ta EU/EEA da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma nuna adadin marasa lafiya a kowace ƙasa tun daga 15 ga Maris, 2020 da karfe 8:00 na dare idan aka kwatanta da na Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Matsayin kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya
A cikin jimlar, yawan adadin kamuwa da COVID-19 a cikin EU/EEA da Burtaniya a cikin kwanaki 14 ya yi daidai da na lardin Hubei, China (Figure 1).
Gabaɗaya a cikin EU/EEA da Burtaniya, adadin kamuwa da COVID-19 ya fara tashi a ranar 21 ga Fabrairu kuma yanzu zai tashi zuwa matsakaicin matsayi a ranar 28 ga Fabrairu, 2020 (Further Information).
Wannan ya kasance ne saboda yawan karuwar yawan kamuwa da cutar a Italiya, amma a duk sauran kasashen EU/EEA da Burtaniya an samu karuwar yawan kamuwa da cutar COVID-19 (Further Information).
Hoto na 2 ya nuna jimlar adadin masu kamuwa da COVID-19, a cikin EU/EEA da UK da kuma a Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya nuna cewa, a ranar 15 ga Maris, 8:00, sauran ƙasashen EU/EEA da Burtaniya sun riga sun nuna adadin adadin marasa lafiya daidai da na Italiya a cikin makonni 3 da suka gabata ko ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa yawan mutanen da aka tabbatar da COVID-19 zai karu da sauri a cikin EU/EEA da Burtaniya.
Canjin yawan adadin masu kamuwa da COVID-19 ya nuna cewa cutar tana yaduwa da sauri a duk ƙasashe.
Wannan ya kasance daidai duk da cewa ƙasashe suna da matakan gwaji daban-daban, matakan kiwon lafiya na canzawa, ƙididdigar kamuwa da cuta na iya bambanta daga ƙasa zuwa ƙasa kuma akwai ƙa'idodi daban-daban don zaɓar marasa lafiya don gwada COVID-19, gami da gwada waɗanda ba su riga sun yi ba.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana cewa kusan kashi 10% na marasa lafiya na COVID-19 suna buƙatar kulawa a cikin asibitocin gaggawa kuma jaridu sun ba da rahoton cewa asibitocin gaggawa na waɗannan yankuna sun riga sun karɓi adadin da ba zai iya wucewa ba.
Bayanai game da marasa lafiya na COVID-19 da aka kwantar a asibiti ko asibiti na yanzu suna samuwa a cikin EU / EEA a yanzu kawai 6% da 1% na marasa lafiya (ba a tabbatar da bayanai ba).
Duk da haka, dole ne a tattara shi a hankali don haɗa bayanai game da marasa lafiya da ake bi a yanzu tare da mai da hankali kan yawan marasa lafiya da aka nuna ta hanyar yawan mutuwar.
Binciken 201011 ya nuna cewa ɗakunan kwanciya da ɗakunan marasa lafiya masu ƙarancin lafiya suna samuwa a Turai a hanyoyi daban-daban, daga gadaje 29,2 a Jamus zuwa 4,2 a cikin mutane 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe suna da mafi yawan kayan aiki ko ƙasa da Italiya (sun sami gadaje masu sauƙi da marasa lafiya 12.5 ga kowane mutane 100,000 a cikin 201011).
Takaddun na shida wanda ya ƙunshi sabon bayanan Hakantaccen Binciken Tasirin ECDC akan COVID-19, ya ba da misalai na ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙidid
Tun da har yanzu wasu yankuna na EU/EEA da na Burtaniya sun fi yawan marasa lafiya, kuma asibitocin gaggawa suna karɓar mutane daga wani yanki, dole ne a sami bayanan marasa lafiya da asibitocin gaggawa a cikin ƙididdigar yanki na 2 (NUTS-2).
Misali na Italiya da kuma halin da ake ciki a wasu ƙasashe na nuna cewa cutar COVID-19 tana yaduwa cikin sauri a cikin EU/EEA da Burtaniya.
Saboda haka, ƙasashe, asibitoci da wuraren gaggawa dole ne su shirya don magance cutar SARS-CoV-2 wanda zai ci gaba da kasancewa a cikin al'umma yayin da yawan masu cutar COVID-19 ke buƙatar kulawa, musamman a cikin kula da marasa lafiya, kamar yadda yake faruwa a yankunan da aka shafa a Italiya.
Kamar yadda aka ambata a cikin binciken gaggawa na ECDC na kwanan nan, yana da mahimmanci a yi amfani da gaggawa da kuma gaggawa na gaba ɗaya don hana yaduwar SARS-COV-2, don haka tsarin rigakafi ya maye gurbin zaman gida, saboda ƙaruwar yawan marasa lafiya da ake tsammani na iya hana masu yanke shawara da masu kula da asibiti isasshen lokaci don nazarin, fahimtar matakan da za a ɗauka da kuma amfani da su yadda ya kamata idan ba a yi aiki da wuri ba.
Binciken gaggawa na al'amuran ya nuna matakan kiwon lafiya na jama'a da za a ɗauka don rage tasirin cutar.
Akwai ƙananan dama ga ƙasashe don ƙara haɓaka matakan da suke ɗauka don hana yaduwar SARS-CoV-2 da tasirinsa a kan kiwon lafiya.
Idan ba a yi haka ba, cibiyoyin kiwon lafiya na sauran ƙasashen EU/EEA na iya fuskantar matsalar yawan marasa lafiya a cikin kwanaki ko makonni masu zuwa.
Cutar cutar sankara ta 2019 (COVID-19), wanda ya haifar da cutar sankara ta SARS-CoV-2 (SARS-CoV-2), ta kashe mutane sama da 3,000 kuma ta kama fiye da 80,000 a China da sauran wurare a duniya, saboda haka bala'i ne ga mutane.
Kamar sauran kwayoyin cuta, SARS-CoV, wanda ya haifar da cutar sankarar ƙwayar cuta (SARS) ga dubban mutane a cikin 2003, SARS-CoV-2 na iya yaduwa ta hanyar cutar ta hanyar kamuwa da cuta tare da alamun bayyanar cututtuka iri ɗaya.
Amma COVID-19 ba ta da tsanani kuma tana kashe mutane da yawa fiye da SARS duk da cewa tana yaduwa da sauri kuma tana da yawa a cikin manya fiye da matasa kuma tana da tasiri sosai a cikin maza fiye da mata.
Saboda yawan adadin bayanai da aka samu game da wannan sabon cuta, wannan takarda ta yi ƙoƙari ta samar da cikakken bincike mai amfani game da wannan batun da ake ci gaba da bincike.
Muna mai da hankali kan manyan abubuwan da ke haifar da cutar kamar gano cutar, abin da ke haifar da ita, kwayar cutar da ke haifar da ita, yadda ake gano ta, yadda ake bi da ita, yadda ake yaduwa da yadda ake hana ta.
Duk da cewa har yanzu akwai tambayoyi da yawa da za a amsa, muna fatan wannan binciken zai taimaka wajen ganowa da kuma kawar da wannan cuta mai haɗari.
Bayan bikin bazara na 25 ga Janairu, 2020, ya sanya tarihin tunawa ga duk Sinawa waɗanda aka ba su umarni su zauna a gida a duk hutun da makonni masu zuwa saboda annobar da sabuwar cutar ta haifar.
Wannan kwayar cuta mai alaƙa da coronavirus (CoV) ta haifar da cutar sankarar cuta mai tsanani (SARS) a cikin 2003; saboda haka Hukumar Lafiya ta Duniya (WHO) ta sanya sunan SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma yanzu ana kiran cutar ta asali da cutar COVID-19 (COVID-19).
An fara cutar ne a birnin Wuhan, China, kuma ta bazu a duk faɗin ƙasar da kuma wasu ƙasashe 50 a duniya.
A ranar 2 ga Maris, 2020, an riga an tabbatar da cewa mutane sama da 80,000 sun kamu da cutar COVID-19, fiye da 40,000 daga cikinsu an riga an sallame su kuma fiye da 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 shine matsayin gaba ɗaya  kuma yana da tasiri mafi girma fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga sama da takardu 200 game da COVID-19, gami da magungunan cutar da ke haifar da ita, cutar, asalinta, kimantawa da kuma hanyoyin magani tun lokacin da aka gabatar da rahoton farko a ranar 7 ga Janairu, 2020 wanda ya bayyana yanayin cutar da aka kama daga marasa lafiya daban-daban.
Wannan bita yana ƙoƙarin taƙaita binciken da aka yi a kan wannan sabon batu da ake bincike sosai.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da sauran cututtukan CoV, kamar cutar mura ta Gabas ta Tsakiya (MERS, wanda aka gano a cikin 2012).
Za mu tattauna darussan da muka samu a kan hana yaduwar cutar da kuma gano dalilin cutar da kuma wasu batutuwan gaggawa da ba a amsa ba.
Kwayar cutar CoVs, wadda aka fi sani da cutar da ba ta kashe mutum, tana haifar da mafi yawan nau'ikan 4 na cutar da ake samu a kusan kashi 15 cikin dari.
Amma, a wannan karni, mun sami ƙwayoyin cuta na CoVs masu cutarwa biyu, SARS-CoV da MERS-CoV, waɗanda suka haifar da annobar da aka gano a China a 2003 da Saudi Arabiya a 2012, sannan kuma suka bazu zuwa wasu ƙasashe da yawa da yawa da yawan kamuwa da cutar da suka mutu.
Wannan shine dalilin da ya sa COVID-19 na zamani shine annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a cikin Hoton Hoton 1.1, an fara gano mutane da ke fama da ciwon kwayar cutar ta hanyar wani abu da ba a sani ba a Wuhan a ranar 31 ga Disamba, 2019 tare da sanar da Hukumar Lafiya ta kasar Sin.
Bayan kwana bakwai, an fitar da takardar da ke bayyana yanayin CoV.
Ranar 15 ga Janairu, 2020, mutum na farko ya mutu a Wuhan.
A halin yanzu, cutar ta bazu cikin sauri zuwa wasu birane, larduna da ƙasashe masu kewaye.
A ranar 20 ga Janairu, an sanar da cewa wasu likitoci sun kamu da cutar, wanda a bayyane yake zai iya kamuwa da cutar daga mutane.
A ranar 23 ga Janairu, an sanya birnin Wuhan a cikin killace tare da dakatar da duk hanyoyin sufuri.
A ranar 24 ga watan Janairu ne aka fara binciken asibiti na cutar, inda aka bayyana cewa, daga cikin marasa lafiya 41 da aka tabbatar da cewa suna dauke da cutar, 21 ne kawai suka isa kasuwar kayayyakin ruwa ta Wuhan inda aka ce cutar ta fito ne daga wani dabba da ba a san shi ba.
A ranar 30 ga Janairu, WHO ta bayyana cutar a matsayin bala'i mai haɗari ga lafiyar duniya.
A lokacin da aka sanar da rahoton, cutar ta riga ta bazu a duk faɗin China da kuma wasu ƙasashe 50 a duniya (Figure (Figure 2).2).
Saboda wannan annobar da ke yaduwa cikin sauri, ba shi da sauƙi a san inda za ta koma da kuma sakamakon.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyin da aka yi a kan marasa lafiya 8,866 da suka hada da marasa lafiya 4,021 da aka gano suna dauke da cutar COVID-19 ya ba da ingantaccen bayanin yadda cutar ta kasance a shafin yanar gizon (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Mutane masu kamuwa da SARS-CoV-2 sun bambanta a cikin shekaru, amma sun fi yawa a tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na wadanda suka kamu da cutar sun wuce shekaru 50, kuma mafi ƙarancin su ƙasa da shekaru 20, yayin da 14 kawai na wadanda suka kamu da cutar suka kasance ƙasa da shekaru 10.
Maza suna da yawan kamuwa da SARS-CoV-2 (0,31/100 000) fiye da mata (0,27/100 000).
COVID-19 ya zama sananne musamman a Hubei da yankunan da ke kusa da shi.
A matsakaici, daga lokacin bayyanar COVID-19 har zuwa lokacin da aka sami gwajin kusan kwanaki 5 (2-9).
A matsakaita, ya ɗauki kwanaki 4.8 kafin ya nuna alamun.
An kwatanta mutum na farko da ya mutu bayan 9.5 (4,8-13) daga bayyanarsa.
Matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin
Adadin masu kamuwa da cutar ya karu sosai kafin 23 ga Janairu, 2020, wanda ya dace da lokacin da yawancin mutane ke tafiya kafin bikin bazara na kasar Sin.
Adadin kamuwa da cutar da aka tabbatar ya kasance 1.44% (95% CI: 1.10-1,86%), kuma yawan mutuwar kamuwa da cutar a cikin dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Matsalar COVID-19 guda uku sune jinsi (maza), shekaru (≥60) da kuma rashin ƙarfi.
CoVs sune nau'ikan manyan ƙwayoyin cuta masu ƙwayoyin cuta waɗanda ke ƙunshe da RNA na tunani guda ɗaya.
Ana iya rarraba su zuwa nau'i hudu, alpha, beta, gamma, da delta. A cikin waɗannan nau'ikan, ƙwayoyin cuta na alpha da beta na CoVs suna iya kamuwa da mutane.
Glycoprotein na kai (S) na rufewa yana ɗaure da ƙwayoyin ACE2 da DPP4 a cikin SARS-CoV da MERS-CoV, sannan kwayoyin suna haɗuwa.
Ana gano kwayar RNA ta kwayar cutar zuwa kwayar halitta; bayan an kwafa kwayar cutar, RNA ta kwayar halitta tare da ƙwayoyin cuta na ƙwayoyin cuta da ƙwayoyin nucleocapsid suna gano ƙwayoyin cuta na ƙwayoyin cuta waɗanda ke haɗuwa da ƙwayoyin cuta zuwa kwayar cuta.
An gano nau'in farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 sabon nau'in beta-CoV ne wanda ya kasance yana da haɗin jini na 99.98% a cikin gwaje-gwaje 10 na kwayar halitta da aka ɗauka a lokacin barkewar cutar, a kasuwar ruwa ta Huanan a Wuhan.
SARS-CoV-2 yana da kwayoyin halitta da yawa kamar SARS-CoV fiye da MERS-CoV.
A cikin microscope na lantarki na bincike na kamuwa da cuta, an gano ɓangarorin SARS-CoV-2 a cikin ɓangarorin da suka fi ƙasa na ƙwayar huhu ta mutum.
An gano cewa kwayar ACE2 a cikin mutum tana da alaƙa da SARS-CoV-2 da SARS-CoV.
Amma SARS-CoV-2 na S yana da alaƙa da ƙwayoyin cuta na ACE2 na ɗan adam a hankali fiye da SARS-CoV, wanda ya dace da tabbatar da cewa SARS-CoV-2 yana da ƙarancin kamuwa da cutar fiye da SARS-CoV.
SARS-CoV-2 na iya zama sabon ƙaramin furotin mai ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ
Protein orf3b na SARS-CoV-2 na iya kasancewa yana da tasiri a cikin ƙwarewar kamuwa da cutar ta kwayar cuta da hana bayyanar IFNβ; amma protein orf8 ba shi da wani tsari ko yanayi da aka sani.
A ranar 18 ga Fabrairu, 2020, Zhou da abokan aikinsa sun ba da sanarwar wani samfurin lantarki mai ƙarancin zafin jiki (cryo-EM) na cikakken ƙarancin ɗan adam na ACE2 a zurfin 2.9 Å a cikin kwayar halitta mai ƙarancin amino acid B0AT1.
An gano cewa ƙwayar cuta, wacce take da siffar bude da rufe, ta haɗu da kwayoyin halitta biyu kuma ƙwayar cuta ta ACE2-B0AT1 na iya haɗawa da sunadarai S guda biyu, wanda ke nuna bayyanar cututtukan cuta na CoV.
Ana iya nazarin B0AT1 ta hanyar nazarin maganin kashe cutar SARS-CoV-2.
Da farko dai, dabba ce da ta zama marar tsarki.
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga mura kuma daga nan ne mutane suka kamu da cutar kwayar cutar.
Ta hanyar kwatanta SARS-CoV-2 da sauran ƙwayoyin cuta na CoVs, an gano cewa ƙwayoyin cuta sune asalin SARS-CoV-2 saboda sabon ƙwayoyin cuta suna da daidaituwa 96% da kuma ƙwayoyin cuta biyu na CoVs kamar SARS waɗanda suka fito ne daga ƙwayoyin cuta bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma dabba mai cutar ta farko da ta taimaka wa kwayar cutar ta zama mai rarrabawa har zuwa kamuwa da mutane ba a san ta ba, kuma ba a san yadda za a iya kamuwa da ita ba.
Ji da abokan aikinsa sun ce macizai na iya zama masu cutar da cutar ta cuta ta cuta wanda ya biyo bayan gano kanta a cikin furotin S.
A cewar wani bincike, masu bincike daga Guangzhou, China, sun ce kwayoyin cuta, dabbobin nono masu dogon baki da ke cin nama da kuma masu amfani da likitoci masu sana'a a kasar Sin, na iya zama farkon masu kamuwa da SARS-CoV-2 saboda yanayin kwayoyin halitta na 99% da aka gano a cikin kwayar cuta ta CoV da SARS-CoV-2.
Amma, bambancin kashi 1 cikin 100 da aka gani a cikin kwayoyin biyu har yanzu yana da girma; saboda haka ana jiran ƙuduri mai kyau (Fig. 33).
Yawancin alamun cutar SARS-CoV-2 ba a sani ba.
Kwayar cutar SARS-CoV da MERS-CoV na iya kasancewa a waje na tsawon awanni 48 a cikin yanayin zafi, har zuwa kwanaki 5 a cikin yanayin zafi na yau da kullun a ƙarƙashin 20 °C da kuma yanayin zafi na 40% zuwa 50%.
SARS-CoV-2 na iya samun alamomi iri ɗaya.
An tabbatar da cewa SARS-CoV-2 ba ya jure hasken rana da zafin jiki na 56 °C a cikin minti 30; ether, 75% ethanol, kayan tsabtace jiki tare da corol, persetic acid, corophorum, da sauran kayan shafawa masu narkewa, amma ba corolysidine ba, na iya kashe kwayar cutar yadda ya kamata.
A gaba ɗaya, ba kowa ba ne ke da cutar SARS-CoV-2 kuma saboda haka ba su da wata sanarwa ga sabon kwayar cutar.
Har yanzu babu cikakken bincike game da yadda jikin mutum ke jure SARS-CoV-2.
Saboda haka, muna amfani da binciken da aka yi a baya kawai akan sauran ƙwayoyin cuta na CoV, musamman SARS-CoV da MERS-CoV (Figure (Figure 4).4).
A gaba ɗaya, lokacin da kwayar ta shiga cikin mai kamuwa da cuta, ana fara gano ta ta hanyar kwayar halitta ta hanyar mai rarrabewa mai rarrabewa (PRR) wanda ya ƙunshi masu karɓa kamar C-type regitins, TLR receptor, NLR receptor da RLR receptor.
A hanyoyi daban-daban, kwayar cutar tana haifar da zazzabi, kumburi na ƙwayoyin cuta, da kuma gina jiki na I-type (IFN) wanda aka tsara don magance kwayar cutar da ke rage yaduwar kwayar cutar da kuma sake cinye kwayar cutar.
Duk da haka, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta zama mai hana rigakafin jiki.
Ba da daɗewa ba, jikin mutum yana da ƙarfin yaƙi da kwayar.
Kwayoyin T sun ƙunshi CD4+ da CD8+ T wanda ke taka muhimmiyar rawa wajen kare lafiyar jiki.
Kwayoyin CD4+ T suna ƙarfafa ƙwayoyin B don gina tsarin rigakafin jiki na ƙwayoyin cuta, kuma CD8+ T yana kashe ƙwayoyin da ke dauke da cutar.
Kwayoyin T masu taimakawa suna samar da sinadarai masu amfani da wuta don taimakawa wajen kare kwayoyin.
Amma CoV na iya lalata aikin T-cell wanda ke haifar da mutuwar T-cell.
Tsarin ruwa na ruwa wanda ya ƙunshi kwayoyin C3a da C5a da kuma tsarin rigakafi na jiki yana da amfani wajen hana kamuwa da cutar.
Alal misali, ƙwayar rigakafi ta mutum daga mai haƙuri da ya warke ta raunana MERS-CoV.
Bugu da ƙari, yawan rigakafin jiki na jiki yana haifar da yawan kwayoyin da ba su da wuri a jiki waɗanda za su iya haifar da lalacewar huhu da sauran gabobin jiki, kuma, a ƙarshe, rashin lafiya, rashin aiki da mutuwa.
Kwayar cutar SARS-CoV-2, wadda aka gano a farkon kamuwa da ita, tana yawan kamuwa da tsofaffi masu fama da wasu cututtuka da kuma mata masu juna biyu.
Mutane da yawa da suka kamu da cutar ko kuma suna da rashin lafiya na jiki suna da haɗarin kamuwa da cutar fiye da sauran.
Matsakaicin kwanakin SARS-CoV-2 a cikin jiki kafin bayyanar cututtuka shine tsakanin 1 zuwa 14 kwanaki, yawanci tsakanin 3 zuwa 7 kwanaki dangane da binciken da aka yi akan marasa lafiya 425 na farko a Wuhan.
Duk da haka, binciken da aka yi a cikin marasa lafiya 1,099 ya nuna cewa lokaci yana daukan kwanaki 3 don bayyanar cututtuka kuma yana faruwa tsakanin kwanaki 0 zuwa 24.
Wani binciken da aka yi kwanan nan, kamar yadda aka ambata a sama, ya nuna cewa lokaci yana daukan kwanaki 4.8 (3,0-7,2) don bayyanar cututtuka bisa ga yawan marasa lafiya 8,866.
Yana da mahimmanci cewa hukumomin kiwon lafiya su tsara lokacin da ya dace don bayyanar cututtuka ta zama mafi mahimmanci, don haka hana masu kamuwa da cutar ba tare da alamun cutar ba.
A al'ada, ana buƙatar keɓewa na kwanaki 14 ga waɗanda suka kamu da cutar ko waɗanda suka kamu da cutar.
Idan aka ƙara tsawon lokacin zuwa kwanaki 24?
Sau da yawa zafi shine babban alamar COVID-19 ta farko, wanda ba zai iya kasancewa tare da wata alama ba ko kuma ya kasance tare da wasu alamomi kamar hawan jini, wahalar numfashi, ciwon hanci, ciwon hanci, ciwon kai, ciwon hanci, yawan mura, ciwon kirji, ciwon hanci, ciwon hanci, ciwon hanci, ciwon hanci da kuma tsokoki.
Wasu marasa lafiya sun sami wahalar numfashi ko kuma rashin iskar oxygen a cikin jini bayan mako guda bayan kamuwa da cutar.
Marasa lafiya masu rashin lafiya sun sami matsala mai tsanani na numfashi, low blood pressure, rashin lafiyar jiki da kuma rashin lafiyar jini.
Dole ne a gwada marasa lafiya da zazzabi ko alamun numfashi da zazzabi, ko da ba su da wata matsala ta huhu.
Binciken a cikin sashin marasa lafiya na ƙarshen Disamba na 2019 ya nuna cewa yawan bayyanar cututtuka ya kasance 98% akan wuta, 76% akan tari, 55% akan matsalolin oxygen da 3% akan numfashi; 8% na marasa lafiya sun nemi injin numfashi.
An kawo irin wannan binciken ne a cikin binciken biyu na baya-bayan nan na masu karɓar haihuwa da kuma waɗanda ba su da alamun cutar.
Kamar wannan binciken, binciken da aka gudanar a shekara ta 2012 kan masu kamuwa da cutar ya nuna cewa masu kamuwa da cutar MERS-CoV sun kamu da zazzabi (98%), kumburi (47%) da rashin iskar oxygen (55%) a matsayin manyan alamomi.
Amma kashi 80% na masu cutar sun nemi injin numfashi fiye da waɗanda ke da cutar COVID-19 kuma yawan mutuwar MERS ya fi na COVID-19.
An kuma lura da ciwon hanci (26%) da ciwon wuya (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, an lura da ƙonewa (99%-100%), ƙonawa (29%-75%), rashin iskar oxygen (40%-42%), tsokoki (20-25%) da ciwon hanci (13-25%) sune manyan alamun cutar a cikin masu haƙuri waɗanda suka nemi injin numfashi na 14%-20%.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 ya kai 2% yayin da aka tabbatar da kamuwa da cutar a duniya a kan 66,576.
Kamar yadda yake a cikin cutar, kamuwa da cutar SARS ya kai kashi 10% na kamuwa da cutar 8,096 a watan Nuwamba na 2002.
A cikin MERS, bisa ga binciken da aka yi a watan Yuni na 2012, yawan mutuwar ya kai 37% na marasa lafiya 2,494 da aka tabbatar.
Wani binciken da aka yi a baya ya nuna cewa yawan adadin kamuwa da cutar SARS-CoV-2 (R0) ya kai 6.47, kuma yawan kamuwa da cutar 95% (CI) ya kai 5.71-7.23, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4 kawai.
Ana samun kwatancen SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun bayyanar cututtuka, yawan mutuwa da R0 a cikin tebur Tebur 1.1.
Bayanai sun nuna cewa SARS-CoV-2 yana da ƙarfin yaduwa fiye da MERS-CoV da SARS-CoV, amma yana kashe mutane da yawa fiye da sauran.
Wannan shine dalilin da ya sa ya fi ƙarfin rigakafin cutar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Sau da yawa, ana samun masu ba da kyauta a cikin iyali ɗaya ko taro ɗaya ko mota ɗaya kamar jirgin ruwa.
Yawancin lokuta, marasa lafiya sun kasance suna tafiya ko zama a cikin lardin Wuhan ko wasu yankunan da aka shafa ko sun sadu da mutane masu kamuwa da cutar ko marasa lafiya a cikin makonni biyu kafin kama su.
Duk da haka, an gano cewa mutane na iya kamuwa da cutar ba tare da bayyanar cututtuka ba har tsawon makonni biyu kuma marasa lafiya da suka warke daga asibiti na iya samun cutar, wanda ke nuna cewa akwai buƙatar tsawaita lokacin daukar hoto.
A cikin kwanaki na farko, marasa lafiya suna da ƙananan ƙananan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Misali, ƙananan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin 1,0909099, wanda aka samu a cikin COVID-19-19 ya samu.
Ƙarin ƙwayoyin cuta na dark matter da ƙwayoyin cuta da miogorbin sun karu a cikin jinin wasu marasa lafiya, kuma ƙaruwar ƙwayoyin cuta da erythrocytes sun karu a cikin jinin marasa lafiya da yawa.
A cikin marasa lafiya, yawan D-dima, ƙwayoyin cuta na jini, da kuma ƙwayoyin cuta na jini sun kasance masu yawa, kuma yawan kwayoyin halitta ya ragu.
Rashin lafiyar ƙwayar cuta ta hanta yana faruwa a cikin yawancin masu cutar COVID-19 kuma ana iya nuna shi ta hanyar ɓoye ɓoye a ɓangarorin biyu ko ƙananan ƙwayar huhu (GGO).
Yawancin lokaci marasa lafiya suna fama da ciwon huhu, ciwon huhu da kuma matsalolin numfashi (ARDS).
Lokacin da akwai rikice-rikice na numfashi (ARDS), yawan zafin jiki, tarin ruwa da kumburi masu zafi suna haifar da mummunar tasiri ga motsi na iska.
Rashin aiki na pinemosites na nau'in I da II yana rage yawan ƙwayar cuta wanda ke rage nisa tsakanin jijiyoyin jiki da kuma haɓaka haɗin gwiwa, don haka rage ƙarfin huhu don cirewa sannan kuma ƙara haɗarin rashin aikin huhu.
Saboda haka, mummunan sakamakon radiation na radiation yana yawanci tare da matsanancin cutar.
A ranar 18 ga Fabrairu, 2020, binciken farko na cutar COVID-19 ya nuna yaduwar cutar pinemosite, kumburi na huhu, ƙwayar cuta mai yawa a cikin iska, da kuma ƙwayoyin cuta masu yawa a cikin huhu na mai haƙuri da cutar, wanda ya dace da tushen kamuwa da cutar da cututtukan numfashi masu tsanani (ARDS), kamar yadda yake a cikin marasa lafiya na SARS da MERS.
An yi amfani da gano RNA na SARS-CoV-2 RNA ta hanyar gwajin RT-PCR a matsayin babban tsari na gwajin COVID-19.
Amma, saboda yawan adadin sakamakon da ke nuna cewa mutum mai tsabta ba shi da gaskiya, wanda zai iya haifar da yaduwar cutar, an fara amfani da alamun a cikin bincike (ba kawai a kan hanyar RT-PCR ba) a China a ranar 13 ga Fabrairu, 2020.
Wannan ya faru ne a gwajin SARS.
Saboda haka, haɗa tarihin cututtuka, alamun cututtuka, gwajin gwaji na dakin gwaje-gwaje da sakamakon gwajin gwaji na da mahimmanci kuma yana da mahimmanci don yin gwajin da ya dace.
A ranar 14 ga Fabrairu, 2020, ƙungiyar da Feng Zhang ke jagoranta ta bayyana wani tsari na amfani da tsarin SHERLOCK wanda ya dogara da CRISPR don gano SARS-CoV-2, wanda ke gano sassan RNA na SARS-CoV-2 a cikin sikelin 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 na shigarwar microlitres) ta amfani da ƙimar amavutta a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai mahimmanci ba.
Ana fatan cewa wannan sabon tsari zai iya inganta ingancin idan aka yi amfani da shi a cikin gwajin likita.
Saboda rashin sanin sabon CoV, likitoci na iya kasancewa kusa da masu cutar COVID-19, yayin da suke gwada magungunan da aka bayar ko kuma ake so kafin magance sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan cuta (Table (Table 2).2).
Wannan magani ya ƙunshi magungunan da za a iya amfani da su tare da maganin rigakafi, maganin hana rigakafi, maganin kumburi, maganin farfadowa daga marasa lafiya, maganin gargajiya na kasar Sin, da kuma maganin zuciya.
Ana so a yi amfani da plasmas daga marasa lafiya masu koshin lafiya don magance cutar.
Kamfanonin samar da magunguna suna aiki ba tare da amfani da su ba don samar da rigakafin jiki da alluran rigakafi na cutar.
SARS-CoV-2 yana kai hari ne ga huhu na farko kuma yana iya kai hari, a ƙananan matakan, ga sauran kwayoyin ACE2 kamar ƙwayar cuta da koda.
Duk da haka, rashin aiki da rashin aiki na numfashi sune matsalolin da ke damun lafiyar marasa lafiya da kuma babban dalilin mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci don rage bayyanar cututtuka da kuma ceton rayuka kuma ya haɗa da ƙara yawan iska, ƙara yawan iska, shigar da na'urar rage numfashi da kuma numfashi na'urar numfashi saboda yanayin rashin lafiya.
Marasa lafiya da ke fama da alamun rashin numfashi mai tsanani dole ne su yi amfani da ECMO, wani magani na karɓar numfashi, wanda ya maye gurbin tsarin numfashi na zuciya da huhu wanda ake amfani da shi wajen magance matsalolin zuciya ko numfashi.
Bugu da ƙari, kula da aikin koda, hanawa da kuma magance wasu cututtuka da kuma ƙananan hawan jini, kula da aikin kwayoyin halitta na musamman ma yana da amfani ga marasa lafiya da SARS-CoV-2.
An san cewa karuwar ƙwayar cuta ta fito ne daga rashin lafiyar jiki a cikin marasa lafiya na SARS da MERS.
Karuwar ƙwayar cuta shine hanyar da ake nunawa ta hanyar gano kwayoyin cuta daban-daban kamar TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wadannan kwayoyin suna sa kwayoyin halitta na jiki su saki yawan kwayoyin halitta marasa ƙarfi wanda shine babban dalilin ARDS da kuma hana aikin kwayoyin halitta.
Rage rashin ƙarfi yana da amfani wajen magance karuwar jini, musamman a cikin marasa lafiya masu rauni.
Ana amfani da corticosteroids da toshilizumab, wanda shine mai tsayayya da IL6 wanda yake da kwayar cutar guda ɗaya, don magance karuwar jini.
Sauran magungunan da ke rage rashin aiki na jiki don magance karuwar ƙwayar cuta sun haɗa da rage ƙarfin rigakafin jiki na T-cell; hana IFN-γ, IL-1, da TNF; hana JAK; cututtuka; rage bayyanar cututtuka na 4 mai suna cytokines; da kuma hana HDAC.
Ana amfani da magungunan rage kumburi, kamar magungunan rage rashin ƙarfi, don magance SARS don rage yawan tasirin rigakafin jiki.
Duk da haka, shan maganin hana kumburi ba shi da tasiri a kan huhu masu ciwon huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, yana iya haifar da matsaloli masu tsanani, musamman cututtukan ƙwayoyin cuta (AVN), wanda ke da tasiri sosai a kan tsarin maganin cututtuka.
Koyaya, ana buƙatar ƙananan allurai na corticosteroids don ba da gajeren lokaci da kuma ingantaccen ilimin ga marasa lafiya masu cutar COVID-19.
A lokacin da aka rubuta wannan rahoto, an gano mutum mai lafiya da ke da rigakafin cutar.
Amma yin amfani da remdesivir, wanda yayi kama da nucleotide, ya tabbatar da amfani ga Amurkawa masu cutar COVID-19.
Remdesivir sabon maganin rigakafi ne da Gilead ta haɓaka don magance cututtukan Ebola da Marlburg.
Daga baya, an gano cewa remdesivir na iya hana sauran kwayoyin RNA, ciki har da MERS da SARS.
Bisa ga bayanan da aka bayar, Gilead ta ba da wannan magani ga China don gudanar da bincike biyu kan mutanen da ke da cutar SARS-CoV-2, wanda ake jiran sakamako mai kyau.
Hakanan an nuna baricitinb, interferon-α, lopinavir/ritonavir da ribavirin don magance cututtukan rashin numfashi mai tsanani.
Ƙarƙashin jiki, ƙyama, tsatsa, ƙarancin ƙwayar cuta da sauran matsaloli masu tsanani da za a iya samu daga haɗuwa da lopinavir/ritonavir.
Dole ne a lura da haɗakar wannan magani da sauran magungunan marasa lafiya.
An cire farsam daga marasa lafiya da suka warke ta hanyar aikin rigakafin jiki
Ana amfani da jinin mutanen da suka warke daga cututtukan cututtuka don magance wasu cututtuka na cututtuka ko kuma don hana marasa lafiya samun cututtuka na dogon lokaci.
Hakika, marasa lafiya da suka warke yawanci suna da ƙwayoyin cuta masu yawa da ke cikin jini.
Maganin garkuwar jiki shine garkin immunoglobulin (Ig) wanda kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwa na musamman wanda ke gano kwayoyin cuta kawai sannan ya kashe su.
Bisa ga abin da aka ambata, an cire plasma daga jinin ƙungiyar masu haƙuri da suka warke daga COVID-19 sannan aka sanya su cikin marasa lafiya 10 masu fama da cutar.
Alamomin sun fara raguwa a cikin sa'o'i 24, tare da raguwar cutar ta kumburi da karuwar adadin ƙwayoyin cuta da oxygen a cikin jini.
Amma ana bukatar a yi bincike don a iya amfani da shi a cikin marasa lafiya da yawa idan ba a yi amfani da magani na musamman ba.
Bugu da ƙari, saboda sakamakon magani, dole ne a bincika wasu sakamako masu illa na plasma da kyau.
Alal misali, tsarin garkuwar jiki zai iya ƙara ƙarfin garkuwar jiki kuma ya haifar da fitowar kwayoyin cuta, waɗanda za su iya zama masu haɗari ga rayuwa.
A yawancin lokaci, ƙwayoyin rigakafi suna da ƙarancin ƙarfi a cikin jini kuma ana buƙatar ƙarin jini don magance cututtukan cututtuka masu tsanani.
Ba shi da sauƙi a samar da tsarin rigakafi na musamman da sauri don magance cutar ta duniya.
Saboda haka, yana da mahimmanci kuma ya kamata a cire kwayar cutar B daga marasa lafiya masu warkewa sannan a sanya lambar rigakafin rigakafi mai ƙarfi ko kuma a bincika rigakafin rigakafin rigakafi wanda ya dace da furotin mai mahimmanci na kwayar cutar.
Don haka, muna iya ƙara yin aikin da zai iya ƙarfafa jikinmu.
An yi amfani da maganin gargajiya na kasar Sin (TCM) don magance cututtuka daban-daban a kasar Sin tun dubban shekaru.
Amma aikinsa ya dogara ne akan haɗa magunguna daban-daban cikin sauyawa ta hanyar bincike na asibiti dangane da hanyar da ake amfani da ita a cikin TCM.
Yawancin magungunan da ke da amfani ba a sani ba ko kuma ba a san su sosai saboda yana da wuya a samu da kuma sarrafa su ko kuma a gwada su.
A yau, saboda rashin takamaiman magani don magance COVID-19, TCM ya zama ɗayan manyan magunguna masu dacewa ga marasa lafiya masu sauƙi da ƙananan alamomi ko marasa lafiya masu sauƙi.
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun tabbatar da cewa za su iya zama masu amfani wajen magance COVID-19.
An sami ƙimar murmurewa a cikin maganin COVID-19 a larduna da yawa na China waɗanda suka yi amfani da TCM a cikin kashi 87% na marasa lafiya na gida, kamar su Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da a lardin Hubei, wanda ya yi amfani da TCM a cikin kusan 30% na marasa lafiya na COVID-19, an sami ƙarancin murmurewa (13%).
Amma wannan kwatanci ne mai kyau saboda akwai wasu dalilai masu tasiri kamar yawan marasa lafiya da lafiyar da za a kula da su a cikin gwajin.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun ba da rahoton binciken da ya kwatanta maganin da ke amfani da magunguna a Turai da Amurka kawai da maganin da ke haɗa WM da TCM.
Sun gano cewa lokutan da ake bukata don dawo da zafin jiki na yau da kullum, warkewar bayyanar cututtuka da kuma asibiti sun fi guntu a cikin rukunin da aka yi amfani da WM+TCM fiye da na WM kadai.
Abin sha'awa, ƙimar ci gaban cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Duk da haka, ana buƙatar ƙarin bincike mai zurfi game da amfani da TCM a cikin mutane da yawa da kuma masana'antu.
Zai zama da kyau a nuna yadda maganin yake aiki da kuma bayyana abubuwan da ke cikin TCM masu amfani a matsayin amfani a matsayin kadai ko a hade idan ya yiwu.
Marasa lafiya da ake zargi ko kuma aka tabbatar da cewa suna da COVID-19 suna yawan jin tsoron cewa cutar tana da matukar yaduwa kuma tana haifar da mutuwa, kuma idan aka killace su, suna fuskantar rashin jin daɗi, kaɗaici da fushi.
Hakanan, alamun kamuwa da cuta kamar zazzabi, rashin numfashi, kumburi da kuma sakamakon miyagun ƙwayoyi kamar rashin bacci na corticosteroid na iya haifar da damuwa mai yawa da kuma rikice-rikice na tunani.
A farkon annobar SARS, an sami cututtukan tunani daban-daban ciki har da damuwa, damuwa, tsoro, damuwa, rashin hankali, damuwa, da son kashe kansa.
Binciken mutane da kuma keɓewa a cikin tsarin COVID-19 na hukumomin kiwon lafiya na gwamnati na iya haifar da damuwa da kuma alhakin sakamakon kamuwa da cuta, warewa da nuna bambanci ga iyalansu da abokai.
Saboda haka, dole ne a ba da sabis na kiwon lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da kamuwa da cutar ta hanyar hulɗa da su da kuma sauran mutanen da ke buƙatar taimako gaba ɗaya.
Taimako na zamantakewa ya kamata ya kasance tare da kafa ƙungiyoyin kula da lafiyar hankali na ƙungiyoyi daban-daban, hanyoyin da za a iya daidaitawa don musayar sabbin bayanai na yau da kullun game da cutar SARS-CoV-2 da hanyoyin kula da marasa lafiya da kuma amfani da kayan aiki da aikace-aikacen fasaha don hana mutane kusanci.
Ana buƙatar allurar rigakafi mai inganci don hana kamuwa da cutar tsakanin dabbobi masu cutar da mutane masu kamuwa da cutar da sauran dabbobi ko mutane masu yuwuwar kamuwa da cutar kuma galibi suna haɗuwa da maganin rigakafin cutar don magance cututtukan da ke haifar da sabon kwayar cutar.
An riga an yi ƙoƙari don samar da allurar rigakafin S-protein don gina tsarin rigakafin jiki na dogon lokaci ko haɓaka ƙarfin jiki don magance SARS-CoV.
An gwada allurar rigakafin cutar a cikin dabbobi akan SARS.
Amma amfanin wannan rigakafin ga dabbobi ko tsofaffi masu rai da kuma masu rashin lafiya da kuma hana su kamuwa da ƙwayoyin cuta na dabba ba za a iya gano su ba sai da bincike na likita.
Wannan na iya kasancewa saboda an shafe shekaru 17 ana cutar SARS kuma babu wanda ya kamu da cutar.
A gefe guda kuma, ƙananan cututtukan MERS suna ci gaba da kasancewa a Gabas ta Tsakiya kuma cutar ta bazu zuwa wasu yankuna saboda dabbobi suna ci gaba da kamuwa da mutane a yankunan da cutar ke.
An tsara matakan rigakafin MERS ta amfani da kwayar cutar da aka hana aiki, purasimides na DNA, kwayoyin cutar, kwayoyin cuta masu yawa, kwayoyin cuta masu kama da kwayar cuta da kuma kwayoyin furotin da aka gano kuma an bincika wasu daga cikin waɗannan matakan a cikin dabbobi.
Yin ingantaccen kuma ingantaccen allurar rigakafin SARS-CoV-2 a cikin mutane marasa kariya ta jiki yana da mahimmanci da gaggawa don magance cutar.
Amma wannan matsala ba ta da sauƙi saboda tsawon lokaci (kimanin watanni 18) da ake buƙata don samar da rigakafi da kuma canjin CoVs.
A matsayin sabon cuta, COVID-19 ya fara nuna yadda za a bi da dubban marasa lafiya.
Sau da yawa, marasa lafiya suna iya warkewa ba tare da yin wani abu ba.
Amma, kamar SARS da MERS, COVID-19 yana ɗaukar mutane da yawa kuma yana kashe mutane da yawa a cikin marasa lafiya masu cutar.
Saboda haka, samar da hanyoyin magance cutar yana da mahimmanci don asibitoci da asibitoci su iya amfani da ayyukan su yadda ya kamata ko kuma a wuraren da ba a da isasshen kayan aiki.
Dangane da binciken asibiti da aka gudanar har zuwa yanzu, waɗannan abubuwan na iya tasiri ko haifar da ci gaban COVID-19 (Table (Table 33):
Shekaru: Shekaru sune babban mahimmin abin da aka samu don nazarin ci gaban SARS, kamar yadda yake tare da COVID-19.
COVID-19 ya fi shafar mutanen da ke tsakanin shekaru 30 zuwa 65 wanda kashi 47.7% na su sun wuce shekaru 50 a cikin binciken da aka yi akan marasa lafiya 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da suka nemi a yi musu asibiti a cikin asibiti suna da ƙarin cututtuka da matsaloli kuma sun fi tsofaffi fiye da waɗanda ba su yi musu ba (a cikin matsakaicin shekaru 66 zuwa 51), wanda ke nufin cewa shekaru suna da tasiri a cikin yawan mutanen da ke fama da COVID-19.
Jima'i: A cewar wani bincike, maza sun fi kamuwa da SARS-CoV-2 (0,31/100 000) fiye da mata (0,27/100 000).
Rashin lafiya da rashin lafiya: Marasa lafiya da ke da cutar COVID-19 da ke neman asibiti na gaggawa galibi suna da cututtukan zuciya masu tsanani da ke haifar da ciwon zuciya.
Hakanan aikin zuciya ya zama babban dalilin mutuwar SARS.
An gano cewa SARS-CoV-2 na iya kamuwa da kwayoyin cutar kwayar cutar da ke dauke da ACE2, wanda zai iya haifar da rikice-rikice a cikin marasa lafiya na COVID-19.
Ya kamata a ce shekarun da mutum yake ciki yana da haɗari sosai kuma yana iya shafar shi.
Ƙididdigar lab na musamman: Matsayin ƙwayar cuta mai ƙarancin ƙwayar cuta (CRP) a cikin jini yana nuna fushin ƙwayar cuta ko ƙwayar cuta kuma an nuna cewa yana iya zama ɗayan abubuwan da ke cikin maganin cuta, yadda magani yake karɓa da kuma murmurewar mai haƙuri.
An kuma gano alaƙar da ke tsakanin CRP da cutar COVID-19 da kuma ci gaba.
Bugu da ƙari, yawan adadin LDH, AST, ALT, da CK na iya taimakawa wajen sanin abin da za a yi maganin cutar.
Wadannan cututtuka suna da kyau a cikin kwayoyin halitta, musamman a zuciya da kuma cikin duhu, kuma suna saki lokacin da aka lalata sassan jiki.
Saboda haka, suna nuna alamun cututtukan zuciya ko kuma duhu.
Muhimman alamomi: An yi amfani da na'urar rigakafi ta hanta da kuma alamun bayyanar cututtuka na ɗan lokaci waɗanda dole ne a kula da su da sauran matsalolin da ake samu a cikin shirin magance matsalolin COVID-19.
Amfani da maganin rigakafi: Kamar yadda aka ambata a sama, maganin rigakafi maganin rigakafi ne wanda aka fi amfani dashi azaman magani na gaba don magance cututtukan cututtuka don rage yawan tasirin rigakafi.
Saboda an yi amfani da yawan adadin corticosteroids da aka samu a cikin marasa lafiya masu cutar SARS, yawancin marasa lafiya sun sami nasarar warkewa daga cutar ƙashin ƙashi da ke tattare da nakasa da rashin lafiya.
Saboda haka, idan ya cancanta, masu cutar COVID-19 dole ne su sha ƙananan allurar rigakafi na ƙarancin lokaci.
Rashin hankali: Kamar yadda aka ambata a sama, a lokacin annobar COVID-19, yawancin marasa lafiya sun sami gajiya ta musamman saboda dogon lokaci na keɓewa da matsanancin damuwa da kuma mutuwar dangin da suka kamu da cutar.
Yana da muhimmanci a ba wa waɗannan marasa lafiya shawara mai kyau da kuma taimako na dogon lokaci don taimaka musu su warke daga gajiya da kuma komawa zuwa rayuwa ta al'ada.
A cewar binciken da aka yi a kan marasa lafiya, COVID-19 yana da alamun da suka bambanta da SARS.
Baya ga cutar ta hanta, SARS-CoV-2 na iya shiga cikin hanta da hanta da kuma bayyanar cututtuka masu sauƙi ko marasa kyau a farkon kwanakin kamuwa da cutar, kamar yadda yake tare da sauran ƙwayoyin cuta na CoVs na yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon kwanaki ko kuma lokacin da alamun cutar suka bayyana suna iya samun ƙimar ƙwayoyin cuta da ke aiki na yau da kullun, wanda ke ƙarfafa ƙarfin rigakafin cutar.
Amma an nuna cewa kamuwa da SARS-CoV yana faruwa ne a lokacin rashin lafiya, saboda yawancin masu kamuwa da cutar ba su da tsabta a farkon kwanakin.
Wannan shine dalilin da ya sa COVID-19 ya fi tsanani da kuma tsananin cutar fiye da SARS.
A halin yanzu akwai wasu matakan da ake ɗauka a kasar Sin kamar tsare-tsaren gida a Wuhan da garuruwan da ke kewaye da ita da kuma ci gaba da keɓewa kusan dukkanin jama'a don hana yaduwar SARS-CoV-2.
Duk da cewa wadannan matakan sun shafi tattalin arziki da sauran bangarorin da ke aiki a kasar, adadin sabbin cututtuka na raguwa, wanda ke nuna cewa annobar tana raguwa.
Wani misali mai ban sha'awa shi ne, cutar za ta ƙare a watan Maris, kuma lokacin da mutane ke komawa rayuwa na tsawon watanni 3 zuwa 4.
Amma, wasu masana ba su da wannan tabbacin.
Paul Hunter da abokan aikinsa sun gano cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare ba a shekarar 2020.
Ira Longini da abokan aikinsa sun tsara tsarin tsara yadda cutar za ta ƙare kuma sun ce SARS-CoV-2 na iya ɗaukar kashi biyu bisa uku na yawan duniya.
Wani rukuni na Kanada ya ba da rahoton cewa an gano SARS-CoV-2 a cikin gwajin huhu da hanci na marasa lafiya waɗanda suka warke bayan makonni 2 daga asibiti, wanda ke nuna yiwuwar sake dawowar sabon kwayar cutar a matsayin cutar mura ta yau da kullun.
Amma akwai wasu alamun da suka nuna cewa akwai kyakkyawan sakamako a kasar Sin dangane da raguwar yawan sababbin cututtuka, wanda ke nuna cewa matakan da aka dauka na iya zama masu tasiri.
Da farko dai an ce mutane miliyan daya za su kamu da cutar Ebola kuma mutane dubu dari biyar za su mutu.
Amma saboda tsauraran matakan ware mutane, an yi nasara wajen kawar da cutar.
Kamar SARS-CoV, yana yiwuwa mutane da yawa ba su kamu da SARS-CoV-2 ba, sannan ya zama ƙarancin ko kuma ƙarancin cutar da ke kashe mutane.
Ana iya samun kwatancen cutar COVID-19 da SARS da MERS a cikin wannan bayanin (Figure (Figure 55).
SARS-CoV-2 yana kamuwa da cutar ta hanyar tari ko kumburi, kuma mutum na iya kamuwa da cutar ta hanyar taɓa abubuwan da ke cikin kwayar.
An gano kwayar cutar a cikin matattarar, wanda ke nufin akwai yiwuwar sabuwar hanyar da za ta iya kamuwa da ita ta taɓa bakin mutum a matattarar.
Wani binciken da aka yi kwanan nan a kan marasa lafiya 138 ya nuna cewa kashi 41% na marasa lafiya na iya kamuwa da cutar ta asibiti, ciki har da marasa lafiya 17 da suka kamu da wasu cututtuka da likitoci 40.
Saboda haka, ana bukatar ƙarin hankali don kare mutane, musamman likitoci, masu ba da magani, 'yan'uwa marasa lafiya, abokan aiki, da kuma masu tafiya da ke fuskantar masu rashin lafiya ko kuma waɗanda suka kamu da cutar.
Hanyar farko da za a iya amfani da ita don rage haɗarin kamuwa da cuta ita ce sanya abin rufe fuska; amfani da abin rufe fuska na likita da abin rufe fuska na N95 (sashin # 1860s) yana taimakawa wajen hana yaduwar cutar.
Masks na likita suna taimakawa wajen hana saukad da daga wanda zai iya kamuwa da cutar daga iska ko kuma daga abubuwa, daga nan zuwa wasu.
Amma kawai N95 masks (sashin # 1860s) zasu iya hana mutum hawan kwayar cutar da ke cikin iska daga 10 zuwa 80 nm, 5% na ƙwayoyin cuta ne kawai zasu iya shiga; SARS-CoV-2 yayi daidai da SARS-CoV a girma kuma duka biyu sun kai 85 nm.
Saboda akwai wasu sassan da za su iya wucewa ta hanyar masks na asibiti guda biyar a jere, likitoci da ke tuntuɓar marasa lafiya akai-akai suna buƙatar saka masks na N95 (sashin # 1860s) maimakon masks na asibiti.
Baya ga sanya abin rufe fuska, likitoci suna bukatar su sa tufafi da aka tsara don rage haɗarin kamuwa da cutar.
Kwayar cuta na iya kama mutum ta fuskarsa.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa ya sa abin rufe fuska na N95; wanda ke nufin cewa kwayar ta shiga jikinsa ta fuskarsa.
Saboda haka, likitoci suna bukatar su saka kayan kāre fuskokinsu ko kuma tabarau na gani na musamman yayin kula da marasa lafiya.
Ga mutane da yawa da ke zaune a yankunan da cutar ta shafa ko kuma waɗanda za su iya kamuwa da cutar, yana da matukar muhimmanci kowa ya wanke hannayensa sau da yawa tare da sabulu mai magani, ya yi ƙoƙarin ware kansa, ya zauna a gida kuma ya guji haɗuwa da waɗanda za su iya kamuwa da cutar.
Ina da mita biyar da ya kamata mutane su ajiye a tsakanin su da mai haƙuri.
Wadannan ayyuka suna da tasiri wajen rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya shigo cikin mutane a matsayin sabon kwayar cuta, kasancewarsa da kamanceceniya da SARS-CoV kamar yadda aka sanar a ranar 7 ga Janairu, 2020 ya kamata ya sa China ta kasance cikin damuwa saboda abin da ta yi tun daga annobar SARS ta 2003.
Duk da haka, a ranar 19 ga Janairu, 2020, shugaban Cibiyar Kula da Cututtuka ta Wuhan ya ƙarfafa jama'a cewa sabon kwayar cutar ba ta da ƙarancin kamuwa da cuta kuma mutane ba su da ƙarancin kamuwa da cuta don haka yaki da cutar ba matsala ba ce.
Wannan sakon ya rage yawan fargaba a cikin al'umma, musamman yayin da duk kasar ke shirin bikin al'adun Spring Festival, kuma damar hana cutar a Wuhan ta lalace.
Cibiyoyin yaki da cututtuka a kasar Sin na iya koyon darasi daga wannan muhimmin darasi kuma su yi canje-canje masu muhimmanci a nan gaba.
Misali, waɗannan cibiyoyin dole ne su (1) zama masu hankali wajen yin sanarwa ga jama'a saboda jama'a suna kula da kowane kalma sannan su canza halayensu da shawarwarin su; (2) su ci gaba da bin bayanan asibitoci na musamman da kuma yanke shawara mai kyau maimakon jiran rahotanni na likitoci ko hukumomi na yau da kullun; (3) su ɗauki ƙarin matakan hana duk wani annoba na faruwa maimakon ƙoƙarin ƙarfafa jama'a; da kuma (4) shirya horo na musamman na musamman don taimakawa jama'a su fahimci yanayin cututtukan cututtuka da kuma gwadawa da inganta matakan magance su a lokuta daban-daban.
Cutar COVID-19 da sabon kwayar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, an riga an faɗaɗa shi a duk ƙasar Sin da kuma wasu ƙasashe 50 a duniya a lokacin da muke rubuta wannan rahoton.
Saboda wannan kwayar cutar tana kama da SARS-CoV kuma alamun cutar suna kama da COVID-19 da SARS, annobar COVID-19 ta haifar da tunanin cewa SARS ya dawo.
Amma akwai bambance-bambance a tsakanin COVID-19 da SARS, waɗanda ke da amfani wajen hana cutar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa kuma ya fi rinjayar maza fiye da mata, kuma yawan mutuwar da ke faruwa a cikin tsofaffi ya fi na matasa.
SARS ya fi kashe mutane fiye da COVID-19 (10,91% zuwa 1,44%).
Masu kamuwa da COVID-19 suna yada kwayar cutar yayin da babu alamun bayyanar cutar kuma masu kamuwa da SARS galibi suna kamuwa da cutar yayin da suke cikin rashin lafiya, wanda ke haifar da hana yaduwar COVID-19 da ƙarfi fiye da SARS.
Wannan yana daga cikin dalilan da yasa SARS-CoV-2 ke yaduwa da sauri da kuma fadin yanki fiye da SARS-CoV.
Gwajin RNA da aka amince da shi don SARS-CoV-2 na iya zama mara ƙarancin kamuwa da cutar a cikin wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke za su iya sake kamuwa da cutar.
Duk wannan yana ƙara haɗarin yaduwar kwayar cutar.
Duk da wannan matakin da binciken COVID-19 ya kawo, har yanzu ana buƙatar amsa wasu mahimman tambayoyi masu zuwa:
Daga ina SARS-CoV-2 ya fito?
Duk da cewa akwai daidaituwa a kashi 96% tsakanin SARS-CoV-2 da kwayoyin cuta biyu na CoVs masu kama da SARS waɗanda ke fitowa daga mura, ba za mu iya tabbatar da cewa SARS-CoV-2 ya fito ne daga mura ba.
Wane dabba ne ya fara kamuwa da cutar ta dabba, wato, ƙwayoyin cuta, kuma ya kamuwa da mutane?
Idan ba mu san amsoshin tambayoyi 1 da 2 ba, ba za mu iya hana yaduwar cutar ba, kuma cutar za ta iya dawowa a kowane lokaci.
Ko da yake binciken kwayoyin halitta da na jiki ya nuna cewa SARS-CoV-2 yana da tasiri akan ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin cuta kuma ta haifar da canje-canje masu zuwa?
Shin kwayar cutar tana kama kwayoyin halitta da ke samar da ACE2 a wasu gabobin jiki?
Idan ba mu sami amsoshin waɗannan tambayoyin ba, ba za mu iya gano cutar nan da nan da kuma yadda ya kamata ba.
Har yaushe cutar za ta kasance?
Ta yaya yanayin kwayar cutar ke canzawa yayin da ta yadu cikin mutane?
Shin zai zama annoba ta duniya, ko kuwa zai zama annoba kamar SARS ko kuma zai sake zama annoba?
Neman amsoshin waɗannan tambayoyin da kuma wasu tambayoyi da yawa yana da muhimmanci amma yana iya ɗaukar lokaci.
Amma duk abin da zai iya faruwa, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mutane su koma rayuwa ta al'ada.
Dabbobin da suka kamu da cutar coronavirus a cikin mutane
Canji da daidaitawa sun haifar da canji a cikin coronavirus (CoVs) na mutum ko dabba, tsawon dubban shekaru.
Kafin 2003, an san cewa CoVs (HCoVs) biyu masu cutar mutum suna haifar da ƙananan cututtuka, kamar mura ta yau da kullun.
Cutar mura mai tsanani (SARS) da cutar mura ta Gabas ta Tsakiya (MERS) sun canza yanayin yadda cutar HCoV ke da tasiri mai tsanani da haɗari ga rayuwa.
Cutar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ta sake haifar da ƙarin maganganun CoVs a cikin kafofin watsa labarai kuma ta ba mu mamaki saboda yanayin da ke da yawa amma ƙarancin yiwuwar kamuwa da cutar idan aka kwatanta da takwaransa SARS-CoV.
HCoV cuta ce ta dabba don haka sanin asalin dabbobi na HCoVs zai taimaka mana.
Yawancin HCoVs sun fito ne daga ƙudan zuma kuma ba su da cututtukan cututtuka.
Ba a san dabbobi da aka riga aka kamu da su ba da wasu HCoVs.
Sanin dabbobi yana da tasiri a kan rigakafin cututtuka da ke kamuwa da mutane.
Binciken hulɗar dabbobi da CoV na iya zama da amfani wajen gano yadda CoV ke kamuwa da cutar a cikin mutane.
A cikin wannan bita, za mu ba da taƙaitaccen bayani game da HCoVs bakwai, tare da mai da hankali kan tarihin asalin dabbobi da yadda suka yadu tsakanin jinsuna daban-daban.
Abu mai mahimmanci shine idan muka kwatanta HCoVs daban-daban muna mai da hankali kan yadda kwayar cutar ke canzawa da yadda kwayoyin halitta ke bayyana kansu.
Ana nazarin cutar COVID-19 ta 2019 a wannan sashin.
Bugu da ƙari, an nuna takardun da ake buƙata don kamuwa da cutar ta hanyar tasirin juyin juya halin ƙwayar cuta.
Kwayoyin cutar Coronaviruses (CoVs) suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin RNA masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta.
Wadannan ƙwayoyin cuta suna da manyan kwayoyin cuta masu nauyin kilowaje 26 zuwa 32 a cikin ƙwayoyin RNA da ake kira CoVs saboda suna kama da ƙwayoyin cuta a cikin microscopes na lantarki.
A cikin tsarin kwayoyin halitta, CoVs suna da kwayoyin halitta marasa sassan da suka dace.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan kwayoyin halitta guda biyu (ORF1a da ORF1b) waɗanda ke haifar da sunadarai pp1a da pp1ab masu amfani daban-daban.
Ana kuma samar da furotin 16 da ba su da amfani a kowane wuri, wanda ake kira nsp1~16.
Sauran ɓangaren kwayoyin halitta sun ƙunshi ORFs na kwayoyin halitta masu kama da juna, ciki har da S, E, M, da kuma nucleoproteins.
Abubuwan da ke cikin kwayoyin cuta da yawa suna da nasaba da kuma tsarin CoVs daban-daban.
Dangane da bambancin tsarin furotin, CoVs sun rarraba zuwa nau'i huɗu (alfa-CoV, beta-CoV, gama-CoV da delita-CoV), kuma nau'in beta-CoV shine mafi yawan HCoVs kuma ya rarraba zuwa nau'i huɗu (A, B, C da D).
Bayanai na asali sun nuna cewa tsutsotsi da tsutsotsi sune asalin mafi yawan alpha-CoVs da beta-CoVs, kuma tsuntsaye sune mafi yawan alƙaluma tare da gamma-CoVs da delita-CoVs.
A cikin dubban shekaru, CoVs sun kasance masu yawa kuma wasu daga cikinsu sun zama manyan ƙwayoyin cuta masu cutarwa.
A halin yanzu, an san nau'ikan CoVs (HCoVs) guda bakwai da ke ɗaukar mutane.
Wannan ya ƙunshi HCoV-229E da HCoV-NL63 waɗanda aka haɗa a cikin alf-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar sankarar cuta mai tsanani (SARS-CoV), cutar sankarar cuta ta Gabas ta Tsakiya (MERS-CoV), da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da ƙananan alamomi, kamar mura na yau da kullun ko kumburi.
A gefe guda, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan sune ƙwayoyin cuta masu cutarwa, waɗanda ke haifar da cututtukan huhu masu tsanani a cikin marasa lafiya da yawa waɗanda ke da haɗarin ciwon cutar numfashi mai tsanani (ARDS) da cututtukan huhu.
An gano nau'in farko na HCoV-229E, B814, a cikin hanci na marasa lafiya na mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin haske daga zurfin binciken HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun kamuwa da cuta.
Haka ne, yawancin mutane sun yarda cewa cutar da HCoVs ke haifarwa ba ta da tasiri har zuwa barkewar cutar SARS.
Cutar SARS ta 2003 ta kasance daya daga cikin cututtukan cututtukan da suka fi tsanani a tarihin kwanan nan, tare da mutuwar kusan kashi 10 cikin dari na mutane 8,000.
Shekaru goma bayan haka, cutar mura ta Gabas ta Tsakiya (MERS) ta haifar da cutar da ke yaduwa a yankin Larabawa kuma a wasu lokuta ta yadu zuwa sauran sassan duniya.
Sabon HCoV 2019 (2019-nCoV), wanda aka sake suna da SARS-CoV-2, shine tushen cutar coronavirus 2019 (COVID-19) ta yau, wanda ya kashe mutane 3,120 kuma ya kama sama da 91,000 a ranar 2 ga Maris, 2020.
An yi gargadin mutane game da yadda duniya za ta kasance a shirye don annobar SARS-CoV-2 mai zuwa.
Dukkanin HCoVs bakwai sun fito ne daga tsutsotsi, beraye ko dabbobi.
Akwai hujjoji da yawa da ke nuna cewa HCoVs sun fito ne daga ƙwayoyin cuta, kuma ƙwayoyin cuta suna da ƙarancin ƙwayoyin cuta amma suna nuna cewa suna da nau'ikan kwayoyin halitta daban-daban.
Cutar COVID-19 ta haifar da manyan matsaloli a fannin kiwon lafiya, ilimi, zamantakewa da ɗabi'a a China da duniya.
Gano asalin HCoVs yana ba da damar fahimtar tarihin halitta, dalilai da shingen tseren.
Wannan na iya taimakawa ko sauƙaƙe aikin gano dabbobi masu cutar SARS-CoV-2, wanda ya riga ya kamu da cutar, wanda ya haifar da yaduwar cutar, wanda zai iya haifar da tasiri mai yawa wajen hana yaduwar ta nan gaba.
A cikin wannan binciken, za mu ba da taƙaitaccen bayani game da asalin HCoVs a cikin dabbobi, yadda suke yaduwa tsakanin jinsuna daban-daban da kuma hanyoyin da suke haifar da cututtuka.
Musamman, muna nunawa da kuma nazarin furcin da aka saba cewa ƙwayoyin cuta masu haifar da HCoVs ba su haifar da cututtukan dabbobi ba amma suna haifar da cututtukan da aka kamu da su a cikin mutum ko sabon dabba bayan sun bazu zuwa nau'ikan daban.
Muna nazarin yanayin HCoVs inda yawan yaduwar yana yawan kasancewa tare da raguwar yiwuwar kamuwa da cutar.
A cikin wannan sashin muna kuma nazarin sakamakon cutar SARS-CoV-2 ta yau.
CoVs sun kama dabbobi da aka sani tun daga ƙarshen 1930s.
Kafin a fara gano wani nau'in asalin HCoV-229E, B814, a cikin hanci na masu cutar mura na yau da kullun, an gano nau'ikan CoVs daban-daban daga dabbobi masu kamuwa da cutar daban-daban, kamar namomin kaza, beraye, shanu, aladu, cats da karnuka.
A cikin shekaru goma da suka gabata, an gano HCoVs bakwai.
Bayanan tarihin gano HCoVs (Table 1) yana ba da bayanai da halayen mutane.
An fara gano nau'in HCoV-229E a cikin huhu na marasa lafiya masu cutar huhu a cikin hanci da hanci a shekara ta 1966, sannan daga baya ya zama sananne don girma a cikin ƙwayoyin huhu na WI-38.
Marasa lafiya da ke dauke da cutar HCoV-229E sun nuna alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Daga baya a 1967, an gano HCoV-OC43 a cikin kwayoyin halitta kuma ya bayyana a cikin kwakwalwar beraye masu cutar.
Alamomin asibiti na cutar HCoV-OC43 suna kama da HCoV-229E, wanda ba za a iya rarrabe shi da sauran ƙwayoyin cuta na huhu kamar ƙwayoyin cuta na tashi da ƙwayoyin cuta na yau da kullun ba.
HCoV-229E da HCoV-OC43 suna samuwa a duk duniya, kuma suna yaduwa sosai a lokacin bazara a lokutan da suka gabata.
Yawanci, lokaci yana daukan aƙalla mako guda kafin bayyanar cututtuka biyu su bayyana, sannan kuma ana samun cutar a cikin mako 2.
A cewar binciken da aka yi a kan mutane masu son rai, mutanen da ba su kamu da cutar HCoV-229E ba sun kamu da cutar mura ta yau da kullun.
Wasu marasa lafiya da ke fama da cututtukan jiki na yau da kullum sun kamu da cututtukan huhu na yau da kullum.
SARS, wanda aka fi sani daumusonga na musamman, shine cutar HCoV ta farko da aka bincika sosai a tarihin ɗan adam wanda ya haifar da SARS-CoV, HCoV na uku.
An fara gano cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta kama mutane 8,096 da aka tabbatar da cutar kuma ta kashe 774, kuma ta bazu cikin ƙasashe da nahiyoyi da yawa.
Baya ga cututtukan cututtuka masu tsanani, an nuna cewa kowane mai haƙuri zai iya kamuwa da cututtuka kamar mutane biyu, lokacin da ya ɗauki alamu ya kasance tsakanin kwanaki 4 zuwa 7 sannan cutar ta zama mafi tsanani a rana ta 10 na kamuwa da cutar.
Masu kamuwa da SARS-CoV sun fara da ciwon gwiwa, ciwon kai, zafi, rashin jin daɗi da kuma tari, sannan kuma wahalar numfashi, kumburi da kuma matsalolin numfashi masu tsanani kamar yadda alamun suka bayyana daga baya.
Ragewar kwayoyin halitta, rashin ingancin gwajin duhu da kuma karuwar creatinine mai tsanani sune matsalolin SARS a cikin dakin gwaje-gwaje.
Rashin lafiyar iska mai tsanani (DAD), yaduwar ƙwayar epithelial da kuma karuwar ƙwayar garkuwar jiki na iya bayyana a cikin marasa lafiya na SARS.
Kimanin kashi 20-30 cikin dari na marasa lafiya suna buƙatar asibiti na gaggawa da kuma na'urorin numfashi.
Baya ga wuraren numfashi na huhu, ana iya samun cututtukan jiki daban-daban kamar su cututtukan jini, duhu da koda a cikin waɗannan marasa lafiya masu rauni, galibi tare da haɓakar sitokin, wanda zai iya haifar da mutuwa musamman a cikin marasa lafiya masu rashin lafiyar jiki.
An fara gano cutar a cikin wani yanki na huhu na mai haƙuri wanda aka fara gano cutar daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an sami ci gaba mai yawa a cikin binciken HCoV.
An gano HCoV-NL63 a cikin jariri na watanni 7 a cikin Netherlands a ƙarshen 2004.
An fara bayyana shi a cikin yara, manya da kuma marasa lafiya masu rashin lafiya na jiki da kuma cututtukan huhu.
HCoV-NL63 yana haifar da hauka a hanci, ja a idanu, ƙonewa a idanu da kuma boroncioritis.
Wani bincike na musamman ya nuna cutar a cikin gwajin hanci na wani yaro mai watanni 8 da ke fama da ciwon kumburi a Netherlands.
Ko da yake an samo shi a Netherlands, a gaskiya ana samun shi a duk duniya.
HCoV-NL63 an kiyasta yana haifar da kusan kashi 4,7% na cututtukan huhu na yau da kullun, kuma yana da mahimmanci a farkon bazara, hunturu da bazara.
HCoV-NL63 yana da alaƙa da cutar ta hanta wanda ke haifar da tashin hankali a cikin hanci da hanci.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da haihuwa wanda ke asibiti tare da ciwon sukari da boronchioritis a Hong Kong.
Baya ga cutar sankara da boron choriosis, an ruwaito cewa HCoV-HKU1 yana haifar da rashin lafiya a cikin masu fama da cutar sankara.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duniya, yana haifar da ƙananan cututtukan numfashi.
Dukkanin HCoVs huɗu suna ɗaukar nau'ikan saboda sun saba da rayuwa a cikin mutane kuma gabaɗaya ba su da inganci don haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
A gaba ɗaya, idan HCoVs sun sami damar yadawa da kasancewa cikin mutane, suna da ƙarancin hauka ko ƙarancin iyawar kamuwa da cutar.
An fara gano MERS-CoV a cikin huhu na wani mai shekaru 60 da haihuwa mai fama da ciwon koda mai tsanani a Saudiyya a shekarar 2012.
Yayin da aka gano yawancin marasa lafiya da gwajin gwaji daga Gabas ta Tsakiya, an gano masu kamuwa da cutar daga wasu ƙasashe a Turai da Tunisia.
Wani karamin annobar cutar da ta barke a Koriya ta Kudu a shekarar 2015 ya kai mutane 186.
Alamun asibiti na MERS suna kama da SARS, wanda ake nunawa ta hanyar cutar ta tsananin zafin jiki.
Bayan SARS, masu cutar MERS sun sami cututtukan koda masu tsanani, kuma har yanzu MERS ce ta musamman a cikin cututtukan HCoV.
Fiye da kashi 30% na marasa lafiya suna nuna alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Tun daga 14 ga Fabrairu, 2020, an gano fiye da 2500 marasa lafiya ta hanyar gwajin gwaji tare da jimillar mutuwar 34,4%, yana mai da MERS-CoV ɗayan ƙwayoyin cuta masu mutuwa da aka sani har zuwa yau.
Daga tsakiyar 2019 zuwa ƙarshen Disamba, an gano mutane da ke da ciwon kumburi wanda aka sani da shi don kamuwa da SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta bayyana cutar ta SARS-CoV-2 a matsayin bala'in kiwon lafiya mai matukar damuwa da ke damun duniya wanda ke kiran cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar a duniya da mutane 90,053, wanda ya kai kashi 3.4 cikin dari na mutuwar.
A wannan matakin, yawan mutuwar a Hubei, China, ya kai kashi 4.2%, kuma a wajen lardin ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Wasu marasa lafiya suna fama da ciwon daji.
Rashin ƙarfi yana cikin alamun bayyanar cututtuka kuma yana iya haifar da rashin lafiya mai tsanani da kuma matsalolin numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda yawan abubuwan da suka dace da tsarin nucleotide na 82%, suna da rassa daban-daban a cikin asalin.
SARS-CoV-2 yana da ƙananan cututtukan cututtuka amma yana da yawa fiye da SARS-CoV da MERS-CoV.
An gano mutane marasa cutar SARS-CoV-2 ba tare da alamun bayyanar cututtuka ba kuma suna iya kasancewa cikin haɗarin yaduwar sauri a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs shida, akwai kamanceceniya da bambance-bambance da ya kamata a kula da su.
Na farko, lokaci da ake bukata don bayyanar cututtuka da tsawon lokacin kamuwa da cutar HCoV suna da alaƙa sosai.
A wannan matakin, SARS-CoV-2 yana bin jerin sunayen sauran HCoVs shida.
Na biyu, yanayin bayyanar cututtukan COVID-19 yana tsakanin SARS-CoV da HCoVs huɗu masu ɗaukar nau'in dangane da wurin da suke (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, SARS-CoV-2 yana nuna alamun bayyanar cututtuka waɗanda suka fi dacewa a lokacin kamuwa da HCoVs na ɗaukar nau'in dangane da wurin, kamar su bayyanar cututtuka na musamman, na asali ko ma ba haka ba.
Hakanan, ƙananan adadin mutanen da ke da cutar COVID-19 na iya kasancewa a lokacin cutar SARS-CoV, duk da cewa ƙimar ta ɗan ƙasa.
Na uku, yaduwar SARS-CoV-2 kuma yana nuna yanayin da ya kamata a kula da shi na gano HCoVs da ke ɗaukar nau'in saboda yanayin SARS-CoV.
A gefe guda, yaduwar SARS-CoV-2 tana da aƙalla daidai da HCoVs da ke ɗaukar nau'in dangane da wurin da suke.
A gefe guda kuma, har yanzu ana buƙatar bincika ko yaduwar SARS-CoV-2 ta ragu bayan kamuwa da cutar kamar yadda yake tare da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 ta hanyar gwajin gwaji.
Dole ne a bincika ko yaduwar SARS-CoV-2 a cikin ƙwayar cuta da kuma cikin magungunan baka yana da tasiri kamar yadda SARS-CoV yake a akalla a wani wuri.
Hakanan yana da mahimmanci a bincika musamman ko SARS-CoV-2 na iya bayyana a yanayi daban-daban kamar yadda yake tare da HCoVs waɗanda ke ɗaukar nau'in dangane da wurin da suke.
Koyaya, alamun SARS-CoV-2 sun haɗa da yadda ake yaduwa, yiwuwar kamuwa da cutar da kuma ci gaba da yaduwar mutum wanda zai iya taimakawa wajen kawo ƙarshen cutar ta COVID-19.
HCoVs suna ɗaukar nau'in saboda yanayin su duka huɗu suna da alamun bayyanar cututtuka waɗanda suka dace da mutane.
A gefe guda kuma, yana yiwuwa cewa a zahiri mutane ne suka sami damar daidaita HCoVs huɗu.
A wasu kalmomin, dukansu na iya tsira daga cutar HCoV ta baya.
HCoVs suna haifar da cututtukan cututtuka masu tsanani da kuma mutuwar mutane masu cutar HCoV.
Don yin hakan, kwayar cutar mutum (HCoV) tana samar da isasshen kwayoyin halitta don ganin yadda suka lalata furotin na jikin da ke hana kwayar cutar girma.
Saboda haka, yayin da cutar SARS-CoV-2 ke ɗaukar lokaci kuma tana ɗaukar mutane da yawa, akwai haɗarin cewa za ta saba da jikin mutum.
Idan aka yi amfani da shi yadda ya kamata, zai yi wuya a hana kamuwa da cutar ta hanyar hanawa ko kuma wasu matakai.
A cikin shekaru da yawa, nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ukan nau'ikan nau'ikan nau'ukan nau'ikan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan nau'ukan
Ba lallai ba ne ƙwayoyin cuta su kasance a cikin dabbobi.
A gefe guda, ƙwayoyin cuta masu cutar SARS-CoV da MERS-CoV ba su da cikakkiyar ƙwarewa ga jikin mutum, wanda ke haifar da ɗaukar ɗan lokaci kaɗan.
Suna bukatar su ci gaba da karuwa a cikin dabbobi masu dauke da kwayar cutar da ke jiran samunsu ga mutane marasa ƙarfi, ta hanyar dabbobi daya ko fiye da suke ci da kuma wadanda suke da yawa.
SARS-CoV-2 yana da siffofi iri ɗaya kamar SARS-CoV/MERS-CoV da HCoV guda huɗu masu yaduwa daga waje.
Yana da yawa kamar cutar HCoV da ke wucewa daga asibiti, aƙalla har zuwa yanzu.
Koyaya, yana haifar da ƙarin cututtuka fiye da ƙwayoyin cuta na HCoV na waje da asibiti kafin ya haifar da cututtuka masu tsanani kamar SARS-CoV ko MERS-CoV.
Har yanzu ana bukatar a duba ko zai saba da mutane sosai kuma ya yi tafiya a tsakanin mutane ba tare da dabba ta fita ba.
Kafin mu tattauna game da asalin HCoV, zai dace mu tattauna ma'anar da kuma halaye na dabbobi da HCoV ke juyawa, rayuwa tare da su, yawan su, da kuma yawan su.
HCoV yana girma a cikin dabbobi idan yana da alaƙa da asalinsa wanda ke da kamanceceniya a cikin tsarin ilimin lissafi.
A cikin yanayin, ƙwayoyin cuta na dabba suna da kyau kuma ba sa haifar da cutar da dabba.
Wannan yana nufin cewa dabbobi masu yawa suna ci gaba da kasancewa cikin yanayin HCoV na dogon lokaci.
A cikin waɗannan dalilai biyu, dabbobi masu ƙwayoyin cuta waɗanda ke da ƙwayoyin cuta suna da ƙwayoyin cuta na HCoV ko ƙwayoyin cuta masu haifuwa.
A gefe guda, idan HCoV ya zo sabon abu a cikin dabba mai girma kafin ko kusa da kamuwa da cutar, ba shi da cikakkiyar hanyar zuwa kuma galibi yana haifar da cututtuka.
Wannan dabba mai girma na iya zama mai saurin kamuwa da cutar da mutum kuma mafi saukin kamuwa da cutar wanda ke sa kwayar ta yi sauri kuma ta kamuwa da cutar ga mutane ta hanyar ƙara yawan kamuwa da cutar ga mutum.
HCoV zai iya zama mai ƙarancin kamuwa da cutar idan bai sami canjin ba a cikin dabba mai girma.
HCoVs, a gefe guda, na iya daidaitawa da dabba da ke girma kuma su kasance a cikinta na dogon lokaci.
A wannan yanayin, dabba mai girma zai zama dabba mai girma.
Bayanai na annobar sun nuna cewa wanda aka fara gano shi da cutar SARS ya kamu da cutar a lokacin farautar dabbobi.
Binciken jini na gaba ya nuna cewa masu sayar da dabbobi sun fi ƙarancin ƙarancin ƙwayar cuta na SARS-CoV IgG fiye da yawan jama'a.
An fara gano cewa karnuka na dabba na dabba suna da kwayar cutar SARS-CoV mai kama da SARS-CoV.
Wannan ya tabbatar da cewa SARS ya ci gaba da kasancewa bayan an kashe dukkan 'yan kasuwa.
Duk da haka, an ce tsutsotsi na daji ko na daji ba su taɓa haɗuwa da dabbobi na kasuwa ba waɗanda aka gwada su ba su da SARS-CoV, wanda ke nufin cewa tsutsotsi ma suna iya zama dabbobi waɗanda SARS-CoV ke girma da kuma girma sosai amma ba za su iya rayuwa tare da su ba.
A cikin wannan yanayin, yayin da kashi 80% na nau'ikan dabbobi a cikin kasuwar Guangzhou ke da masu tsaron SARS-CoV, babu shakka yawancin ƙananan nau'ikan dabbobi na SARS-CoV na iya samun karuwa da yaduwa.
Dukkanin waɗannan ba su da wata sanarwa ga SARS-CoV.
Binciken da aka yi a kan dabbobi da ke dauke da cutar SARS-CoV da ba ta girma ba ya nuna cewa CoV mai kama da CoV na kumburi, wanda ake kira SARS na kumburi CoV HKU3 (SARSr-Rh-BatCoV HKU3), yana cikin kumburi na kasar Sin.
Wannan kwayar cutar tana da masu kare kansa daga SARS-CoV da kuma tsarin kwayar SARSr-Rh-BatCoV HKU3.
Wadannan CoVs na ƙwayoyin cuta suna da kashi 88-92% na yanayin SARS-CoV.
Wannan binciken ya tabbatar da sabon ra'ayi cewa ƙwayoyin cuta da ke dauke da kwayar cutar da ba ta girma ba suna haifar da cututtuka a cikin mutane.
Yawancin SARS-like CoVs (SL-CoVs) an gano su a cikin mura, amma babu wani sai WIV1 wanda aka ɗauka a matsayin cutar mai cutar.
An gano wani abu mai kama da cutar a cikin mutum (ACE2) wanda ke karɓar SARS-CoV.
WIV1 an samo shi ne daga gwajin gwajin da aka yi na amfani da ACE2 na kwayoyin cuta, hanta da kuma mutum don shiga cikin jiki.
Abin mamaki shine, ƙwayar cutar ta SARS ta iya hana cutar ta WIV1.
Har zuwa yanzu, WIV1 ya nuna cewa ya fito ne daga SARS-CoV na kumburi, wanda ke da kashi 95% na kowa a cikin ƙwayar cuta.
Ko da yake waɗannan ƙwayoyin cuta biyu suna da alaƙa, ana ɗauka cewa WIV1 ba shine mai haifar da SARS-CoV ba kuma ƙwayoyin cuta ba su da tushen SARS-CoV.
Binciken juyin halitta na kwayar cuta ya sanya MERS-CoV cikin rukuni ɗaya na ƙwayoyin cuta na CoV-HKU4 da CoV-HKU5.
CoV-HKU4 na kumburi da MERS-CoV suna karɓar kwayar cutar DPP4, wanda kwayar cutar ke amfani da shi don shiga cikin jiki.
Tsarin RNA polymerase na MERS-CoV yana da kamanceceniya da ƙwayar cutar beta-CoV da aka gano a Turai da Afirka.
Har yanzu babu wani kwayar cutar MERS-CoV mai rai a cikin kwari a cikin daji.
MERS-CoV da sauran kwayoyin cuta masu kama da CoV-HKU25 sun kasance daidai da kashi 87% na binciken.
Saboda haka, ƙwayoyin cuta ba su da wani nau'in cutar MERS-CoV.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuma suna da ƙarancin ƙarfi ga ƙwayoyin cuta na MERS-CoV, kamar raƙuman da ke Gabas ta Tsakiya a yawancin ƙasashen Afirka.
Kwayar cutar MERS-CoV mai rai tana kama da kwayar cutar da aka samo a cikin mutane daga gwajin hanci na raƙuma, wanda ya ƙara nuna cewa raƙuma ita ce ainihin wurin da cutar ta MERS-CoV take.
Hakanan ya kamata a ambaci alamun bayyanar cututtuka masu sauƙi amma waɗanda ke nuna cewa kwayar ta girma daga yawan da aka gano a cikin raƙuman da aka yi bincike da cutar ta MERS-CoV.
Musamman, raƙuma masu kamuwa da cutar sun saki cutar ba kawai ta hanyar numfashi ba har ma ta hanyar tsatsa, wanda shine babban hanyar watsa ƙwayoyin cuta daga kumfa.
Duk da haka, akwai wasu tambayoyi da ake yi saboda yawancin waɗanda aka tabbatar da cewa suna da cutar MERS ba su taɓa saduwa da raƙuma ba kafin bayyanar cututtuka, wanda za a iya kira mutum ko kuma ba a san inda aka watsa shi kuma yana iya zama cewa jinsunan da ba a san su ba suna da cutar MERS-CoV.
SARS-CoV-2 yana da kashi 96,2% na ƙwayar cuta da CoV RaTG13 na ƙwayar cuta wanda aka samo daga nau'in cuta.
A cikin SARS-CoV da MERS-CoV, bambancin da ke tsakanin SARS-CoV-2 da RaTG13 yana da girma sosai don ba za a iya danganta su da juna ba.
Cutar zafin jiki ba zata iya zama cutar SARS-CoV-2 ba sai dai idan a cikin kwanaki masu zuwa akwai bayyanar irin wannan cutar ta CoV.
Ana iya samun dabbobi masu tasowa na SARS-CoV-2 daga cikin dabbobin da ake siyarwa a cikin gandun daji a cikin Kasuwar Hanyoyin Jirgin Ruwa ta Huanan, inda yawancin masu kamuwa da COVID-19 na farko suka fito, wanda ke nuna yiwuwar kamuwa da mutane daga dabbobi.
Yawancin binciken da aka yi kwanan nan dangane da tsarin metagenome sun nuna cewa ƙungiyar ƙananan ƙwayoyin cuta masu haɗari da aka sani da ƙwayoyin cuta na iya zama tushen kwayar cutar beta-CoV da ke da alaƙa da SARS-CoV-2.
Waɗannan sabbin kwayoyin CoV na kwayar cutar suna da kashi 85-92% na ƙwayoyin cuta na SARS-CoV-2.
Duk da haka, suna da alaƙa da RaTG13 wanda ya kai kashi 90% a matakin ilimin lissafi.
Suna cikin ƙananan rukuni biyu na ƙwayoyin cuta masu kama da SARS-CoV-2 a cikin juyin halitta na ƙwayoyin cuta, ɗayan yana da ƙwayoyin cuta na ƙwayar cuta (RBD) wanda yayi kama da SARS-CoV-2 a cikin 97,4% na amino acid.
A bambance-bambance, RBD na SARS-CoV-2 da RaTG13 sun bambanta sosai, kodayake suna da kamanceceniya sosai game da alaƙar kwayoyin halitta.
Binciken da aka yi a baya kan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cututtukan cuttukan
Wannan binciken ya yi amfani da nau'ikan haɗuwa da zaɓi don samar da tsarin kwayoyin halitta guda ɗaya wanda ya ƙunshi kashi 86,3% na yawan kwayoyin cutar.
Ba tare da yin magana ba, akwai yiwuwar cewa kwayar cutar ta zama ɗaya daga cikin masu karɓar kwayar cutar SARS-CoV-2.
Koyaya, babu wata hujja a halin yanzu da ke tabbatar da cewa SARS-CoV-2 yana fitowa kai tsaye daga kwayar cutar saboda bambancin yanayin SARS-CoV-2 da SARS-CoV-2 dangane da beta-CoV yana ɗaukar kwayar cutar.
Kuma, nisan tsakanin SARS-CoV-2 da RaTG13 shine gajeren tsakanin SARS-CoV-2 da SARS-CoV-2 dangane da beta-CoV mai ɗaukar kwayar cuta.
Dole ne a bayyana hanyar canjin SARS-CoV-2 a cikin tsutsotsi, kwari da sauran dabbobi.
Duk da yake an sami babban haɗin kai a cikin RBD tsakanin SARS-CoV-2 da kwayar cuta, SARS-CoV-2 tare da beta-CoVs, SARS-CoV-2 da RaTG13 suna da haɗin gwiwa na manyan kwayoyin halitta.
An yi ikirarin cewa yawan RBD na SARS-CoV-2 tsakanin beta-CoV mai ɗaukar hoto da SARS-CoV-2 yana haifar da canjin zaɓi.
Wani aikin kuma yana neman musayar kwayar halitta tsakanin SARS-CoV-2 da beta-CoV wanda ke ɗaukar kwayar cutar da RaTG13 kuma ya sanya shi a cikin nau'in daji na uku.
A cikin yanayin da ke haifar da canji, ana yin canjin kwayar halitta a cikin beta-CoVs.
Hukumar ta ci gaba da nazarin kwayoyin da ke da ƙwayar SARS-CoV-2.
Baya ga HCoVs masu cutarwa, an kuma yi nazarin asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 a cikin dabbobi.
Bayanan juyin halitta na ƙwayoyin cuta sun nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga CoV na ƙwayoyin cuta, yayin da ƙwayoyin cuta masu haifar da HCoV-OC43 da HCoV-HKU1 suka samo asali a cikin kumfa.
An bayyana cewa an gano wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
A gefe guda, HCoV-229E yana da alaƙa ta hanyar kwayoyin halitta da wani nau'in CoV na ƙwayoyin cuta, mai suna Hipposideros/GhanaAug/19/2008, wanda aka gano a Ghana, yayin da ake zargin nau'in raƙumi yana dauke da cutar.
Don bayyanawa, ilimin da ke akwai game da dabbobi da aka sani da su ne suka kawo cutar HCoVs an taƙaita su a cikin Hotuna 1 da Table 2.
Nazarin juyin halitta na kwayar cutar ya ba da hujjoji na tarihi na kamuwa da kwayar HCoV tsakanin jinsuna.
Lokacin da HCoV-OC43 ya samo asali daga wasu kwayoyin da ke kamuwa da cutar daga dabbobi a cikin gida a cikin 1890s, an gano cutar cuta ta numfashi.
Tarihin kamuwa da kwayar cutar HCoV-229E tsakanin jinsuna ba shi da tabbas.
An gano alpha-CoV na ƙwayar cuta mai kama da HCoV-229E.
Wannan ya ƙunshi alpha-CoV mai kama da cutar.
Akwai hujjoji da yawa da suka nuna cewa kamuwa da cutar ta kamuwa da cuta daga kwayar cuta zuwa mutum.
Da farko, mutane da yawa da ba su da aure sun taru a cikin gida ɗaya.
Amma, mutane ne suka fi fuskantar irin wannan yanayin.
Na biyu, HCoV-229E na alpha-CoV na kumburi ba shi da cutar kumburi kuma ba shi da cutar kumburi, wanda alpha-CoV na kumburi ya haifar da cutar numfashi a cikin dabbobi.
Daga nan kuma an gano alpha-CoV na cikin daji.
Saboda haka, babu shakka, ana iya samun kamuwa da cutar HCoV-229E ta alpha-CoV a cikin mutane.
A takaice dai, kwari ne ke kamuwa da cutar sankarar jini, Ebola, Nipah, da Hendra.
Saboda haka, ba abin mamaki bane cewa ƙwayoyin cuta na iya kamuwa da cutar HCoV-229E a cikin mutane.
A akasin haka, inda alpha-CoVs ke cikin rukunin kwayoyin HCoV-229E, ƙwayoyin cuta na iya zama masu ƙaruwa daga kwayar cutar zuwa kwayar cutar mutum, daidai da kwayar cutar MERS-CoV.
MERS-CoV misali ne mai kyau na kamuwa da kwayar cutar tsakanin jinsuna daga kumburi zuwa raƙuma zuwa raƙuma zuwa mutane.
An gano asalin asalin MERS-CoV a cikin ƙwayar cuta lokacin da aka fara gano shi kuma an tabbatar da shi ta hanyar binciken da ya biyo baya.
A bayyane yake cewa kwari suna da babban rukuni na ƙwayoyin cuta na dabba a cikin ƙwayar cuta da kuma watsawa tsakanin dabbobi.
Rayuwa mai ɗorewa, zama a wuri ɗaya, kasancewa kusa da juna da kuma iyawar tashi suna sa tsutsotsi su zama manyan dabbobi masu " yada kwayar cutar ".
A gefe guda, cutar MERS-CoV ta shiga raƙuma shekaru da yawa da suka gabata.
Ya saba da yadda raƙuma suka daina zama dabbobi masu cin abinci kuma suka zama dabbobi masu ƙwayoyin cuta masu aminci da kuma na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana canzawa a cikin waɗannan dabbobi.
Cutar da ta shafi mutane haɗari ne kuma mutane ba su kamu da cutar MERS-CoV ba saboda rashin yaduwar cutar.
Ba kamar yadda yake ba da gudummawar raƙumi ga kamuwa da cutar MERS-CoV, gudummawar ƙwayoyin cuta, idan akwai, ga kamuwa da cutar SARS-CoV-2 ya bambanta.
A cikin ƙwayoyin cuta, beta-CoV yana da matukar cutarwa ga ƙwayoyin cuta.
Suna iya ƙunsar kwayar cutar SARS-CoV-2 da ke tattare da beta-CoV amma ba su iya kamuwa da cutar kamar kumburi ga SARS-CoV ba.
Akwai yiwuwar cewa ana iya tabbatar da cutar ta SARS-CoV-2 daga dabbobi zuwa ga mutane ko ba za a iya tabbatar da ita ba a cikin binciken da za a yi a nan gaba.
Na farko, ƙwayoyin cuta na iya zama ƙwayar cutar da ke da alaƙa da SARS-CoV-2 wanda ke da alaƙa da cutar SARS-CoV-2.
Mutane za su iya samun gidajen da za su zauna tare ta hanyar tiyata da kuma hakowa.
Na biyu, ƙwayoyin cuta na iya kasancewa daga cikin dabbobi masu ƙwayoyin cuta da yawa waɗanda suka sami kamuwa da cutar SARS-CoV-2 da sauri.
Mutane suna kamuwa da cutar ta hanyar tiyata da cin naman dabbobin daji.
Ana iya zargin cewa yawancin dabbobi masu shayarwa ciki har da dabbobi na gida suna da cutar SARS-CoV-2.
Binciken dabbobi da na daji ya gano cewa suna da makamai masu yaki da cutar.
Na uku, daga cikin bayanan da aka bayar game da canjin kwayar halitta da kuma daidaitawar SARS-CoV-2 na iya kasancewa a cikin nau'in na uku na dabbobi da aka kamu da cutar ta tsutsa da raƙumi.
Ana ci gaba da binciken dabba mai haifar da SARS-CoV-2.
Baya ga nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ukan nau'ikan nau'ikan nau'ukan nau'ikan nau'ukan nau'ikan nau'ukan nau'ikan nau'ukan nau'ukan nau'ukan nau
Na farko, yana da matukar muhimmanci a cikin tsarin RNA.
Idan aka kwatanta da sauran kwayoyin cuta na RNA guda ɗaya, canjin CoV yana cikin A ko A kuma matsakaicin canjin jini shine ~10-4 a kowace shekara don kowane jini 2, dangane da matakin haɓakar CoV a cikin sabon mai ɗaukar.
CoV yana da wani enzyme wanda ke canza RNA, yana ɓoye ɓangarorinsa wanda ke haifar da canje-canje masu yawa zuwa rashin ƙarfi ko rashin rayuwa.
Abin mamaki, a cikin ɓangaren ƙwayar cuta, Remdesivir an san shi da hana haɓakar CoV ta hanyar enzyme wanda ke hana aikin RNA polymerase.
Remdesivir yana cikin magungunan da ke da tabbaci na SARS-CoV-2 da aka gwada ta likita.
Duk da haka, bambancin CoV ya kusan miliyan fiye da na dabbobi da ke cinye cutar.
Kuma yawanci canjin yana da yawa idan ba a san CoV sosai ga dabbobi masu girma ba.
A cikin kwatancen SARS-CoV mai canzawa, ana iya ganin canjin SARS-CoV-2 a ƙasa, wanda ke sa ya zama mafi dacewa ga mutane.
An ce ya riga ya saba da wasu dabbobi sosai.
Bayan SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya saba da zama a cikin raƙuma.
Saboda haka, ba zai yiwu ba cewa canje-canjen kwayoyin halitta da ke rage cutar SARS-CoV-2 su iya lalacewa da sauri.
Na biyu, babban kwayar RNA a cikin CoVs yana amfani da wasu hanyoyin canzawa a cikin kwayar halitta da kuma canzawa; don haka, yana haɓaka damar jujjuyawar dabba, wanda ke ba da fa'ida ga ci gaban sabbin ƙwayoyin CoVs a lokacin da ya dace.
Wannan yana da nasaba da tsarin RNA na furotin da kuma tsarin da ke cikin sashi na 3 na genome.
Na uku, CoV yana canzawa kuma galibi yana canzawa zuwa wasu RNA ta hanyar sakewa da ake buƙata .
A cikin dabba mai ciki, sauye-sauyen kwayoyin halitta suna faruwa sau da yawa yayin da RNA na CoV ke shiga cikin ƙwayar.
RNAs suna da kama da juna kuma suna da ƙarin kwayoyin halitta waɗanda zasu iya canza tsarin don samar da sabon CoV.
An gano bambance-bambancen kwayoyin halitta na kwayar cutar a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoVs masu ɗaukar dabbobi kamar SL-CoV da batCoV-HKU9 a cikin ƙwayoyin cuta.
Hadin kan kwayoyin cuta da dabbobi a cikin kamuwa da cuta
Baya ga ƙwayoyin cuta uku da aka ambata a sama, hulɗar ƙwayoyin cuta da dabba da ke girma a ciki wani dalili ne na kamuwa da cutar tsakanin jinsuna daban-daban.
Saboda haka, an dauki juyin halitta na SARS-CoV a matsayin misali mai kyau, wanda ya nuna kyakkyawan zaɓi na ɓangaren jiki wanda kwayar cutar ke watsawa tsakanin dabbobi.
Bisa ga bincike na kwatancen SARS-COV da ke kamuwa da cutar huhu, ana tsammanin SARS-CoV yana da saurin daidaitawa da yanayin yanayin da ke cikin jikin mutum, musamman ma canjin RBD na furotin S.
A cikin al'ada, RBD na kwayar cutar CoV ta S yana da ƙwayar ƙwayar cuta mai karɓa da kuma zaɓaɓɓu ta hanyar ƙwayoyin cuta na jiki.
A cikin SARS-CoV, RBD yana matsayi na 318 zuwa 510 a cikin amino acid na S1, yana ɗaukar ACE2 na mutum kuma yana ɗaukar ƙwayar cuta ta hanyar shiga cikin jiki.
SARS-CoV RBD na iya gano ACE2 mai karɓar ƙwayoyin cuta na dabbobi daban-daban, gami da tsutsotsi, tsutsotsi, beraye, nau'in tsutsotsi, wanda ke haifar da kamuwa da ƙwayoyin cuta a cikin dabbobi.
A takaice dai, an gano amino acid 6 ne kawai da suka bambanta da na mutum da na kwayar cutar RBD kuma 4 daga cikinsu suna da wani ɓangare na mai karɓar ACE2.
SARS-CoV na hanta tare da bambance-bambancen K479N da S487T a cikin RBD na iya haɓaka haɗin gwiwa tare da furotin S da ACE2 na mai karɓar kwayar cutar.
A wasu kalmomi, canza waɗannan amino acid biyu na iya zama mahimmanci don ƙwayoyin cuta su saba da jikin mutum.
Yana da ban sha'awa cewa SARS-CoV-2 yana karɓar kwayar cutar ta hanyar ƙwayar cuta iri ɗaya da SARS-CoV.
Akwai bambance-bambance na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin sashin S1 na furotin S wanda ke nuna alaƙar da ke tsakanin wannan furotin S da ACE2 na ɗan adam wanda zai iya zama canji.
A zahiri, binciken cryo-EM ya nuna 10 - 20 nau'ikan haɗuwa mai ƙarfi tsakanin ACE2 na ɗan adam da furotin S na SARS-CoV.
Yana da ban sha'awa a tabbatar da ko akwai wani kwayar cutar da ake amfani da ita wajen kamuwa da SARS-CoV-2.
Abin mamaki shine, HCoV-NL63 ma yana da alaƙa da ACE2 amma a wani ɓangare na furotin S.
Akwai sauran kwayoyin da ke karɓar HCoV, kamar aminopeptide N na HCoV-229E, da silicic acid tare da acetyl 9-O na HCoV-OC43.
Zai iya bayyana yadda kwayoyin cuta na CoV ke daidaita jikin mutum da cutar dabbobi da suka girma a ciki.
Baya ga ƙwayoyin cuta na ƙwayar cuta, ƙwayoyin cuta na HCoV suna sarrafawa ta hanyar haɓakar su da ƙwayoyin cuta.
Bambancin waɗannan furotin na ci gaban kwayar cutar tsakanin mutane da dabbobi ya haifar da kwayar cutar HCoV kamar ƙuda, raƙuma da tsutsotsi wanda zai iya hana kamuwa da kwayar cutar tsakanin jinsuna daban-daban.
HCoVs suna canza sigogin da ke cikin gida kuma suna lalata ƙwayoyin cuta na ƙwayoyin cuta don su iya kamuwa da sauran dabbobi.
Saboda haka, dole ne a ci gaba da gano da kuma bayyana ƙwayoyin kwayoyin a cikin wannan dangantaka mai ƙarfi tsakanin kwayar cutar da dabba mai girma.
Binciken kwayar halitta na ƙwayar cuta da kuma furotin mai kare cutar SARS-CoV-2 ta amfani da fasahar CRISPR ta zamani na iya haifar da sakamako mai kyau.
Bayyanar sabon kwayar HCoV: Tushen
Yawancin nau'ikan CoV na mura suna ba da babbar dama ga bayyanar sabon kwayar HCoV.
Saboda haka, CoV na kumburi shine tushen kwayoyin HCoV.
Kuma sauye-sauye da sauye-sauyen kwayoyin halitta suna haifar da juyin HCoVs, manyan matakai biyu a cikin wannan aikin.
Alal misali: Samun ko rasa kwayoyin halitta da ke samar da furotin yana da ikon canja wani ɓangaren kwayar cutar sosai.
A cikin kwayoyin halitta na SARS-CoV, ana tunanin ORF8 yana da mahimmanci don daidaitawa da jikin mutum, kuma an ware ƙwayoyin cuta na cutar SARS-CoV don samar da wani nau'in furotin na ORF8.
An gano samfurin 29 na SARS-CoV a cikin kwayoyin halitta a farkon annobar cutar a cikin mutane.
Wannan ƙwayar tana rage ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin zai iya daidaitawa da canjin da ke haifar da canjin dabba.
Kuma SARS-CoV an san shi da canza tsarin kwayar cutar alpha da gamma-CoV, inda yawancin kwayoyin da aka canza suka zama masu rarraba RNA polymerase.
An sake yin amfani da shi a cikin nsp9, mafi yawan nsp10, da kuma sassan nsp14.
A wani ɓangare kuma, cutar ta MERS-CoV ta canza tsarin tsakanin nau'ikan ƙwayoyin cuta guda biyu da aka samu a cikin raƙuman Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an kuma sami aikin gyare-gyare a cikin sauran HCoVs, inda HCoV ke canza tsarin CoV na wasu dabbobi zuwa kwayoyin halitta na musamman.
Ya kamata a lura cewa zaɓin da ba na halitta ba zai iya haifar da canje-canje marasa ma'ana a cikin kwayoyin cutar, wanda zai haifar da kwayar cutar ta fitowa daga yankin da aka zaɓa, kamar garkuwar jikin dabba inda kwayar cutar take.
Misali na wannan aikin shine rashin kwayar ORF4 ta yau da kullun a cikin HCoV-229E wanda ke haifar da ɓarna na kwayar halitta.
Yayin da aka gano ORF4 mai ƙarfi a cikin ƙwayoyin cuta da ƙwayoyin cuta na cuta da ke da alaƙa da HCoV-229E, alpha-CoV na cuta ya nuna ƙwayoyin cuta na cuta na cuta na cuta, wanda ke haifar da canji.
A ƙarshe, canje-canje na sabon kwayar HCoV suna haifar da matsalolin rashin ɗorewar dabbobi.
Rashin bayyanar cututtuka ko alamun bayyanar cututtuka na musamman da aka gano lokacin da kwayoyin cuta suka kamu da CoV, sun zama masu daidaitawa tsakanin CoV da cuta.
A bayyane yake cewa ƙwayoyin cuta suna da ƙwarewar jiki don daidaitawa da CoV.
Misali: Rashin aiki na kwayoyin rigakafi a cikin kumburi yana rage cututtukan da ke tattare da cutar CoV.
Kuma kwayoyin halitta na kashe kwayar cutar a cikin ƙwayoyin cuta sun daina aiki saboda ƙara kwayoyin masu karɓar kwayar cutar NKG2/CD94 da kuma rashin bayyanar kwayoyin da ke sarrafa haɗin kai na jini na I.
Hakanan, yawan adadin sinadarin oxygen (ROS) na yawancin ayyukan kwayoyin cuta na iya hana CoV ya zama mai ƙonewa kuma yana tasiri ga daidaita aikin enzymes masu canzawa, don haka zaɓar kwayoyin cuta masu cutarwa yayin da suke shiga cikin sababbin dabbobi.
Sauran kwayoyin cuta na CoV suna canzawa, suna samar da sabon furotin ko sassansa wanda ke sa dabbobi su saba da cutar.
Saboda haka, ba shi yiwuwa a sami sabbin kwayoyin HCoV guda uku a cikin shekaru ashirin da suka gabata.
CoV ba zai haifar da cututtuka ko alamun cututtuka a cikin dabbobi masu yawa kamar ƙwayoyin cuta da raƙumi ba.
Suna da ƙarfi sosai kuma suna fuskantar mummunan yaƙi daga garkuwar jiki.
Wannan shine dalilin da yasa dabbobi da ke dauke da cutar ba su nuna alamun cutar ba kuma dalilin da yasa mutane ke kamuwa da cutar.
Alamomin da suka fi tsanani sun kasance saboda yawan aikin garkuwar jiki da kuma yawan sakin kwayoyin cuta, yayin da garkuwar jiki ta kara karfafawa, cutar ta ci gaba da lalacewa.
Wannan ya bambanta da na dabbobi marasa alamun cutar, inda tsarin rigakafin jiki na CoV ke canzawa.
Tsarin rigakafi na iya zama da amfani wajen magance cutar SARS-CoV-2.
Protein yana da ƙarfi a cikin ƙwayar cuta.
Don haka samar da furotin mai kare kwayar cutar nau'in I ba tare da kamuwa da SARS-CoV-2 ba zai zama da amfani.
Hakanan furotin mai kare kansa na NLRP3 ba ya aiki a cikin kumburi.
A cewar wadannan ra'ayoyin, hana aikin furotin NLRP3 tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Bayyanar SARS-CoV-2 ya biyo bayan fitowar SARS-CoV da MERS-CoV.
A yayin da aka gano cewa beta-CoV na kumfa yana da kashi 95% na rashi tare da SARS-CoV, haka nan kuma yana da kashi 96% na rashi tare da SARS-CoV-2.
A cikin kwayoyin halitta da kuma wasu dabbobi na kasuwa, an gano cewa suna da kwayar cutar da ta yi kama da SARS-CoV, amma babu wani kwayar cutar SARS-CoV-2 da aka gano.
An gano beta-CoV na kwayar cuta wanda yayi kama da SARS-CoV-2, wanda ke nuna cewa kwayar cuta na iya zama dabba mai girma ko kuma beta-CoV na kwayar cuta wanda shine ɗayan kwayoyin halitta waɗanda ke haɗuwa da SARS-CoV-2.
Duk da wasu tambayoyi, babu wata hujja cewa SARS-CoV-2 na mutum ne ko kuma na gangan.
An sake samun rahoton CoVs saboda sabon kamuwa da cutar SARS-CoV-2.
Binciken CoV a cikin kumfa da sauran dabbobi ya canza tunaninmu game da HCoV a cikin kamuwa da mutane.
Akwai alamun cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun fito ne daga kumburi kuma sun kamu da cutar ta hanyar dabbobi masu girma.
Idan kamuwa da cutar SARS-CoV ta samo asali ne daga kusanci na mutane da dabbobi zuwa wuraren kiwon dabbobi, rufe su da kashe ƙwayoyin da ke ciki zai iya hana cutar ta SARS.
Hakanan, ana buƙatar cire kwari daga wuraren sayar da dabbobi don hana su kamuwa da sauran dabbobi, bisa ga binciken da aka yi game da asalin beta-CoV na kwari wanda ke da alaƙa da SARS-CoV-2.
Amma yadda mutane ke watsa kwayar SARS-CoV-2 daga kwayoyin cuta da sauran dabbobi masu shayarwa ya kamata a bayyana a cikin binciken da za a yi.
A gefe guda, cutar MERS-CoV ta daɗe tana rayuwa a cikin raƙuma.
Waɗannan raƙuma suna da muhimmanci wajen sayar da nama, madara, fata, da kuma sutura ga mazaunan yankin.
Sun zama sananne a Gabas ta Tsakiya da Afirka.
Saboda haka, ba za a iya ba da dukkan raƙuman don yaki da cutar MERS ba, kamar yadda aka yi a cikin kasuwannin dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana cutar ta MERS ta sake faruwa, dole ne a ɗauki matakan da suka dace da ƙarin matakan rigakafi da allurar rigakafin cutar ta MERS-CoV.
Idan ba za a iya kawar da ƙwayoyin cuta ba, sabon nau'in kwayoyin cuta zai iya bayyana kuma ya haifar da annoba.
CoVs daban-daban suna ɗaukar dabbobi masu yawo a cikin gandun daji.
A cikin yanayin, CoVs na ƙwayoyin cuta suna da damar da ta dace.
A nan gaba, yana yiwuwa CoV ya kamu da dabba, yana haifar da sabon nau'in CoV mai yaduwa ko kisa.
Dole ne a kawar da cin nama a wasu sassan kasar Sin, kuma a hana mutane da dabbobi kusanci da ba dole ba.
Saboda ci gaba da rikice-rikice na SARS, MERS da COVID-19, ana buƙatar ingantaccen tsarin yaki da ƙwayoyin cuta.
A takaice dai, an yi amfani da ƙwayoyin cuta da yawa a duniya a cikin dogon lokaci.
Suna zama a cikin gida har sai sun sami damar fita.
Ko da yake kwari suna da dalilai masu yawa na yada kwayar cutar, ana iya rage haɗarin mutane su kamu da kwari da sauran nau'ikan namun daji idan aka koya wa mutane su guje wa su.
Kula da dabbobi masu shayarwa yana da mahimmanci don fahimtar yanayin CoV da dabbobi masu shayarwa, wanda ke da mahimmanci don hana dabbobi kamuwa da cutar da ke faruwa a nan gaba.
A ƙarshe, hanya mafi kyau ta hana kwayar cutar ta dabba ita ce mutane su fahimci yadda ƙwayoyin cuta da dabbobi suke girma.
Har yanzu akwai nau'ikan dabbobi da yawa waɗanda ba a san asalin SARS-CoV-2 ba.
Na farko, idan kwari suna kamuwa da kwari wanda ya haifar da SARS-CoV-2, yana da ban sha'awa a ga dalilin da yasa kwari da kwari suke zama a wuri guda.
Na biyu, idan kwari suna kai tsaye ga mutane, dole ne a bayyana yadda mutane ke fuskantar cutar.
Na uku, idan dabba ta uku ta yi aiki kamar dabba ta ci gaba da girma, to, ta yaya za a fahimci yadda ta ke rayuwa tare da nau'ikan dabbobi daban-daban, kamar mutane, kwari da kuma kwari.
Bayan haka, idan akwai dabbobi da yawa da ke cikin gida waɗanda za su iya kamuwa da SARS-CoV-2, dole ne a lura da su kuma a bincika yadda za a iya kamuwa da cutar.
Ko dai kwayar cutar ce, ko kuma wata dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kuma kwayar cutar da ke haifar da ita za ta bayyana a cikin dabbobi masu girma a nan gaba.
Ci gaba da nazarin dabbobi a cikin waɗannan halittu zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, wanda zai taka muhimmiyar rawa wajen rigakafi da rigakafin COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idojin gwajin COVID-19  masu cutar da ake zargi  da waɗanda aka tabbatar da cutar 
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta ba da sanarwar gaggawa ta jagororin da suka haɗa da shawarwari don ganowa da magance sabon kamuwa da cutar coronavirus na 2019 (2019-nCoV), kuma jagororin sun ba mu ƙwarewa da ingantaccen bayani game da yaƙin cutar a duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma ra'ayoyinmu da iliminmu game da ita suna haɓaka a hankali dangane da bincike da ayyukan likita; saboda haka ana ci gaba da sabunta hanyoyin bincike da magani.
A cikin wannan wasiƙar, mun amsa wata shawara game da ƙa'idodinmu kuma mun gabatar da sababbin ka'idoji don kimantawa masu da'awar cutar da masu da'awar cutar bisa ga sabon jagorar bincike da magani na COVID-19 (mataki na bakwai) da kwamitin kula da lafiyar jama'ar kasar Sin ya fitar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da annoba, wanda yanzu ana kiransa cutar coronavirus 2019 (COVID-19) kuma an kira cutar cutar cutar ta hanyar numfashi mai tsanani ta coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annobar duniya.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta kafa ƙa'idodin gaggawa na gaggawa kuma an sanar da su a kan layi a cikin binciken likita na Sojoji a ranar 06 ga Fabrairu, 2020.
Tun lokacin da aka wallafa shi, mutane da yawa sun ji daɗin wannan littafin.
Amma yana da mahimmanci a fahimci cewa COVID-19 sabon cuta ne, tunaninmu da iliminmu suna ci gaba da haɓaka a hankali dangane da bincike da ayyukan likita; saboda haka, ana ci gaba da sabunta hanyoyin bincike da magani.
Misali, Jagorar Bincike da Kula da COVID-19 da Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya bayar tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, ya wallafa littattafai bakwai tare da wasu canje-canje masu mahimmanci.
Yanzu kuma tsarinmu ya karɓi shawarar Zhou da sauransu, waɗanda suka ƙirƙiri tsarin da ya fi sauƙi don ba da maki bisa ga kwarewar likitanci.
Ayyukan su sun kara sabbin alamomi masu amfani da ke nuna yanayinmu kuma suna ba da bayanai masu amfani game da wannan annoba mai barazanar duniya.
Muna tallafa musu kuma muna godiya da aikinsu.
Duk da haka, ana buƙatar sabunta ayyukan su daidai da sabon jagororin bincike da magani na COVID-19 (Gwaji na bakwai) da kuma sabon bincike.
Kamar yadda aka nuna a littafin na bakwai (3 ga Maris, 2020) don tabbatar da cewa wanda ake zargi da cutar dole ne ya haɗu da ɗayan alamun tarihin cutar da alamun cutar biyu don cikakken bincike, ko kuma dole ne ya haɗu da alamun cutar uku idan tarihin cutar bai bayyana ba:
Tarihin annobar: (1) Akwai tafiya ko zama a Wuhan da kewaye da ita, ko kuma wasu mutane da suka kamu da COVID-19 sun bayyana a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) akwai haɗuwa da masu kamuwa da SARS-CoV-2 (tare da alamun ƙwayoyin cuta na nucleic acid); (3) akwai haɗuwa da marasa lafiya da ke da ƙonewa ko alamun numfashi daga Wuhan da kewaye da ita, ko kuma akwai COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) akwai haɗuwa da marasa lafiya na gida (mafi da 2 marasa lafiya da ke da ƙonewa ko alamun numfashi da aka nuna a cikin makonni 2 a cikin jirgin ruwa, gida, ofis, makaranta, da sauran wurare).
Alamun cutar: (1) wuta ko alamun rashin numfashi; (2) tare da alamun kamuwa da COVID-19; (3) jimlar adadin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Ana buƙatar tantance mai cutar da aka tabbatar da shi bisa zargin kamuwa da cutar da ke nuna ɗayan alamun cutar ko na jini masu zuwa: (1) wani samfurin PCR na ainihi wanda ya nuna cutar SARS-CoV-2; (2) jerin manyan sassan kwayar cutar da ke nuna alaƙa da sabon coronavirus da aka sani; (3) nuna rashin lafiya ga ƙwayoyin cuta na musamman na IgM da IgG ga SARS-CoV-2 a cikin gwajin jini; ko kuma karuwar ƙwayoyin cuta na musamman na SARS-CoV-2 daga marasa lafiya zuwa bar, ko kuma fiye da sau 4 a cikin sashin murmurewa na cutar mai tsanani.
Mun lura cewa an ɗauki matakan numfashi na nucleic acid ko samfurin jini lokacin da aka ƙara su zuwa na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
Gano cutar a cikin gwajin jini na jini an ƙara shi a cikin littattafan da aka buga na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan an ƙara alamun jini zuwa littafin da aka buga na bakwai.
Waɗannan canje-canjen sun dogara ne akan ci gaba da bincike na masu bincike don neman ingantaccen hanyar gano acid na nucleic don saurin bincike, da kuma samfurin numfashi wanda ya haɗa da samfurin jini, wanda ke ba da damar samar da nau'ikan samfurori daban-daban, kuma yana tallafawa samar da ƙwayoyin cuta na musamman a cikin ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai alamun da ke nuna cewa muna bukatar mu yi hankali da marasa lafiya da ba su da alamun cutar.
Saboda haka, dole ne a sake duba jadawalin Zhou da sauransu, kamar yadda suka rarraba mutumin da ba shi da alamun cutar a matsayin "ƙananan haɗari".
Hakanan dole ne a bincika tsarin ƙimar a cikin sauran ayyukan likita da bincike.
A ƙarshe, muna fatan ƙarin tabbaci na kai tsaye zai bayyana kuma muna tambayar masu karatu su ba da ra'ayinsu.
Game da binciken "masu zargin rashin lafiya" da "masu tabbatar da rashin lafiya", muna roƙon ku ku bi da kuma bin sababbin ƙa'idodin ƙasashensu.
Ƙungiyarmu za ta kuma sabunta ƙa'idodinmu a kai a kai don ba da taimako.
Bangladesh ta ba da rahoton mutuwar mutane biyar da suka mutu sakamakon COVID-19, wanda ya fi girma a cikin rana ɗaya
Jiya, Bangladesh ta tabbatar da cewa mutane biyar sun mutu sakamakon COVID-19 a wannan ranar.
Wannan shi ne adadin mutuwar da aka yi a rana guda da cutar.
A jiya, Cibiyar Kula da Cututtuka da Binciken Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin masu kamuwa da cutar ya kasance 114 da aka warke da kuma 33 da suka warke a gida.
Yawan mutanen da suka mutu shi ne mutane 17.
A cikin wani labarin da aka yada a yanar gizo, Shugaban IEDCR, Dakta Meerjady Sabrina Flora, ta ce daga cikin wadanda suka mutu akwai maza hudu da mace daya.
A cewar Dr Meerjady, matalauta biyu sun wuce shekaru 60, biyu sun kasance tsakanin shekaru 51 zuwa 60 kuma daya ya kasance tsakanin shekaru 41 zuwa 50.
Ya kuma bayyana cewa biyu daga cikin wadanda cutar ta kashe sun kasance daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya sanar da Anadolu, wata jarida ta kasar, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, shugaban hukumar yaki da cin hanci da rashawa a Bangladesh, wanda ake jinya a asibitin Kuwait Maitree.
A wani sakon bidiyo da aka wallafa a ranar Lahadi, Ministan Harkokin Kasuwanci na Bangladesh, Obaidul Quader, ya ce an dakatar da zirga-zirgar jama'a fiye da yadda aka tsara har zuwa wannan Asabar.
An shirya dakatar da zirga-zirgar jiragen sama daga ranar 26 ga Maris zuwa ranar Asabar, 4 ga Afrilu.
Abubuwan da aka fi sani da su sun hada da magunguna, kwayoyi, da abinci da aka ba da izinin sufuri.
An fara samun kamuwa da COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da wata mace daga Italiya.
A ranar 9 ga Maris, waɗannan mutane uku sun warke.
SARS-CoV-2 ya riga ya kamu da mutane sama da miliyan a duniya
A ranar Alhamis, adadin masu kamuwa da cutar SARS-CoV-2 ya wuce miliyan ɗaya a duniya, a cewar rahoton Jami'ar Johns Hopkins.
Kimanin mutane dubu 52 ne suka mutu sakamakon COVID-19, cutar da ke tattare da coronavirus.
Wannan adadin ya bayyana a ranar da Malawi ta ba da rahoton kamuwa da cutar coronavirus ta farko tare da Zambiya ta fara mutuwar cutar coronavirus.
A ranar Alhamis, Koriya ta Arewa ta bayyana cewa tana ɗaya daga cikin ƙasashe da suka rage ba tare da kamuwa da cutar coronavirus ba.
A jiya, Hukumar Lafiya ta Duniya ta ba da sanarwar cewa an tabbatar da kamuwa da mutane 1,051,635, daga cikinsu akwai mutum 79,332 da suka kamu da cutar a cikin awanni ashirin da hudu kafin karfe 10:00 na tsakiya na Turai (08:00 GMT) a ranar 4 ga Afrilu.
A Amurka, an ba da rahoton cewa sama da mutane 244,000 sun kamu da cutar coronavirus, kuma mutuwar 5,900 daga cikinsu.
Bisa ga bayanan Jami'ar Johns Hopkins, CBS News ta ba da rahoton mutuwar mutane 1,000 a Amurka a ranar Laraba sakamakon cutar coronavirus.
A duniya, ƙasashe sun ba da sanarwar matakan da suka dace don hana yaduwar cutar.
A ranar Alhamis, magajin birnin Moscow, Sergei Sobyanin, ya kara tsawon lokacin zama a gida har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa 'yan Rasha masu karɓar albashi ba za su tafi aiki ba har zuwa 30 ga Afrilu.
Majalisar dokoki ta Portugal ta kara wa dokar ta baci na tsawon kwanaki 15 a kasar, inda ta amince da zaben mutane 215, goma suka tsaya, daya kuma ya ki.
Saudiyya ta kara yawan lokutan da za a yi zaman a cikin biranen Makka da Madina inda za a yi zaman yini; a baya, zaman ya kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand na shirin yin wani taron da zai faru tsakanin 22:00 zuwa 04:00.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa gwamnatinsa ta kara wa'adin zaman gida har zuwa 1 ga Mayu.
Shagunan Australiya sun kafa iyakar adadin takardun tsabtace jiki da za a iya saya
A daren Asabar zuwa Lahadi, shagunan Woolworths da Coles na Ostiraliya sun rage adadin takardun wanke zuwa biyu kuma babu wanda ya wuce fakitin takarda guda ɗaya a duk waɗannan shagunan a duk faɗin ƙasar.
A ranar Litinin, ALDI ta sanar da cewa ba za a iya samun fiye da fakiti ɗaya ba.
An sanar da iyakar adadin a matsayin sanarwa a wuraren biya, da kuma a shafukan Facebook na shagunan.
An ce masu amfani suna sayen takardun tsabtace gida a cikin babban adadin saboda tsoron COVID-19 lokacin da ake buƙatar keɓewa.
A ranar Laraba, Woolworths ta rage adadin takardun tsabtace gida don kowane tsari.
Canje-canjen da suka biyo baya sun ce babu wanda ya wuce fakitin takardu huɗu da aka kafa ta Woolworths da Coles Stores a ranar 4 da 5 ga Maris.
A cikin sanarwar da aka fitar a watan Maris, Coles store ya sanar da cewa a karkashin ka'idojin da aka kafa na kada a wuce fakitin guda hudu na takardun tsabtace jiki, manyan shaguna suna kashe kaya bayan hour na buɗewa, kuma ya sanar da cewa irin wannan sayayya "ba ta faru ba", yayin da ALDI a ranar Talata ta sanar a Facebook cewa wannan "ba a yi tsammani ba".
Tallace-tallace sun "ƙaru sosai" a makon da ya gabata, a cewar wani mai magana da yawun kantin sayar da kayayyaki na Woolworths.
Costco store a Canberra ma ya rage adadin zuwa fakitin takarda mai tsabta biyu a makon da ya gabata.
Don rage ƙarancin takaddun shaida, Coles Store ya ba da umarnin manyan fakiti ga masu siyarwa kuma ya ƙara yawan kayan aiki, kuma Woolworths ya ba da umarnin ƙarin takaddun shaida, yayin da ALDI ta kawo kayayyaki na ranar Laraba a cikin shagon da aka sayar da su.
Russell Zimmerman, babban jami'in kungiyar 'yan kasuwa ta Australiya, ya ce 'yan kasuwa na iya ƙara tallace-tallace, amma dokokin da majalisar ta kafa game da motocin sarrafa kayayyaki sun sanya hakan wuya.
Ta yi imanin cewa farashin kayayyaki zai karu, yayin da masu sayar da kayayyaki ke ƙoƙarin biyan bukatun abokan ciniki, da kuma ba su ƙananan tallace-tallace.
A ranar Talata, ALDI ta sanar da cewa saboda an sayar da kayayyakin da wuri, wasu shaguna ba za su iya ba da tallata ranar Laraba ba.
A cikin wani rahoto daga News.com.au, Dr Gary Mortimer, masanin harkokin kasuwanci a Jami'ar Queensland ta Fasaha, ya ce shagunan suna ajiye kayayyaki a cikin shagon da daddare.
Ya kuma bayyana cewa takarda mai tsabta abu ne da ke cikin marufi, wanda ke sa a samu karancin kayayyaki a shago, kuma idan aka sayar da su, suna ba da sarari a kan shafuka da ba su da, wanda ke sa mutane su ji kamar an gama kayayyakin.
Russell Zimmerman na ABC News ya ce: Cole's da Woolworths Stores suna ganin cewa samun karin kayayyaki a kan katako kamar takarda mai tsabta da maganin kashe ƙwayoyin cuta a kan wadata zai rage yawan tsoron mutane 
Kamfanin Who Gives a Crap wanda ke sarrafa takardun tsabtace gida, ya ce kayayyakin sun shiga shagon a ranar Laraba da ta gabata.
News.com.au ta ba da sanarwar cewa Kamfanin Kimberly-Clark wanda ke samar da tufafi masu tsabta na Kleenex da Solaris Paper wanda ke samar da takarda mai tsabta na Sorbent, sun tabbatar da cewa za su yi aiki 24/7 don isa kasuwa.
Domain.com, wani dandalin sayar da dukiya, ya sanar da cewa masu sayar da gidaje za su ba da takardun tsabtace gida kyauta ga masu nuna gidaje a farkon hasumiyar Melbourne, inda ba a amfani da su sosai ba saboda masu amfani da su suna da hutu na ranar aiki da ya dace da karshen mako.
Labarin ranar Alhamis na NT News, jaridar da ke buga takarda a Darwin, ya ƙara shafuka takwas da za a iya yanke su don amfani da su a matsayin takarda mai tsabta.
Shaguna ba su so su kafa dokoki ba, a cewar wani rahoto na ABC Australia na 3 ga Maris, inda ya ce ba su shirya yin dokoki game da sayayya ba.
Russell Zimmerman ya ci gaba da cewa wasu kayayyakin da suka fi sayarwa sun hada da masks, maganin kashe kwayoyin cuta, abinci mai bushewa, sabulu don wanke hannu da farar hannu.
Haka kuma, a waje da Ostiraliya, a daren Lahadi, wani kantin sayar da intanet na Ocado na Burtaniya ya rage yawan takardun wanke Andres zuwa fiye da fakiti biyu da ke dauke da 12.
Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana cutar COVID-19 ta yau da kullun da ke tattare da cutar SARS-CoV-2 a matsayin annoba.
Duk da yake kalmar "annoba" tana nufin yadda cutar ta yadu zuwa kasashe da yawa, ba ta ma nuna yadda ta yi girma ba, WHO ta nuna cewa akwai bukatar a ba da gudummawa ga gwamnatoci wajen magance ta:
"Dukkanin kasashen duniya na iya canza yanayin annobar.
Tedros Adhanom Ghebreyesus, Babban Daraktan WHO ya ce: "}asashe masu zaman kansu ba su san inda za su iya yin gwaji, magani, ware masu kamuwa da cutar ba, karɓar waɗanda suka kamu da cutar da kuma ƙarfafa mutane su guji".
"Muna matukar damuwa da saurin yaduwar cutar da kuma rashin daukar mataki kan ta.
A cewar Dr. Tom Frieden, tsohon shugaban hukumar kula da cututtuka da rigakafin cututtuka ta Amurka, cutar "ba ta taɓa faruwa ba".
A wata sanarwa da CNN ta bayar a watan Fabrairu, ya ce: Babu wani kwayar cuta da ta wuce lokacin da ta bayyana kuma ta zama annoba a duniya.
Ghebreyesus ya yi magana a kan batun, inda ya ce: "Ba mu taɓa ganin cutar coronavirus ba.
Ya ci gaba da cewa: Kuma ba mu taɓa ganin cutar da za a iya magance ta ba .
Canjin ya biyo bayan shawarar WHO ta Janairu ta bayyana cutar a matsayin bala'in kiwon lafiya na duniya.
Babban darektan Cibiyar Kula da Cututtuka da Cututtuka na Amurka (NIAID), Dokta Anthony Fauci, ya ce: A bayyane yake cewa annobar ta kara yin mummunan aiki
A ranar Alhamis, Ofishin yada labarai na Associated Press ya ba da rahoton cewa kusan mutane 126,000 sun kamu da COVID-19 a duniya, wanda sama da 4,600 daga cikinsu sun mutu.
Cutar coronavirus ta 201920 ita ce cutar ta yanzu ta COVID-19 (COVID-19), wanda ke haifar da cutar sankarar cuta mai tsanani (SARS-CoV-2).
A watan Disamba na 2019, an gano cutar a Wuhan, China; a ranar 30 ga Janairu, 2020, an bayyana ta a matsayin bala'in kiwon lafiya na duniya, kuma a ranar 11 ga Maris, 2020, an bayyana ta a matsayin annoba.
Ya zuwa ranar 10 ga Afrilu, 2020, kusan mutane miliyan 1,61 sun kamu da COVID-19 a cikin ƙasashe da yankuna 210, daga cikinsu kusan 97,000 sun mutu.
Kimanin mutane 364,000 ne suka warke.
Yawan mutuwar ya kai kashi 4 cikin 100 a kasar Sin, yayin da a duniya ya kai kashi 13.04 cikin 100 a Algeria da 0.8 cikin 100 a New Zealand.
Alamun sun haɗa da wuta, tari, da kuma rashin numfashi.
Alamun cututtuka sun hada da ciwon hanci da kuma matsalar numfashi.
Idan ka lura da wani abu, alamun bayyanar cututtuka sun fara ne a cikin kwanaki biyar, amma suna iya wucewa daga kwana biyu zuwa kwana goma sha huɗu.
Babu allurar rigakafi da magani da aka sani don magance cutar.
Abubuwan da ake bukata don kauce wa cutar sun hada da wanke hannu, rufe bakinka lokacin da kake motsawa, sanya nesa tsakanin kai da wasu, sa ido da keɓewa daga waɗanda ake zaton suna da kamuwa da cutar.
Shugabannin duniya da ke fama da annobar sun dakatar da tafiya, sun ware, sun yi watsi da aikin, sun hana annobar a wuraren aiki da kuma rufe masana'antu.
Cutar ta haifar da rikice-rikice na tattalin arziki da zamantakewa, jinkirta ko dakatar da wasanni, addini, siyasa da ɗabi'a da kuma haifar da ƙarancin kayayyaki a duniya wanda ya haifar da yawan masu sayen kayayyaki saboda tsoron cutar.
Makarantu da jami'o'i sun rufe a matakin kasa ko na yanki a kasashe 193, wanda ya shafi kusan kashi 99.4 cikin dari na ɗaliban duniya.
Labaran cutar sun bazu a yanar gizo, tare da wasu ayyukan zalunci ko nuna bambanci ga baƙi musamman Sinawa, 'yan asalin Gabas da Kudu maso Gabashin Asiya, da sauransu daga yankunan da cutar ta mamaye.
Saboda rage yawan zirga-zirga da kuma rufe manyan masana'antu, gurɓataccen iska da kuma iska sun ragu.
A ranar 31 ga Disamba, 2019, Hukumar Lafiya ta Wuhan, China (babbar birnin lardin Hubei) ta sanar da kamuwa da cutar sankara ta hanyar wani abu da ba a sani ba, kuma an fara binciken a farkon Janairu 2020.
Masu cutar suna da alaƙa da babban kanti na Huanan Seafood, inda ake zargin cewa kwayar ta samo asali ne daga dabbobi.
Wani sabon kwayar cutar da aka gano wanda ya haifar da cutar da ake kira SARS-CoV-2, wanda ya yi kama da kwayar cutar mura, kumburi da SARS-CoV. Mutumin farko da aka sani da bayyanar cututtuka ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma mutumin bai da alaƙa da kowa a wannan wurin da ake kula da dabbobi ba.
An sake samun wasu cututtukan farko a watan Disamba na 2019, kashi biyu bisa uku daga cikinsu suna da alaƙa da wannan kasuwar.
A ranar 3 ga Maris, 2020, wani rahoto da ba a tabbatar ba da jaridar South China Morning Post ta bayar ya nuna cewa kamuwa da cutar a ranar 17 ga Nuwamba, 2019, wanda ya bayyana a cikin wani mutum mai shekaru 55 a lardin Hubei, yana iya zama farkon kamuwa da cutar. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa sababbin kamuwa da cutar sun ragu a China amma sun karu sosai a Italiya, Iran da Koriya ta Kudu, yawan sabbin kamuwa da cutar a waje da China ya fi yawan sabbin kamuwa da cutar a China a baya.
Wataƙila akwai mutane da yawa da ba a sanar da su ba; musamman waɗanda ke da alamun bayyanar cututtuka.
A ranar 26 ga Fabrairu, an ba da rahoton ƙananan ƙarancin kamuwa da cutar a tsakanin matasa, waɗanda ke da shekaru 19 da ƙasa da kashi 2.4% na kamuwa da cutar a duniya. Mai ba da shawara kan kimiyyar gwamnati na Burtaniya, Patrick Vallance, ya ce kashi 60% na yawan jama'ar Burtaniya na iya kamuwa da cutar kafin a sami allurar rigakafi.
Yawan masu kamuwa da cutar shine yawan mutanen da aka gwada COVID-19, kuma an tabbatar da gwajin bisa ga tsarin gwamnati.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da 3% na yawanta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain da Switzerland sun kafa ƙa'idodin ƙin gwada waɗanda ke da alamun cutar.
Wani bincike da aka fitar a ranar 16 ga Maris ya nuna cewa, a ranar 23 ga Janairu, kashi 86% na masu kamuwa da COVID-19 a China sun kasance ba a gano su ba, yayin da kashi 79% na masu kamuwa da cutar da ba a rubuta su ba.
Binciken kididdigar da aka fitar a ranar 30 ga Maris ya nuna cewa adadin kamuwa da cutar a Italiya ya fi na da.
Adadin sabbin kamuwa da cutar COVID-19 (R0) ya kasance daga 1,4 zuwa 2,4.
Wani bincike da Cibiyar Kula da Cututtuka da Rigakafin Amurka ta yi ya nuna cewa wannan adadi zai iya zama 5,7.
Yawancin mutanen da ke da cutar COVID-19 sun warke.
A cikin marasa lafiya, lokacin bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, amma mafi yawan kwanaki 14 ne.
A ranar 10 ga Afrilu, 2020, kusan mutane 97,000 sun mutu sakamakon COVID-19.
A kasar Sin, har zuwa 5 ga Fabrairu, kashi 80% na mutuwar sun wuce shekaru 60, kuma kashi 75% na sauran cututtukan zuciya da ciwon sukari. Lambobin da gwamnati ta bayar game da mutuwar COVID-19 sun kasance mafi yawa na mutanen da aka gwada COVID bisa ga tsarin gwamnati.
Yawan mutuwar COVID-19 na ainihi na iya zama mafi girma fiye da na rahoto, saboda ba ya haɗa da mutuwar da ba a bincika ba, misali: waɗanda suka mutu a gida, a wuraren kula da tsofaffi da sauransu.
Wasu rahotanni daga Italiya sun ce yawan mutuwar da aka samu a lokacin annobar ya fi adadin mutuwar da gwamnati ta bayar da rahoton cutar COVID a cikin matsakaici 4-5.
Mai magana da yawun Hukumar Kula da Cututtuka ta Amurka (CDC) ya ce: "Mun san cewa adadin mutuwar da aka bayar ba daidai ba ne da ainihin adadin mutuwar, wanda ya dace da rahoton da aka bayar cewa ba za a sami cikakken taimakon cutar a Amurka ba. Yawancin lokaci wannan taimakon yana faruwa a lokacin annobar kamar lokacin annobar 2009 H1N1 swine flu. Ranar 9 ga Janairu, 2020 ne aka tabbatar da mutuwar mutum na farko daga cutar.
Ranar 1 ga Fabrairu, mutum na farko ya mutu a waje da China a Philippines, kuma mutum na farko a waje da Asiya ya mutu a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an kashe mutane fiye da goma sha biyu a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, fiye da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a duk nahiyoyi sai Antarctica. Ana amfani da matakan da yawa a wurare daban-daban don ƙididdigar mutuwar.
Wannan adadi ya bambanta daga yanki zuwa lokaci, kuma ya danganta da ƙimar da aka ɗauka, tsarin kula da lafiya, rigakafi, lokacin da cutar ta ɓace da yanayin jama'a kamar shekaru, jinsi da lafiyar su gaba ɗaya.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar kamuwa da cuta ya kai kashi 6.0% (97,039,1/617,204) har zuwa 10 ga Afrilu, 2020.
Yawan adadin ya bambanta daga yankin zuwa yankin.
A kasar Sin, yawan mutuwar masu kamuwa da cuta ya ragu daga kashi 17.3% (mafi yawan marasa lafiya a ranar 110 ga Janairu 2020) zuwa kashi 0.7% (mafi yawan marasa lafiya bayan 1Fabrairu 2020). Sauran matakan sun haɗa da CFR, wanda ke nuna yawan waɗanda suka kamu da cutar suka mutu, da kuma infusion rate (IFR), wanda ke nuna yawan waɗanda suka kamu da cutar (ko dai ɗaya ko ba ɗaya ba) suka mutu daga cutar.
Waɗannan kididdigar ba su da tushe kuma suna bin wasu mutane na musamman daga waɗanda suka kamu da cutar har zuwa warkewa ko mutuwa.
Jami'o'i da yawa sun yi ƙoƙari su ƙidaya waɗannan ƙididdigar.
Cibiyar Kula da Ilimin Kimiyya ta Jami'ar Oxford ta ce yawan kamuwa da cutar a duniya yana tsakanin 0.1% zuwa 0.39%.
Babban adadin wannan matakin ya dace da sakamakon gwajin farko na COVID-19 na mutanen da aka yi wa rigakafi a Jamus da kuma ƙididdigar binciken da ke nuna yawan mutuwar da aka yi wa gwaji.
Hukumar ta WHO ta ce za a iya magance cutar.
Lokaci da kuma tsawon lokacin da cutar ta ke gudana ba a sani ba kuma yana iya bambanta daga yanki zuwa yanki.
Maciej Boni daga Jami'ar Jihar Penn ya ce: Ba tare da lura ba, cututtukan cututtuka sukan kasance na ɗan lokaci kuma su fara raguwa lokacin da cututtuka suka rasa masu kamuwa da cutar.
Amma yana da wuya a yi tunanin abin da zai faru a nan gaba.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, Zhong Nanshan, ya bayyana cewa: "Yana iya zama cewa cutar ta ƙare a watan Yuni" lokacin da dukkan ƙasashe suka bi shawarar WHO don hana yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magunguna ta London ya ce SARS-CoV-2 zai koma daga wuri zuwa wuri, mai yiwuwa na shekara ɗaya ko biyu.
A cewar wani bincike na Imperial College karkashin jagorancin Neil Ferguson, dole ne a bi tsarin kula da mutane da sauran matakan "har sai an samu allurar (a cikin watanni 18 ko fiye)".
William Schaffner daga Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu ba cewa cutar coronavirus, saboda ta zama mai yaduwa, za ta ƙare gaba ɗaya kuma za ta iya zama cuta ta ɗan lokaci kuma ta sake dawowa kowace shekara.
Sake dawowar wannan kwayar cutar mai yaduwa zai kasance sakamakon rashin lafiyar jikin mutum da kuma canjin kwayar cutar.
Alamun COVID-19 na iya zama na musamman kuma mutane masu kamuwa da cutar na iya zama marasa alamun bayyanar cututtuka.
Mafi yawan alamun bayyanar cututtuka sune ƙonewa (88%) da kuma ciwon daji (68%).
Alamomin da ba sa bayyanawa sune gajiya, rashin numfashi, rashin numfashi, rashin numfashi, ciwon hanci da jijiyoyi, ciwon hanci, ciwon kai, sanyi, hawaye, zubar da jini, kumburi ko kuma ciwon fata. WHO ta ba da rahoton cewa kusan mutum 1 cikin 6 na duniya zai kamu da cutar kuma yana da matsalar numfashi.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka (CDC) ta nuna alamun cututtuka na rashin lafiya ciki har da rashin numfashi, ciwon zuciya ko ciwon kirji, tashin hankali, tashin hankali, fuska ko bakin ciki, ana ba da shawarar cewa waɗanda ke da waɗannan cututtuka su nemi likita nan da nan idan alamun ba su da kyau. Idan cutar ta ci gaba da girma, zai iya haifar da ciwon huhu, matsalolin numfashi, zubar da jini, matsalolin acid na jiki da mutuwa.
Idan wasu mutane da suka kamu da cutar ba su da wata alama, idan babu wata alama amma sakamakon gwajin ya nuna cewa sun kamu da cutar, masu bincike sun ba da shawarar cewa waɗanda aka tabbatar da cewa sun kamu da cutar su kamata a bi su sosai kuma a bincika su don tabbatar da cewa ba su kamu da cutar ba.
Kasar Sin ta ce yawan rashin bayyanar cututtuka ya tashi daga kashi 44 cikin dari.
Lokacin bayyanar cututtuka na yau da kullun (lokacin da ya rage tsakanin kamuwa da cuta da bayyanar cututtuka) ya kasance daga rana ɗaya zuwa kwanaki 14; yawanci kwanaki kaɗan. Misali mai ban mamaki shine cewa adadin waɗanda ke da COVID-19 ba su da ƙanshi a baya sun ragu da 30% zuwa 15%.
Wasu daga cikin cututtukan da ke tattare da cutar ba su da tabbas.
Ana ganin cewa cutar tana kamuwa da cutar ta hanyar kusanci da ruwa mai yawa wanda ya zo daga ƙasa da mita 1 ko 2.
Bincike ya nuna cewa yin tari a hankali zai iya sa ruwa ya yi zurfi daga mita 4.5 zuwa 8.2.
Wasu kuma sun ce kwayar cutar za ta iya kamuwa da cutar ta hanyar dogon lokaci na iska wanda zai iya fitowa yayin magana.
Wannan ruwa zai iya shiga cikin bakunan mutane ko hanci ko kuma numfashi zuwa huhu.
Wasu hanyoyin magani kamar shigar da numfashi a cikin huhu da kuma daukar mutum (CPR) na iya sa wannan numfashi ya shiga cikin iska kuma cutar ta yada ta hanyar iska.
Yana iya yaduwa idan mutum ya taɓa wani wuri da ke dauke da cutar kamar fata kuma ya taɓa fuska, hanci ko baki.
Idan akwai damuwa game da yiwuwar yaduwar yashi, ana ganin cewa waɗannan bala'in ba su da yawa.
Gwamnatin kasar Sin ta musanta cewa SARS-CoV-2 tana kamuwa da cutar daga tsire-tsire da ke kamuwa da cutar kuma ƙwayoyin cuta suna shiga cikin bakunan da ke kamuwa da cutar. Kwayar cutar tana kamuwa da cutar sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya yaduwa kafin bayyanar cututtuka da kuma lokacin da cutar ta yi tsanani.
Idan aka gwada mutane da suka kamu da cutar kwanaki uku kafin bayyanar cututtuka, za su iya kamuwa da cutar kafin bayyanar bayyanar cututtuka.
Akwai wasu rahotanni na kamuwa da cutar da ba su nuna alamun gwaji ba, amma an samu kamuwa da cutar ba tare da alamun bayyanar cututtuka ba a wasu ƙasashe yayin binciken da aka yi na mutane da suka kamu da cutar.
Cibiyar Tarayyar Turai don hana cututtuka da rigakafi (ECDC) ta ba da rahoton cewa ba a bayyana yadda cutar za ta iya kamuwa da sauƙi ba, wanda ya kamu da cutar zai iya kamuwa da wasu mutane biyu ko uku. Kwayar cutar tana ɗaukar awanni ko kwanaki a wani wuri.
A takaice, kwayar cutar na iya wucewa har zuwa kwanaki uku akan kayan filastik (poriporopyrene) da kwana 304 akan kayan da ba su da faduwa, kwana ɗaya akan kwali da har zuwa kwanaki huɗu akan kayan ƙarfe.
Amma, yanayin ya bambanta dangane da yanayin da zafin jiki. An gano dabbobi da sauran dabbobi masu cutar COVID-19.
Babu wata alama da ke nuna cewa dabbobi za su iya kamuwa da cutar ga mutane, ko da yake hukumomin Burtaniya sun ba da shawarar cewa mutane su wanke hannayensu bayan sun taɓa dabbobi da kuma bayan sun yi aiki a wuraren da mutane masu cutar suka yi aiki.
Cutar mura mai tsanani (SARS-CoV-2) sabon kwayar cuta ce, wacce aka samo daga mutum uku da suka kamu da cutar kumburi da ke da alaƙa da cutar mura mai tsanani a Wuhan.
Dukkanin nau'ikan sabon SARS-CoV-2 suna kama da na coronavirus. Ba a cikin jikin mutum ba, an kashe kwayar tare da sabulu na gida wanda ke lalata ƙwayar cuta kuma ya rufe ta. Kwayar SARS-CoV-2 tana kama da ƙwayar cuta ta SARS-CoV.
An yi zaton cewa ya fito ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa coronavirus yana cikin rukuni ɗaya da Betakoronavirus, wanda yake cikin dangin Saribekoviruses (dangin B) kuma duka biyu sun fito ne daga ƙwayoyin cuta.
Ya kasance a cikin kashi 96% na kwayoyin halitta na sauran kwayoyin cutar coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike a China sun gano bambanci tsakanin amino acid guda ɗaya na tsarin kwayoyin halitta tsakanin kwayar cutar da aka samo daga kwayoyin cuta da kuma wanda aka samo daga mutane.
Har zuwa yanzu, idan aka kwatanta dukkanin kwayoyin halitta, an gano cewa har zuwa kashi 92% na kwayoyin halitta na coronavirus na kwayoyin cuta da SARS-CoV-2 bai isa ya tabbatar da cewa kwayoyin cuta sun kamu da cutar ba.
Ana iya gwada kamuwa da cutar ta ɗan lokaci bisa ga alamun, yayin da ake jiran cikakken tabbatarwa ta hanyar gwajin gwajin rRT-PCR na kwararar kwari ko CT.
Wani bincike na PCR da CT da aka yi a Wuhan ya nuna cewa CT ya fi kyau wajen gano sifofin kwayar cutar fiye da PCR, ko da yake ba a bayyana shi ba, wasu halaye na wannan aikin na dakin gwaje-gwaje suna da alaƙa da sauran gwajin ƙwayar cuta da sauran cututtuka.
Har zuwa Maris 2020, Kwalejin Nazarin Kwalejin Kwalejin Amurka ta ce: Ba za a yi amfani da CT ba don gano ko amfani da shi azaman babban hanyar gano COVID-19.
Hukumar ta WHO ta sanar da jerin hanyoyin gwajin RNA na SARS-CoV-2, wanda na farko ya fito ne a ranar 17 ga Janairu.
Ana yin gwajin ta amfani da tsarin gwajin gwaji na rRT-PCR na ainihi.
Ana iya yin gwajin a kan siginan numfashi ko jini.
Sau da yawa, ana samun amsoshin cikin sa'o'i ko kwanaki.
Ana yin wannan gwajin ne ta hanyar yin amfani da na'urar daukar kwayar hanci, ko da yake ana iya yin amfani da na hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna aiki akan gwajin jini da kuma gano masu garkuwar jiki.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan hanyoyin da suka tabbatar da cewa suna ba da ƙididdigar ƙididdiga daidai don amfani da su a wurare da yawa.
A Amurka, an amince da gwajin jini na Cellex a matsayin magani amma ana amfani da shi ne kawai a cikin dakin gwaje-gwaje masu izini.
Ana amfani da CT da kuma bincike na jiki don gano alamun bayyanar cututtuka, ciki har da gano ko akwai GGO ko ruwa a cikin huhu.
Ƙungiyar likitancin Italiya ta hanyar amfani da allurar rigakafi tana samar da kundin bayanai na duniya na sakamakon gwajin allurar rigakafi ga waɗanda aka tabbatar da rashin lafiya.
Saboda haɗuwa da wasu cututtukan cututtuka kamar adenovirus, ƙididdigar ƙarfe da aka ƙayyade ta PCR ba za ta iya nuna ainihin kamuwa da COVID-19 ba.
Wani bincike mai zurfi a kasar Sin wanda ya kwatanta sakamakon gwajin kirji ta hanyar CT da PCR ya nuna cewa duk da cewa gwajin na'ura ba ya nuna cutar sosai, yana da sauri kuma yana nuna yanayin cutar sosai, wanda za a iya ɗauka a matsayin gwajin cutar.
An yi amfani da hanyar CNN ta hanyar amfani da hankali na fasaha don gano siffar hoto na kwayar cutar ta amfani da na'ura mai kwakwalwa da CT.
Matsayin hana yaduwar cutar gabaɗaya ya ƙunshi tsabtace jiki, wanke hannu, guje wa taɓa fuska, hanci ko bakinka ba tare da wanke hannu ba, da kuma tari ko shafawa da sutura da kuma zubar da sutura a cikin shara.
Ana ba da shawarar waɗanda suka kamu da cutar su saka abin rufe fuska a lokacin da suke cikin jama'a.
Matakan hanawa suna da mahimmanci don hana yaduwar cutar. Yawancin gwamnatoci sun hana ko kuma sun hana mutane yin tafiye-tafiye marasa mahimmanci zuwa ko daga ƙasashen da cutar ta shafa.
Amma a wurare da yawa a duniya, cutar ta kai ga kamuwa da mutane.
Wannan yana nufin cewa cutar tana yaduwa cikin al'umma, kuma wasu daga cikin al'umman ba su san inda aka kamu da ita da kuma yadda ta kamu ba. Masu ba da sabis na likita da ke kula da wanda zai iya kamuwa da cutar suna ba da shawara su bi ƙa'idodin kariya na yau da kullun, ƙa'idodin guje wa kusanci, kariya ta fuska. Kula da waɗanda suka kamu da cutar yana da mahimmanci ga hukumomin kiwon lafiya don gano asalin kamuwa da cutar da hana sake yaduwa.
Amfani da gwamnati da bayanan gida ta wayar salula ya haifar da damuwa game da sirrin sirri inda Amnesty International da fiye da kungiyoyi 100 suka fitar da sanarwar da ke kira ga dakatar da wannan tsarin sa ido.
An kirkiro aikace-aikace daban-daban ko kuma an nemi amfani da su da yardar rai, sannan a ranar 7 ga Afrilu, 2020, ƙungiyoyin masana sama da goma sha biyu sun nemi mafita mai zaman kanta kamar amfani da fasahar Bluetooth don adana bayanan wayar hannu da ke tattare da juna.
Masu amfani da wayoyin suna karɓar saƙonni idan sun kusanci wani wanda aka gwada da COVID-19. Akwai wasu labaran da ba daidai ba da ke gudana don hana kamuwa da cutar; misali, yin tafin hanci da kuma sanya maganin shafawa a baki ba su kashe kwayar ba.
Babu allurar rigakafin COVID-19, amma akwai cibiyoyi da yawa da ke aiki a kan shi.
Yin wanka hannu yana da muhimmanci don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na tsawon dakika ashirin; musamman, bayan sun bar wurin wanka ko sun san hannuwansu sun lalace, kafin cin abinci, bayan sun numfashi, sun yi tari ko sun yi gumi.
Wannan yana faruwa ne saboda lokacin da ƙwayar cuta ba ta cikin jikin mutum ba, sabulu na gida yana da ikon lalata ƙwayoyin cuta na ƙwayar cuta.
CDC ta kuma ba da shawarar yin amfani da maganin wanke hannu wanda ke da ƙarancin kashi 60% na ƙarancin ƙarancin ruwa idan babu sabulu da ruwa.
Hukumar ta WHO ta ba da shawara cewa kada a taɓa fuska, hanci ko bakinka da hannuwan da ba su dace ba.
Ana iya kashe ƙwayoyin cuta a wurare daban-daban tare da maganin da aka tsara (a cikin minti ɗaya bayan haɗuwa da maganin kashe cututtuka a kan ƙarfe mai hana lalacewa), ciki har da 6271% ethanol, 50100% isoporopanor, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide da 0.27.5% iodine povidone.
Sauran kwayoyi kamar benzariconium chloride da korohexigisidine gurukonate ba su da tasiri sosai wajen kashe kwayoyin cuta.
CDC ta bukaci cewa idan akwai wata sanarwa ko tabbatacciyar kamuwa da COVID a wani wuri kamar ofis ko wurin kiwon lafiya, ko'ina kamar ofis, wanka, wuraren taruwa, na'urorin fasaha kamar kwamfutar hannu, na'urorin sarrafawa, ɓangaren kwamfutar hannu, kwamfutar tafi-da-gidanka da na'urar ATM da marasa lafiya ke amfani da su, dole ne a yi musu allurar kashe kwayoyin cuta.
Cibiyoyin kiwon lafiya suna buƙatar mutane su rufe bakinsu da hanci tare da kusurwar ƙuƙwalwarsu ko kuma suturarsu lokacin da suke yin aiki ko kuma cire su kuma su watsar da suturar nan da nan a inda aka tsara ta.
Masks na likita suna da kyau ga waɗanda suke da cutar, saboda saka masks yana hana yawan hatsi da kuma yawan kwararar da ake fitarwa lokacin da kuka yi magana, kuka yi magana da kuma kuka.
Hukumar ta WHO ta ba da umarni kan lokacin da kuma yadda za a sa abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Hukumar ta WHO ta bukaci marasa lafiya su sa abin rufe fuska ne kawai idan suna da haɗarin kamuwa da cutar, kamar yadda ta ba da shawara ga mutumin da ke da COVID-19, kuma ta amince da cewa yin abin rufe fuska yana hana mutane taɓa fuska.
Kasashe da yawa sun fara ƙarfafa mazauninsu su yi amfani da abin rufe fuska.
A Amurka, CDC ta bukaci mutane su sa masks da aka yi a cikin tufafin da ba na likita ba. Musamman, China ta bukaci marasa lafiya su yi amfani da masks na likita da aka yi amfani da su bayan an yi amfani da su musamman idan sun kusanci mutane a nesa da mita 1.
Hong Kong ta bukaci mutane su sa masks na likita a lokacin tafiya ko taron jama'a.
Hukumomin kiwon lafiya a Thailand za su karfafa mutane su yi aiki a gida tare da rufe fuska da aka shafa a cikin tufafi da wanke su a kowace rana.
A Jamhuriyar Czech da Slovakia an hana mutane fita ba tare da abin rufe fuska ko rufe hanci ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska don ya sadu da mutane da yawa don kariya da kariya daga wasu.
Gwamnatin Ostiraliya ta ba da umarnin cewa duk wanda ya shiga kantin abinci ya sa abin rufe fuska.
Isra'ila ta bukaci dukan jama'a su sa abin rufe fuska a lokacin da suka haɗu da jama'a.
Afrilu 1; Taiwan, wadda ke samar da masks fiye da miliyan goma a kowace rana, ta bukaci masu tafiya a kan jiragen kasa da bas da ke haɗa birane su sa masks.
Panama ta kafa dokar saka abin rufe fuska a duk lokacin da kake fita waje, kuma tana buƙatar yin abin rufe fuska na gida ga waɗanda ba za su iya siyan kayan masana'antu ba.
Ana amfani da masks a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Kawai nesa (wanda aka fi sani da nesa) ya ƙunshi ayyukan hana kamuwa da cuta don rage yaduwar kwayar cutar da aka faɗaɗa tsakanin mutane.
Hanyoyi sun haɗa da hana zirga-zirga, dakatar da zirga-zirga da rufe makarantu, wuraren aiki, filayen wasa, wuraren wasan kwaikwayo, ko shaguna.
Mutane za su iya yin amfani da hanyoyin da za su iya guje wa kusanci ta wajen kasancewa a gida, rage tafiye-tafiye, guje wa taron jama'a, yin amfani da hanyoyin da za su iya yin gaisuwa ba tare da yin taro ba, da kuma yin nesa da juna.
A halin yanzu, ƙasashe da yawa suna yin umarni ko umarni ga mutanen da ke cikin yankunan da cutar ta fi yawa don guje wa kusanci.
Ƙididdigar yawan jama'a da aka buƙata ta hukumomin gwamnati da cibiyoyin kiwon lafiya na Amurka an rage shi cikin sauri daga 250 (lokacin da aka san babu cutar COVID-19 a yankin) zuwa 50, sannan a rage shi zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taron mutane fiye da biyu. Manya da waɗanda ke fama da wasu cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma rashin lafiyar jiki da ke da haɗarin kamuwa da cuta da cututtukan lafiya an shawarce su da CDC su zauna a gida idan za su iya kamuwa da cutar. A ƙarshen Maris 2020, WHO da sauran kungiyoyi sun fara maye gurbin kalmar "karɓar ba kusa" da "saukewa tsakanin kai da abokin tarayya", don bayyana a fili cewa abin da ake nufi shi ne kauce wa aiki yayin da akwai yiwuwar kamuwa da cutar tsakanin mutane.
Amfani da kalmar "karɓar hulɗa" ya sa mutane su yi tunanin cewa dole ne su ware kansu, maimakon ƙarfafa su su ci gaba da kasancewa tare da wasu ta hanyar da ta dace. Wasu hukumomi sun ba da umarni game da ingantaccen jima'i a wannan lokacin annobar.
Waɗannan umarnin sun ce ka yi jima'i da abokin tarayya ne kawai, ba tare da cutar ko alamun cutar ba.
Ana buƙatar keɓewa a gida don mutanen da aka gwada su da COVID-19 idan ana zaton suna da cutar.
Cibiyoyin kiwon lafiya sun ba da cikakkun bayanai game da yadda za a yi keɓewa. Kasashe da yawa sun ba da umarni ko kuma sun ba da umarnin cewa duk waɗanda ke zaune a wuraren da cutar ta kamu da cutar su keɓe kansu.
An ba da umarnin keɓewa ga waɗanda ke cikin rukunin da ke da haɗarin kamuwa da cutar.
Wadanda suka haɗu da wani wanda ke da COVID-19 da kuma waɗanda suka yi tafiya a cikin ƙasashe ko yankuna masu cutar da aka ba da shawarar keɓewa na kwanaki 14 daga ranar ƙarshe na kamuwa da cutar.
Matakan da za a iya ɗauka don hana cutar su kasance ko kuma su hana su yadawa.
Ana gudanar da rigakafin cutar a farkon annobar kuma ana nufin sa ido da keɓe masu kamuwa da cutar da kuma aiwatar da ƙarin matakan hana kamuwa da cutar da kuma yin allurar rigakafi don hana cutar ta ci gaba da yaduwa zuwa sauran al'ummomi.
Idan ba za a iya hana yaduwar cutar ba, sai a mai da hankali kan rage yaduwar: matakan da za a ɗauka don rage yaduwar da kuma rage tasirin cutar ga fannonin kiwon lafiya da kuma al'umma.
Ana iya ɗaukar matakan hanawa da rage yaduwar lokaci guda.
Dakatar da annobar yana buƙatar tsauraran matakan dakatarwa ta rage yawan sabbin kamuwa da cuta zuwa ƙasa da 1. Wani ɓangare na aikin magance cutar ta yaduwa shine ƙoƙarin rage yawan kamuwa da cuta wanda aka sani da rage yawan sababbin kamuwa da cuta.
Yana rage matsalolin da ake samu a fannin kiwon lafiya na yawan marasa lafiya da kuma samun lokaci mai yawa don neman allurar rigakafi da magani.
Hanyoyin hana kamuwa da cutar ba tare da magani ba sun haɗa da magance cutar ta hanyar matakan kariya na musamman kamar tsabtace wuka, sanya masks da keɓewa; matakan da ke cikin al'umma ba su da kyau kamar rufe makarantu da dakatar da ayyukan jama'a; buƙatar wayar da kan jama'a da amsawa; da matakan muhalli kamar share wuraren aiki. An ɗauki wasu matakan da suka dace don magance cutar a China yayin da cutar ta fara kamala kamar keɓewa ta birane gaba ɗaya da kuma sanya ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'an ƙa'idodin ƙa'an ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'un ƙa'idodin ƙa'idodin ƙa'idodin ƙa'an ƙa'idodin ƙa'idodin ƙa'un ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'un ƙa'idodin ƙa'idodin ƙa'idodin ƙa'un ƙa'idodin ƙa'un ƙa'idodin ƙa'un ƙa'idodin ƙa'un ƙa'idodin ƙa'un ƙa'idodin ƙa'un ƙa'un ƙa'idodin ƙa'un ƙa'idodin ƙa'un ƙa'idodin ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un da ƙa'un ƙa'un da ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un ƙa'un da ƙa'un da ƙa'un da ƙa'un da ƙa'un da ƙa'un da ƙa'un da ƙa'un da ƙa'un ƙa'un da ƙa'
Sauran ƙasashe ma sun ɗauki matakai daban-daban don hana yaduwar cutar.
Koriya ta Kudu ta fara yin gwaji mai yawa da kuma ware wasu sassan da kuma sanar da tafiye-tafiye masu kamuwa da cutar.
Singapore ta ba da tallafin kuɗi ga masu kamuwa da cutar da suka keɓe kansu kuma ta ba da lada mai yawa ga waɗanda ba su yi hakan ba.
Taiwan ta kara yawan yin amfani da masks da kuma hukunta masu satar kayan aikin likita. Har ila yau, Burtaniya da Amurka sun nuna cewa rage yawan kamuwa da cutar (rage yawan kamuwa da cutar ba zai hana yaduwar cutar ba) da kuma hana shi (rage yawan sababbin kamuwa da cutar) sun kasance manyan kalubale.
Matakan rage yawan kamuwa da cuta na iya rage yawan yawan bukatar da ake samu na samun magani zuwa kashi biyu bisa uku da kuma rage yawan mutuwar zuwa kashi biyu, amma ba zai hana dubban mutane mutuwa ba kuma ba za a iya samun karin marasa lafiya ba.
Zai fi kyau a dakatar da kamuwa da cutar amma ya kamata a ci gaba da yin hakan yayin da allurar ta kasance cikin mutane (ko har sai an sami rigakafi, dangane da abin da ya faru a baya), kamuwa da cutar da kuma sake dawo da cutar idan an sauƙaƙe matakan.
Yin aiki na dogon lokaci don dakatar da cutar yana haifar da haɗari ga rayuwar jama'a da tattalin arziki.
Babu takamaiman magungunan da aka tabbatar don rage cutar COVID-19, amma ana ci gaba da aikin samar da su, gami da nazarin magungunan da ke rage cutar.
Shan maganin mura ba tare da takardar sayan magani ba, shan ruwa mai yawa, da kuma hutawa na iya rage alamun cututtukan.
Saboda yanayin zafi, ana bukatar maganin oxygen, maganin ruwa, da kuma taimakon numfashi.
Yin amfani da maganin steroid zai iya sa ka rashin lafiya.
Ana gudanar da bincike kan yawancin magungunan da aka tabbatar don magance wasu cututtukan cutar don amfani da su don magance COVID-19.
Hukumar ta WHO ta ba da sanarwar cewa: Tambayar gargajiya da aka yi a gida na iya rage yawan cutar Symptoms da SARS-CoV-19 ke haifarwa.
Ƙarfafawa da daidaitawa don biyan bukatun cibiyoyin kiwon lafiya don kula da marasa lafiya na COVID-19 an bayyana su ta WHO a matsayin manyan matakan magance cutar.
ECDC da Hukumar Kula da Yankin Turai ta WHO sun ba da umarni ga asibitoci da masu ba da sabis na kiwon lafiya na asali don canza abubuwan da aka yi amfani da su a cikin ayyukan sauran hukumomi, kamar sanya ayyukan dakin gwaje-gwaje su mai da hankali kan gwajin COVID-19, dakatar da ayyukan likita marasa mahimmanci, keɓancewa da keɓewa na waɗanda suka kamu da COVID-19, da haɓaka ƙarfin sabis na gaggawa tare da horar da likitoci da haɓaka yawan kayan aikin iska don marasa lafiya da gado.
Akwai bayanai daban-daban game da asalin cutar ta farko (wanda aka fara gano cutar).
An fara gano sabon kamuwa da cutar korona a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin masu kamuwa da cutar coronavirus a Hubei ya karu.
A yawancin lokuta, masu kamuwa da cutar sun kasance suna da alaƙa da Huanan Seafood Wholesale, wanda ke sayar da dabbobi masu rai, kuma wasu rahotanni sun nuna cewa kwayar ta samo asali ne daga wasu daga cikin waɗannan dabbobi; a wasu kalmomin, ta samo asali ne daga dabbobi. An bincika marasa lafiya da ke fama da cutar ta hanyar wani abu da ba a sani ba a ranar 26 ga Disamba kuma likita Zhang Jixian na asibitin lardin Hubei ya kula da su, wanda Cibiyar Wuhan Jianghan CDC ta sanar a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, ƙungiyar likitoci a Wuhan Central Hospital ta sanar da abokan aikinta cewa akwai "SARS wanda yayi kama da coronavirus".
Wasu daga cikin likitocin, ciki har da Li Wenliang, sun tuntubi 'yan sanda don yada jita-jita, wani kuma mai suna Ai Fen, jami'an gwamnati sun gargadi shi ya bayyana lamarin.
Hukumar lafiya ta Wuhan ta fitar da sanarwar sanarwa a ranar 31 ga watan Disamba don sanar da WHO.
Hukumomin lafiya sun sanar da cewa akwai mutane da yawa da ke fama da ciwon kumburi wanda ba a san dalilinsa ba a Wuhan, wanda ya haifar da fara gwajin a farkon watan Janairu.
A farkon da tsakiyar watan Janairu na 2020, cutar ta bazu zuwa wasu lardunan China, tare da sabon tafiya a China da kuma Wuhan kasancewa cibiyar sadarwa da kuma babbar hanyar jirgin kasa zuwa larduna daban-daban.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin mutane 140 da suka kamu da cutar a rana guda, ciki har da biyu daga Beijing da ɗaya daga Shenzhen.
Bayan haka, bayanan gwamnati sun nuna cewa mutane 6,174 sun nuna alamun cutar a ranar 20 ga Janairu, 2020. Zuwa ranar 26 ga Maris, Amurka ta riga ta wuce China da Italiya tare da mafi yawan adadin waɗanda aka tabbatar da cutar a duniya. Zuwa ranar 9 ga Afrilu, 2020, an ba da rahoton kamuwa da cutar sama da miliyan 1,61 a duniya; tare da mutuwar sama da 97,000 da kuma warkewa sama da 364,000.
Kusan ƙasashe da yankuna 200 sun sami kusan mutum ɗaya da aka kamu da cutar.
Saboda annobar da ta barke a Turai, kasashen yankin Schengen sun rage tafiye-tafiye da kuma kafa hanyoyin hana kamuwa da cuta a kan iyakoki.
Kasashe sun aiwatar da matakan hana cutar kamar akato (wanda aka fi sani da tsarin kulle-kulle) da kuma tsarin su. A ranar 2 ga Afrilu, kusan mutane miliyan 300 ko kusan kashi 90% na yawan jama'a za su bi tsarin kulle-kulle a Amurka, kuma fiye da miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu da kuma mutane biliyan 1.3 a Indiya suna cikin tsarin kulle-kulle.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin tsarin zama a gida, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu, kusan kashi ɗaya bisa uku na yawan duniya.
An fara tabbatar da kamuwa da COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; rahotanni marasa tabbaci sun ce an fara gano mutum a ranar 17 ga Nuwamba.
Likita Zhang Jixian ya lura da mutanen da suka kamu da cutar ta ciwon kumburi ta hanyar wani abu da ba a san shi ba a ranar 26 ga Disamba, kuma asibitin da yake aiki ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Binciken asali na kwayoyin halitta da aka yi wa marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai SARS mai kama da coronavirus.
Hukumar Kula da Lafiya ta Wuhan ta fitar da sanarwar ta yau da kullun a ranar 31 ga Disamba.
Hukumar ta WHO ta samu wannan bayanin a ranar.
A cikin sanarwar, likitocin Wuhan sun yi gargadin 'yan sanda saboda " yada jita-jita" game da annobar.
Hukumar Lafiya ta kasar Sin ta farko ta bayyana cewa babu "babban tabbacin" kamuwa da cutar.
A karshen watan Janairu, gwamnatin kasar Sin ta sanar da kaddamar da wani babban shiri, wanda Babban Sakataren Jam'iyyar Kwaminis ta kasar Sin, Xi Jinping, ya bayyana cewa "yan Adam ne ke da hakkin yaƙi" don hana yaduwar cutar.
A cikin abin da aka bayyana a matsayin "ƙuntatawa mafi girma a tarihin ɗan adam", an sanar da matakan dakatar da zirga-zirga a ranar 23 ga Janairu don dakatar da zirga-zirga zuwa ko daga Wuhan, wanda aka kara zuwa birane 15 na Hubei, wanda ke da kusan mutane miliyan 57.
An dakatar da motocin mutane a cikin birni.
An soke bikin bikin sabuwar shekara na kasar Sin (25 ga Janairu) a wurare da dama.
Hukumomi sun kuma sanar da cewa za a gina asibitin wucin gadi na Huoshenshan, wanda aka gina a cikin kwanaki 10.
Sauran asibitoci an gina su daga baya a matsayin asibitin Leishenshan, don kula da sauran marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta sake gyara wasu gine-gine 14 a Wuhan, kamar gine-ginen taro da kuma wuraren wasanni na asibitocin wucin gadi. A ranar 26 ga Janairu, gwamnati ta ba da ƙarin umarni don magance cutar COVID-19, gami da samar da umarnin lafiya ga masu tafiya da kuma ƙara hutun bazara (Festival na bazara).
Jami'o'i da makarantu a kasar ma an rufe su.
Yankunan Hong Kong da Macau sun ɗauki matakai daban-daban; musamman, game da ilimi da jami'o'i.
An dauki matakan samar da nesa a yankuna daban-daban na kasar Sin.
An fara aiwatar da umarnin hana zirga-zirga a ciki da wajen Hubei.
Gidan kayan gargajiya na kasar Sin ya rufe jigilar jama'a.
An gudanar da bincike kan zirga-zirgar zirga-zirgar jama'a a biranen da dama, inda aka ba da umarnin barin gida ga kusan mutane miliyan 760 (fiye da kashi ɗaya cikin biyu na yawan jama'a). Bayan barkewar cutar ta zama gama gari a watan Maris, hukumomin China sun ɗauki matakan da suka dace don hana "tafiyar" cutar daga ƙasashen waje.
Alal misali, Beijing ta sanya dokar hana fita ta kwanaki 14 ga duk masu shigowa daga kasashen waje zuwa birnin. A ranar 23 ga Maris, wani mutum a China da ya shiga cikin kasar cikin kwanaki biyar da suka gabata, ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da kamuwa da cutar a cikin kasar, kuma yanzu ana yaki da cutar a kasar Sin.
A ranar 26 ga Maris, 2020, Ma'aikatar Harkokin Wajen China ta ba da sanarwar cewa an dakatar da masu shigowa da biza ko izinin zama a kasar daga ranar 28 ga Maris, ba tare da ba da cikakken bayani game da lokacin da waɗannan umarnin za su ƙare ba.
Masu neman shiga kasar Sin dole ne su nemi takardar visa a ofishin jakadancin kasar Sin ko ofishin jakadancin kasar.
Ranar 30 ga watan Maris; gwamnatin kasar Sin ta bukaci masu gudanar da harkokin kasuwanci da masana'antu da su sake budewa, ta kuma ba da tallafin kudi don sake gudanar da harkokin kasuwanci. Majalisar tarayya ta sanar da cewa ranar makoki ta kasa da kasa za ta fara da minti uku a ranar 4 ga watan Afrilu, da karfe 10:00 na yamma, tare da taron al'adu na Qingming, inda gwamnatin kasar ta bukaci iyalai su yi wa marayu sujada ta hanyar intanet don kauce wa kusanci da kuma hana sake barkewar cutar COVID-19.
A ranar 20 ga Janairu, an tabbatar da cewa COVID-19 ya isa Koriya ta Kudu daga China.
A ranar 20 ga watan Fabrairu, Hukumar Lafiya ta Kasa ta sanar da cewa an samu karuwar kamuwa da cutar, musamman sakamakon taron da aka yi a Daegu na sabon addini da ake kira Shincheonji Church of Jesus.
Shincheonji da suka zo ziyarci Daegu daga Wuhan ne suka haifar da cutar.
A ranar 22 ga Fabrairu, a cikin dukkan membobin cocin, 9,336 ne, daga cikinsu 1,261 ko kusan 13% sun ba da rahoton bayyanar cututtuka. A ranar 23 ga Fabrairu, 2020, Koriya ta Kudu ta ba da rahoton mafi yawan kamuwa da cutar.
A ranar 28 ga Fabrairu, an tabbatar da cewa an kamu da mutane fiye da 2,000 a Koriya, kuma a ranar 29 ga Fabrairu, adadin ya kai 3,150.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi tsarin tafiye-tafiye na jirgin sama kuma ana yin canje-canje. Koriya ta Kudu ta ƙaddamar da tsarin gwajin kamuwa da cuta, wanda ake ɗauka a matsayin babban tsari na duniya don gwada kamuwa da cutar, da kuma bin diddigin kamuwa da cutar da ke tattare da shi.
Tsarin gwaji yana nuna lokacin da kake da alamun cutar a cikin masu shigowa daga ƙasashen waje ta hanyar aikace-aikacen wayar hannu, gwajin cutar da ba ta fito daga mota ba inda sakamakon ya bayyana a rana mai zuwa, da haɓaka ƙarfin gwajin don gwada mutane 20,000 kowace rana.
An dauki shirin Koriya ta Kudu a matsayin mai nasara wajen hana annobar ba tare da buƙatar keɓe dukkan birane ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a gurfanar da Moon saboda rashin kulawar gwamnati game da annobar, wasu kuma suna yaba da matakin da aka dauka na yaki da annobar.
A ranar 23 ga Maris, an ba da sanarwar cewa Koriya ta Kudu ta sami ƙananan adadin kamuwa da cutar a rana ɗaya a cikin makonni huɗu.
A ranar 29 ga Maris, an sanar da cewa daga 1 ga Afrilu, sababbin masu shigowa daga waje za su yi zaman killace na makonni biyu.
A ranar 1 ga Afrilu, a cewar wani sanarwa na jaridar, Koriya ta Kudu ta nemi fiye da ƙasashe 121 su taimaka mata wajen gwada cutar.
A ranar 18 ga Fabrairu, Iran ta ba da sanarwar cewa an fara tabbatar da kamuwa da cutar SARS-CoV-2 a Qom, inda mutane biyu suka mutu a wannan ranar, a cewar Ma'aikatar Kiwon Lafiya da Ilimi na Likita.
Matakan farko da gwamnati ta sanar sun hada da dakatar da zanga-zangar da sauran ayyukan al'adu, wasanni, sallar Juma'a, rufe jami'o'i, kwalejoji da cibiyoyin ilimi.
Iran ta ba da dala biliyan biyar don yaki da cutar.
A ranar 26 ga Fabrairu, 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na keɓe yankunan da cutar ta shafa, amma ana buƙatar keɓe masu kamuwa da cutar ne kawai.
An sanar da shirye-shiryen rage zirga-zirgar birane a watan Maris, duk da cewa yawancin zirga-zirgar birane sun ci gaba kafin bikin cika shekaru takwas na Farisa na Nowruz.
Masallacin Shia na Qom ya ci gaba da budewa masu tafiya har zuwa 16 ga Maris, 2020. A watan Fabrairu, Iran ta sami mafi yawan kamuwa da cutar bayan China.
An ci gaba da zargin Iran da ɓoye adadin kamuwa da cutar, inda har zuwa 28 ga Fabrairu fiye da ƙasashe goma da ke bin diddigin kamuwa da cutar sun gano cewa sun bar Iran; yana nuna cewa cutar na iya zama mafi muni fiye da mutane 388 da gwamnatin Iran ta ba da rahoton cutar zuwa wannan ranar.
Majalisar dokokin Iran ta dakatar da ayyukanta, inda aka gano cewa 23 daga cikin 290 membobinta sun kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch (HRW) ta bukaci hukumomin kurkuku a Iran da su saki 'yancin bil adama da aka tsare da su a kurkuku saboda rashin bin doka ba tare da amfani da makamai ba da kuma sake sakin duk fursunonin da aka ba su izini.
Ya kara da cewa zai haifar da hadarin kamuwa da cutar a cikin ƙananan wurare masu yawa kamar kurkuku, inda ba a samun isasshen magani.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, wanda shine mafi girma a kasar tun lokacin da annobar ta fara.
17 ga Maris, aƙalla 'yan siyasa ko ma'aikatan gwamnati 12 da ke aiki ko da suke aiki a Iran sun mutu sakamakon cutar.
A ranar 23 ga watan Maris, a Iran, ana samun sabbin kamuwa da cutar 50 a kowace awa kuma mutum daya ya mutu a kowane minti 10 saboda cutar coronavirus.
Wani jami'in WHO ya ce akwai yiwuwar kamuwa da cutar a Iran sau biyar na yawan wadanda aka samu.
An kuma bayar da rahoton cewa takunkumin da Amurka ta dauka kan Iran na iya shafar karfin tattalin arzikin kasar wajen yaki da annobar.
Hukumar kare hakkin bil'adama ta Majalisar Dinkin Duniya ta yi kira ga a sassauta takunkumin tattalin arziki ga kasashen da cutar ta shafa, ciki har da Iran.
A ranar 31 ga Janairu, an tabbatar da cewa cutar ta kai Italiya lokacin da aka gwada matafiya biyu na kasar Sin da cutar SARS-CoV-2 a Roma.
Yawan kamuwa da cutar ya karu sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen sama daga China kuma ta ayyana dokar ta baci.
An gano nau'ikan mutane da ke da cutar COVID-19 inda a ranar 21 ga Fabrairu, an sami mutane 16 da suka kamu da cutar a Lombardy. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon tsarin kula da annobar, wanda ya haɗa da killace mutane sama da 50,000 daga birane daban-daban na arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce: "An hana shiga da fita daga wuraren da cutar ta shafa.
A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe makarantun da jami'o'i a duk faɗin ƙasar bayan da Italiya ta rasa mutane 100.
Duk manyan wasanni, gami da gasar kwallon kafa ta Italiya, an buga su ba tare da magoya baya ba har zuwa Afrilu; amma a ranar 9 ga Maris, an sanar da cewa an dakatar da duk ayyukan wasanni gaba ɗaya a cikin wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai kantunan abinci da kantunan magani. A ranar 6 ga Maris, Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar Kula da Cibiyar.
A ranar 19 ga watan Maris, Italiya ta zarce China ta zama ƙasa da ta fi yawan mutuwar coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 na cutar.
A ranar 22 ga Maris, an sanar da cewa Rasha ta tura jiragen saman soja tara masu dauke da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an tabbatar da cewa mutane 128,948 sun kamu da cutar, mutane 15,887 sun mutu, kuma mutane 21,815 sun warke a Italiya, yawancinsu daga Lombardy.
Rahotanni na CNN sun nuna cewa yawan tsofaffi a Italiya da kuma rashin iyawar da ba za a iya gwada duk masu dauke da cutar ba har zuwa wannan lokacin na iya haifar da babban adadin mutuwar.
A farkon matakin da Birtaniya ta dauka na yaki da cutar ya bayyana a matsayin mai sauki idan aka kwatanta da sauran kasashen da suka samu kamuwa da cutar; kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta kafa matakan da za su iya hana kowa shiga ko kuma su zauna a gida ba.
A ranar 16 ga Maris; Firayim Ministan Burtaniya, Boris Johnson, ya sanar da cewa duk balaguron da ba dole ba ne da kuma kusanci da jama'a ba a yarda da su, yana ba da umarni ga mutane suyi aiki daga gida idan ya yiwu kuma su guji haɗuwa da jama'a kamar gidajen abinci, gidajen cin abinci da wuraren fim.
A ranar 20 ga Maris, gwamnatin ta sanar da rufe wuraren shakatawa kamar wuraren shakatawa, wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan har zuwa 80% na albashi na ma'aikata da ba fiye da £ 2,500 a wata don hana mutane mutuwa daga rashin aikin yi a lokacin annobar. A ranar 23 ga Maris, Firayim Minista ya sanar da cewa an gabatar da matakan hana kusanci, hana haɗuwa da mutane fiye da biyu, dakatar da tafiye-tafiye da ayyukan waje don yin abubuwan da suka fi dacewa.
An riga an dauki matakan da suka shafi 'yan sanda, wanda ya hada da tarar da tarar da mutane da kuma kora masu halarta.
An bukaci rufe yawancin ayyukan kasuwanci, ban da ayyukan da ake ganin dole ne", ciki har da shagunan abinci, kantunan magani, bankuna, shagunan kayan gini, tashoshin mai da kuma na'ura mai amfani.
A ranar 20 ga Janairu, mutum na farko da aka tabbatar da kamuwa da COVID-19 a yankin Pacific Northwest, Washington, wani mutum ne da ya dawo daga Wuhan a ranar 15 ga Janairu.
A ranar 29 ga Janairu, an kafa Kwamitin Shugaban Amurka don yaki da cutar coronavirus.
A ranar 31 ga watan Janairu, gwamnatin Trump ta bayyana cewa akwai bala'i mai barazanar lafiyar jama'a, kuma ta kafa umarnin hana masu shigowa daga kasar Sin shiga kasar.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Lafiya ta Jama'a ta CDC ta Amurka ta ba da sanarwar cewa ta samar da kayan aikin bincike na cutar.
Duk da haka, Amurka ta fara gwajin cutar a hankali, wanda bai bayyana ainihin halin annobar ba a lokacin.
Gwajin kwayar cuta da kayan aikin da ba su da inganci da gwamnatin Amurka ta yi a watan Fabrairu, rashin amincewar gwamnatin Amurka da kayan aikin da ba ta yi ba (misali na jami'o'i, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma umarnin da waɗanda suka cancanci a gwada su har zuwa farkon Maris (bayan haka an bukaci takardar shaidar likita).
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ba da rahoton cewa an gwada mutane 4,000 kawai a Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa an gwada mutane 14,000 kawai.
A ranar 22 ga watan Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cutar da kuma takardar shaidar likita suna jira na sa'o'i ko kwanaki don a gwada su. Bayan mutuwar mutum na farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya sanar da dokar ta baci a jihar, sauran jihohi sun sanar da hakan nan da nan.
Makarantun da ke cikin yankin Seattle sun dakatar da karatun a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantun da ke cikin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masana cututtukan cututtuka a Kwalejin Imperial ta London ta shawarci Amurka game da tasirin sabon coronavirus a ƙasar.
A wannan ranar ne Shugaba Trump ya sanya hannu kan dokar yaki da cutar coronavirus, wadda ta ba da dala biliyan 8.3 don tallafawa ayyukan gaggawa na kamfanonin Amurka don yaki da annobar.
Kamfanoni sun dakatar da tafiye-tafiyen ma'aikata, sun dakatar da tarurruka, kuma sun ƙarfafa ma'aikatan su su yi aiki daga gida.
A ranar 11 ga Maris, Trump ya sanar da dakatar da zirga-zirgar jiragen ruwa daga Turai, ban da Burtaniya, na kwanaki 30 daga ranar 13 ga Maris.
Kashegari, sai ya ƙara Ingila da Ireland zuwa ƙasashen da aka hana.
A ranar 13 ga Maris, ya sanar da dokar ta baci ta kasar, wanda ya ba da damar samun taimakon Amurka don magance cutar.
Tun daga 15 ga Maris, yawancin kamfanoni sun rufe ko rage lokutan aiki a duk faɗin Amurka don rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cewa an kai ga ƙarshe a duk jihohi 50 da kuma yankin Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City ta sami kamuwa da cutar ta coronavirus 10,700, wanda ya fi yawan kamuwa da cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya ce, guje wa kusanci ya yi kyau, maimakon sau biyu na kamuwa da cuta ya ɗauki kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, an tabbatar da kamuwa da cutar a New York City, 32,308 daga cikinsu 672 sun mutu. A ranar 26 ga Maris, Amurka ta ba da rahoton mafi yawan kamuwa da cutar a duniya, gami da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da kamuwa da cutar a Amurka, mutane 4,335, da kuma mutuwar 12,841.
A cewar rahotanni a ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita dokar hana fita zuwa ranar 30 ga Afrilu.
A wannan rana, jirgin USNS Comfort wanda ya ƙunshi asibiti da gadaje 1000, ya isa gabar tekun New York.
A ranar 3 ga Afrilu, mutane 884 sun mutu daga cutar coronavirus a cikin awanni 24 a Amurka.
A ranar 3 ga Afrilu, a jihar New York, adadin masu kamuwa da cutar ya wuce 100,000. Shugaban Amurka ya zargi rage yawan cutar da kuma kula da saƙonnin da aka bayar kuma ya umarci hukumomin cibiyoyin kiwon lafiya da masana kiwon lafiya da su bincika maganganu da bayanan da aka yi wa jama'a da kuma sanarwar da ofishin mataimakin shugaban kasar, Mike Pence ya yi.
A gaba ɗaya, ba a yarda da amincewar Trump game da annobar ba tare da goyon bayansa ba.
Wasu jami'an Amurka da manema labarai sun soki Amurka kan jinkirin shigo da kayayyakin aiki na asali daga China, gami da kayan aikin likita na asali.
An bincika zirga-zirgar jiragen sama don ganowa da tsara yadda cutar za ta yadu kuma an buga su a cikin The Journal of Travel Medicine a tsakiyar watan Janairu 2020.
Bisa ga bayanan 2018 da aka bayar daga Hukumar Kula da Sufuri ta Jiragen Sama (IATA), Bangkok, Hong Kong, Tokyo da Taipei sun sami manyan adadin masu tafiya daga Wuhan.
Dubai, Sydney, da Melbourne sun kuma zama sananne ga masu ziyara daga Wuhan.
An sanya Bali a cikin jerin biranen 20 da aka fi ziyarta amma ba su da shiri don magance cutar, yayin da biranen Ostiraliya suka kasance a shirye. A ranar 7 ga Fabrairu, Ostiraliya ta sanar da shirin yaki da sabon nau'in coronavirus (COVID-19).
Ya ce akwai bukatar bincike mai yawa game da COVID-19, kuma Ostiraliya za ta mai da hankali sosai kan kula da iyakoki da musayar bayanai kan yawon shakatawa.
A ranar 21 ga Maris, Ostiraliya ta sanar da dokar hana kamuwa da cutar da kare jama'a.
Bisa ga sakamakon dakatar da zirga-zirgar jama'a a Wuhan, Hubei, ƙasashe da yawa sun shirya jigilar 'yan ƙasa da jakadu, galibi ta hanyar jigilar jirage zuwa ƙasashensu, yayin da hukumomin China ke ba da takardun da suka dace.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand suna cikin kasashe na farko da suka shirya yin ƙaura.
Pakistan ta ce ba za ta sake dawo da al'ummarta daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta yi wa 'yan Brazil 34, ko kuma danginsu, horo bayan 'yan Poland hudu, Sin da Indiya.
An mayar da 'yan Poland, China da Indiya zuwa Poland, inda jirgin Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da suka je Wuhan a sansanin soja kusa da birnin Brasília.
A wannan ranar, an tura 'yan Kanada 215 (176 na jirgin farko da 39 na jirgin biyu da gwamnatin Amurka ta bayar) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama da ke dauke da 'yan Kanada 185 daga Wuhan ya fadi a CFB Trenton.
A ranar 3 da 4 ga Fabrairu, hukumomin Ostiraliya sun kwashe mutane 277 zuwa gidan yari na Christmas Island, wanda aka sauya zuwa gidan killace na kwanaki 14.
Jirgin da ke dauke da masu dawowa zuwa New Zealand ya isa Auckland Airport a ranar 5 ga Fabrairu; an killace fasinjojinsa (ciki har da na Australia da tsibirin Pacific) a sansanin soja na Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta dawo da Amurkawa daga jirgin Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama da ke dauke da fasinjoji 129 na Kanada da aka kwashe daga Diamond Princess ya fadi a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin kamfanin South African Airways da gwamnatin Afirka ta Kudu ta bayar ya kwashe 'yan Afirka ta Kudu112.
An fara gwajin asibiti, inda 'yan Afirka ta Kudu huɗu suka nuna alamun cutar coronavirus da aka sanya su don rage haɗarin.
Sai dai mutanen Afirka ta Kudu da ba su nuna alamun cutar ba ne aka yi musu jinya.
Sakamakon binciken ya nuna cewa duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal da kuma sojojin da ke cikin ayyukan agaji, a matsayin kariya, an ci gaba da duba su kuma an killace su na kwanaki 14 a cikin gidan The Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara dawo da wani ɓangare na sojojin da ke Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi zuwa kasar Sin.
Wasu daliban jami'o'i na kasar Sin da ke Amurka sun hada kai wajen taimakawa wajen tura tallafi zuwa yankunan da cutar ta shafa a kasar Sin, inda wani babban rukuni a Chicago ya tattara kimanin 50,000 na N95 don a ba da su ga asibitocin lardin Hubei a ranar 30 ga Janairu. Hukumar agaji ta Direct Relief, tare da haɗin gwiwar FedEx, ta aika da 200 000 na masks da sauran kayan kariya, gami da takalma da sutura, waɗanda aka kai su a cikin jirgin sama na musamman zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun ba da sanarwar cewa sun ba da kyautar dala miliyan 100 ga WHO don tallafawa bincike kan allurar rigakafi da kuma kare "masu haɗarin haɗari a Afirka da Asiya".
Gidan talabijin na Interaction ya ruwaito cewa gwamnatin kasar Sin ta ba da takunkumi 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya tura takunkumi miliyan 3,16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar Red Cross ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da takunkumi miliyan 1 ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da ƙarin tan na kayan aikin likita ga Wuhan, Malaysia ta ba da sanarwar bayar da takunkumi miliyan 18 ga China, Jamus ta ba da takunkumi daban-daban na kayan aikin likita ciki har da takunkumi 10,000 na rigakafi na musamman kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin bayar da ƙarin dala miliyan 100 don tallafawa tattalin arzikin sauran ƙasashen da suka sha wahala daga cutar.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da kwararru don taimakawa Italiya wajen magance cutar coronavirus.
Jack Ma ya tura kayan aikin bincike miliyan 1.1 da masks miliyan 6 da kuma tufafi 60,000 zuwa Addis Ababa, Habasha don yada su ga kungiyar tarayyar Afrika.
Daga baya, ya tura kayan bincike 5,000 zuwa Panama, masks 100,000, da kuma na'urori masu numfashi 5.
Ma kuma ta ba Kanada kayan aikin likita. Netherlands, Spain, Turkey, Georgia, da Czech Republic sun nuna damuwa game da masks da kayan aikin bincike na asibiti da aka yi a China.
Misali, Spain ta dakatar da amfani da na'urori masu gano cutar coronavirus 58,000 da aka yi a China da ke da inganci na 30%, yayin da Netherlands ta cire masks 600,000 da aka yi a China daga kasuwa saboda sun zama masu lahani.
Belgium ta cire masks 100,000 da ba za a iya amfani da su ba, wanda ake zargin ya fito ne daga China, amma a gaskiya daga Colombia.
A wani bangare kuma, an yi maraba da taimakon da kasar Sin ta bayar a wasu sassan Kudancin Amirka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da ayyukan gaggawa na gaggawa a kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba da ayyukan da shugabannin kasar Sin ke yi wajen sarrafawa da hana annobar.
Hukumar Lafiya ta Duniya ta ce akwai bambanci tsakanin annobar SARS ta 2002-2004, inda aka zargi jami'an kasar Sin da ɓoyewa da kuma hana matakan hanawa da kuma hanawa, da annobar yanzu inda gwamnati "ta samar da bayanai masu inganci don ba da tabbacin tashin hankali kafin hutun Sabuwar Shekara".
A ranar 23 ga watan Janairu, bayan babban hukuma ta yanke shawarar aiwatar da dokar hana amfani da kayan masarufi a Wuhan, babban wakilin Hukumar Lafiya ta Duniya Gauden Galea ya ce duk da cewa "ba shawarar WHO ba ce", hakan ma "babban tabbaci ne na sha'awar hana cutar a halin da ta kasance mafi muni" kuma ya kira ta "ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan an tabbatar da cewa mutane suna kamuwa da cutar a wajen kasar Sin kuma yawan kamuwa da cutar na ci gaba da ƙaruwa a ƙasashe, Hukumar ta Duniya ta bayyana cutar a matsayin gaggawa ta gaggawa a matsayin matsalar lafiyar duniya kamar ta MICP, wanda aka kama da cutar ta shida a duniya a shekarar 2009.
Babban daraktan Hukumar Lafiya ta Duniya, Tedros Adhanom, ya ce, PHEIC na da nasaba da hadarin yaduwar cutar a duniya, musamman a kasashe masu talauci da kasashe masu tasowa ba tare da cibiyoyin kiwon lafiya masu karfi ba.
Game da aiwatar da dokar hana zirga-zirga, Tedros ya ce "babu bukatar a yi wasu matakan da ba su da muhimmanci da za su hana zirga-zirgar mutane da kasuwanci" kuma "WHO ba ta bukatar a yi dokar hana zirga-zirga da zirga-zirga".
A ranar 5 ga watan Fabrairu, WHO ta bukaci kasashe su ba da tallafin dala miliyan 675 don tallafawa matakan da za a dauka na shirya cutar a kasashe masu talauci, ta ce yana da gaggawa a tallafa wa kasashen da "suke da shirye-shiryen gano wadanda suka kamu da cutar, ko da sun bayyana".
Tedros ya kuma bayyana cewa "duk muna iya kasancewa da ƙarfi kamar rashin ƙarfi" kuma ya bukaci ƙasashe "su saka hannun jari a yau ko su biya ƙarin daga baya". A ranar 11 ga Fabrairu, a wata hira da manema labarai, WHO ta amince da COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya sanar da cewa Sakataren Majalisar Dinkin Duniya António Guterres ya amince ya ba da "dukan ƙarfin Majalisar Dinkin Duniya wajen neman amsar".
Saboda haka, an kafa Ƙungiyar Kula da Matsalar Majalisar Dinkin Duniya, wadda ta haɗa dukkan ayyukan Majalisar Dinkin Duniya, wadda Hukumar Kiwon Lafiya ta ce za ta "mai da hankali sosai ga taimakon kiwon lafiya yayin da sauran sassan za su iya ba da kwarewarsu wajen magance tasirin zamantakewar al'umma, tattalin arziki, da ci gaban duniya na annobar".
A ranar 14 ga watan Fabrairu, an kafa wata kungiya ta WHO da ke jagorantar kasar Sin don zaɓar kwararrun masana na duniya da na WHO da aka tura zuwa China don taimakawa wajen sarrafawa da sarrafa yaduwar cutar" tare da gudanar da horo da shawarwari tare da manyan hukumomin kasar da kuma ziyartar wurare daban-daban don nazarin "matsayin da ayyukan yaki da cutar za su iya yi a larduna da yankuna da yankuna da garuruwa". A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "duniya ta kamata ta dauki mataki don shirya don magance cutar", ta sanar da cewa duk da cewa an riga an fara cutar coronavirus, dole ne "kasashen duniya su shirya don cutar".
Don magance ci gaban annobar a Iran, WHO ta tura wani rukuni na hadin gwiwa don duba halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga gwajin kamuwa da cutar coronavirus a duniya daga matakin "babba" zuwa matakin "babba", matakin gargadi da kimantawa na tasiri.
Mike Ryan, shugaban ayyukan agaji na WHO, ya yi gargadin cewa "Wannan misali ne na gaskiya ga kowace ƙasa a duniya: Ku farka.
Wannan kwayar cutar tana gabatowa kuma dole ne ku kasance a shirye", in ji shi, yana mai jaddada cewa tsauraran matakai na magance ta na iya taimakawa wajen hana "hadarin da take haifarwa".
Ryan ya kara da cewa, ba a taba samun bayanai da suka sa hukumar kiwon lafiya ta duniya ta bayyana cewa cutar ta zama babbar annoba ba, yana mai cewa sanarwar za ta nuna cewa "a gaskiya mun yi imani cewa kowa a duniya zai kamu da cutar".
A ranar 11 ga Maris, WHO ta ayyana coronavirus a matsayin annoba.
Babban daraktan ya bayyana cewa WHO "ta damu sosai game da karuwar gaggawa da rashin daukar matakan". WHO ta yi ta sukar abin da ya zama kamar rashin tsauraran matakan hana cutar, kamar sanarwar da ke magana game da bala'in lafiyar jama'a da kuma sanya cutar cikin cututtukan cututtuka.
Wani takaddama da aka yi ya hada da bukatar da aka yi na cewa Babban Daraktan WHO, Tedros Adhanom ya mika wuya, har zuwa 6 ga watan Afrilu, wanda ya riga ya samu amincewar mutane 733,000.
A ranar 26 ga Maris, 2020, masana kan haƙƙin ɗan adam na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum a lokacin annobar COVID-19.
Wannan rukunin masana sun bayyana cewa kowa yana da 'yancin yin ayyukan da ke kare lafiyarsa kuma alhakin gwamnati ne.
Wannan rukunin ya jaddada cewa rashin wadata ko inshorar lafiya bai kamata ya zama dalilin nuna bambanci ga wani rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin kiwon lafiya, ciki har da nakasassu, na kungiyoyin da ke cikin ƙasa, tsofaffi, masu gudun hijira, marasa gida, talakawa, fursunoni, da 'yan gudun hijira da sauran kungiyoyin da ba na musamman ba da ke bukatar taimakon gwamnati.
Kungiyoyin duniya da gwamnatoci suna aiki tare don magance matsalolin tattalin arziki da zamantakewar jama'a da cutar COVID-19 ta haifar.
Kungiyar Tattalin Arziki da Ci Gaban ta kaddamar da wani dandamali na samar da cikakken bayani game da manufofin da ke magance wannan matsalar a cikin ƙasashen duniya, da kuma ra'ayoyi da shawarwari daban-daban.
Daga manufofin karfafawa na kiwon lafiya da tattalin arziki na duniya don hana tasirin tsarin tsare-tsaren gida da rage yawan zirga-zirgar mutane, matakan da aka dauka na fasaha sun haɗa da Hanyar gano masu kamuwa da cutar, kuma suna nufin taimaka wa ƙasashe su koya daga juna da kuma taimaka musu su daidaita matakan duniya don magance cutar coronavirus.
Gwamnatin kasar Sin ta yi ta sukar Amurka, Ministan majalisar ministocin Birtaniya Michael Gove, da Eduardo Bolsonaro, dan shugaban Brazil Jair Bolsonaro, kan yadda suka magance cutar da ta barke a lardin Hubei.
An kori jami'an jam'iyyar kwaminis ta kasar Sin (CPC) da dama daga cikin manyan jami'an larduna saboda yadda suka yi aiki a kan batun warewar jama'a a tsakiyar kasar Sin, wanda ya nuna rashin jin dadin matakan da jami'an siyasa suka dauka wajen magance annobar a yankunan.
Wasu masu sharhi sun ce wannan shawarar ta yi ne don kare Babban Sakataren Jam'iyyar Kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da annobar coronavirus.
Wasu daga cikin shugabannin kasar Sin, ciki har da Zhao Lijian, sun ƙi sanin cewa cutar ta coronavirus ta fara ne a Wuhan, suna tallafawa koyarwar ɓoyewa game da COVID-19 daga Amurka ko Italiya.
Gwamnatin Donald Trump a Amurka ta kira coronavirus "Cinese virus" ko "Wuhan virus" inda ta ce kasar Sin ta ɓoye bayanai da suka sa cutar ta zama annobar duniya. Amma wasu mutane sun yi watsi da wannan a matsayin nuna wariya da kuma sa mutane su manta da rashin iyawar gwamnatinsa wajen hana annobar.
Shafin yanar gizo na Daily Beast ya samu bayanan gwamnatin Amurka game da dabarun sadarwa da ake zargin sun fito ne daga Hukumar Tsaro ta Kasa, inda aka bayyana cewa, "Dukkanin suna da alaƙa da China.
An gaya mana cewa mu yi iya ƙoƙarinmu mu sa wannan saƙon ya zama sananne a ko'ina, kamar a cikin tattaunawa da manema labarai da kuma talabijin. "Magazannin labarai kamar su Politico, Foreign Policy, da Bloomberg sun nuna cewa ikon da kasar Sin take amfani da shi wajen tura kuɗi zuwa ƙasashen waje hanya ce ta samun iko a duniya.
Shugaban jam'iyyar Tarayyar Turai na kasa da kasa Josep Borrell ya yi gargadin cewa akwai matsala a harkokin siyasa tsakanin kasashen ciki har da gwagwarmayar neman mulki a kasashen waje ta hanyar nuna gaskiya da kuma 'yancin kai'".
Borrell ya kuma ce "China ta ba da sako a fili cewa, ba kamar Amurka ba, ita ce abokiyar kirki da kuma abin dogaro".
China ta kuma bukaci Amurka ta soke takunkumin da ta dauka kan Syria, Venezuela da Iran, yayin da kuma ake zargin cewa kasar Sin ta tura kudade zuwa Venezuela da Iran.
A ranar 3 ga Afrilu, an kama kyautar Jack Ma na masks 100,000 da za mu kai Cuba saboda takunkumin da Amurka ta yi mana.
An kuma zargi hukumomin Amirka da yin amfani da kuɗin da aka ba su a ƙasashen waje a ƙasarsu.
Akwai wasu takaddama game da rufe fuska da suka taso tsakanin wasu ƙasashe; kamar Jamus, Austria da Switzerland; har ma tsakanin Czech Republic da Italiya.
Ƙari ga haka, Turkiyya ta kama ɗaruruwan na'urori masu ba da iska da suke zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai saboda rashin nuna hadin kai ga Italiya a lokacin da cutar ta addabe ta.
Maurizio Massari, jakadan Italiya a Tarayyar Turai ya ce: "China ce kaɗai ta taimaka wa Italiya.
Wannan ba alama ce mai kyau na haɗin kai na Turai ba".
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya rundunar sojin Rasha don aika da sojoji na likitoci, motocin kashe kwayoyin cuta, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi amfani da "bayanan wani babban jami'in" da ba a bayyana sunansa ba, inda ta ce kashi 80 cikin 100 na tallafin da Rasha ke bayarwa "ba su da amfani ko kuma ba su da amfani ga Italiya".
Mai bayar da rahoton ya zargi Rasha da neman tayar da "damuwar siyasa da diflomasiyya" tsakanin kasashen.
Shugaban Lombardi, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi Di Maio, sun musanta wannan sanarwa a kafofin watsa labarai kuma sun bayyana suna yaba wa Rasha.
Rasha ta kuma tura wani jirgin sama mai dauke da kayan aikin likita zuwa Amurka.
Kakakin shugaban Rasha Dmitry Peskov ya ce: "Idan Putin ya ba da taimako ga 'yan'uwansa a Amirka, yana ganin cewa idan Amirkawa suka yi nasara wajen samar da kayan aikin likita, za su iya taimaka mana idan ya cancanta".
An shirya shirin NATO na soja na "Defender 2020" a Jamus, Poland, da Baltic, wanda shine mafi girman shirin NATO na soja tun bayan yakin sanyi, za a gudanar da shi a cikin matsakaici.
Babban sakataren harkokin yaki da makaman nukiliya, Kate Hudson ta soki wannan atisayen soja da aka kira Defender 2020': "A cikin wannan matsalar lafiyar jama'a da muke ciki, ba kawai rayuwar sojoji na Amurka da sauran kasashen Turai da ke cikin haɗari ba amma na jama'ar da ke zaune a ƙasashen da sojoji ke aiki". Wannan kwayar cutar ta yi tasiri sosai a gwamnatin Iran, inda akwai wakilai na jama'a ashirin da ɗaya da kuma wasu manyan 'yan siyasa da suka kamu da cutar.
A ranar 14 ga Maris, 2020, Shugaban Iran, Hassan Rouhani, ya rubuta wata wasika ta gaggawa ga shugabannin duniya da ke neman taimako, yana mai cewa kasarsa tana fama da annobar saboda rashin iyawar ta da kasuwanni na duniya saboda takunkumin da Amurka ta dauka kan Iran. Wannan annobar ta sa Amurka ta bukaci kafa manufofin inganta rayuwar da ake samu a sauran kasashe masu arziki, gami da kiwon lafiya ta duniya, kula da yara a duniya, hutun iyali da aka biya, da kuma inganta ingantaccen tallafin kiwon lafiya ga jama'a.
Masu sharhi kan siyasa sun yi tunanin cewa zai iya shafar nasarar da Donald Trump zai samu na sake zabar shugaban kasa a shekarar 2020.
Koriya ta Kudu ta soki Japan saboda "ta amfani da karfi wajen ware mutane" bayan da Japan ta sanar da cewa za a ware duk wanda ya bar Koriya ta Kudu a cikin makonni biyu a wuraren da gwamnati ta kafa.
A farkon, mutanen Koriya ta Kudu sun sami rashin fahimta game da halin Shugaba Moon Jae-in game da batun.
Yawancin 'yan Koriya sun sanya hannu kan bukatar cire Moon daga mulki saboda zargin da ake yi da rashin nasarar gwamnati wajen magance cutar, ko kuma sun yaba da yadda ta amsa.
Wasu masu ba da shawara sun nuna damuwa cewa hakan zai iya sa gwamnati ta ci gaba da kasancewa da ƙarfi.
A Hungary, majalisar dokokin kasar ta amince da firaministan kasar Viktor Orbán ya yi mulki ba tare da an san shi ba, ya dakatar da majalisar dokoki da kuma zaben, kuma ya hukunta wadanda ake zargi da yada labaran karya game da cutar da kuma yadda gwamnati ke magance matsalar.
Cutar coronavirus ta haifar da mummunan tasirin rashin kayayyaki, daga karuwar amfani da kayan aikin rigakafin annoba a duniya, yawan cinikin mutane saboda tsoro, da kuma rikice-rikice na masana'antu da ayyukan su.
Hukumar Kula da Abinci da Magunguna ta Amurka ta yi gargadin rashin magani da kayan aikin likita saboda karuwar bukatar masu amfani da su da kuma matsalar rashin amfani da kayayyaki.
A wurare da yawa, mutane suna sayen abubuwa da yawa saboda tsoro da ke sa wasu abubuwa masu muhimmanci a cikin shaguna kamar abinci, takardu, ruwa a kwalba su shiga cikin matsalar rashin kayayyaki a kasuwa.
Masana'antun fasaha sun ba da shawara ga mutane game da jinkirin aikawa da kayayyakin lantarki.
A cewar shugaban hukumar lafiya ta duniya Tedros Adhanom, ya ce, bukatar kayan kariya ta ninka sau 100.
Wannan ya haifar da karin farashin kusan sau ashirin fiye da na yau da kullun kuma ya haifar da raguwa a kan samar da kayan aikin likita na watanni hudu zuwa shida.
Wannan ya kuma haifar da matsalar rashin kayan kariya a duniya, WHO ta ce hakan zai sa lafiyar ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu kasuwanci ba bisa ka'ida ba don sayar da kayayyakin Ostiraliya zuwa China.
Wannan aikin ya haifar da raguwar yawan shan madara ga jarirai a wasu yankuna kuma daga baya Gwamnatin Ostiraliya ta dakatar da su. Duk da cewa yawan kamuwa da COVID-19 ya karu a arewacin Italiya da lardin Wuhan, tare da karuwar yawan masu bukatar abinci, a cikin waɗannan yankuna biyu babu wata babbar matsala game da rashin abinci.
Matakan da kasar Sin da Italiya suka dauka na yaki da cinikin da ba a yarda da shi ba sun yi nasara, kuma hakan ya rage rashin abinci kamar yadda ake tsammani a Turai da Arewacin Amirka.
Arewacin Italiya na da yawan amfanin gona, ba a taɓa raguwa sosai ba, amma jami'an masana'antu sun ba da sanarwar cewa farashin zai iya tashi.
Shagunan abinci marasa amfani sun kasance na ɗan gajeren lokaci, har ma a Wuhan, jami'an gwamnatin China sun buɗe shagon sayar da kayan alade don samar da isasshen abinci ga jama'a.
Irin wannan dokar ta wanzu a Italiya kuma tana bukatar masana'antun abinci su ci gaba da adana kayayyakin da za a iya ajiye su a cikin yanayi mai tsanani.
Rashin tattalin arzikin duniya ya shafi kasar Sin: a cewar wani rahoto na jaridu a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi matukar damuwa a farkon watanni biyu na shekarar 2020 sakamakon matakan da gwamnati ta dauka na hana yaduwar cutar, kuma yawan kasuwancin da ke cikinta ya ragu da kashi 20.5%.
A matsayin babbar tattalin arziki da masana'antu na kasar Sin, annobar cutar ta zama babbar matsala ga tattalin arzikin duniya.
Agathe Demarais na kamfanin leken asiri a cikin The Economist' ya ba da rahoton cewa kasuwanni za su ci gaba da rikicewa har sai an bayyana cikakken hoto game da yiwuwar samun riba.
A watan Janairun 2020, wasu masu sharhi sun nuna cewa matsalar tattalin arziki da annobar ta haifar ga ci gaban tattalin arzikin duniya na iya fice da annobar SARS ta 2002-2004.
Wani ƙididdiga daga Jami'ar Washington a St. Louis ya nuna cewa, wannan zai iya haifar da tasiri mai yawa na dala biliyan 300 a kan darajar duniya, kuma wannan zai iya ɗaukar shekaru biyu.
An ce kungiyar OPEC ta "yi matukar damuwa" bayan da farashin man fetur ya fadi saboda kasar Sin ba ta bukatar hakan ba.
A ranar 24 ga Fabrairu, kasuwannin kuɗi da na jari na duniya sun faɗi saboda karuwar yawan kamuwa da COVID-19 a wajen China.
A ranar 27 ga Fabrairu, sakamakon karuwar matsalolin yaduwar cutar coronavirus, farashin kasuwa da kuma wasu kasuwannin Amurka, ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun nuna mummunan asara tun daga 2008, inda Dow ya fadi da maki 1,191, wanda shine mafi muni a cikin rana ɗaya tun lokacin da aka fara rikicin tattalin arziki na 2007-08.
Dukkanin gwaje-gwaje uku sun kammala sati a kasa da 10%.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta amince da tsarin ba da bashi na kasar Sin, amma ya ci gaba da nuna rashin jin daɗi.
Kasuwancin kuɗi da hannun jari sun faɗi saboda tsoron coronavirus, wanda ya faru a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa za a iya samun ciwon tattalin arziki.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna da gwamnatoci saboda matakan agaji da suka dace.
Babban bankin kasa da kasa ya farfado da cutar da sauri fiye da yadda suka yi a lokacin Babban Rashin tattalin arziki na 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da cutar ta fi shafa saboda dakatar da tafiya, rufe wuraren taron jama'a tare da wuraren da ke da kyawawan wurare, da kuma shawarar gwamnati na hana kowane irin tafiya a duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun dakatar da zirga-zirgar jiragen sama saboda karancin fasinjoji, ciki har da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na Flybe wanda ke aiki ne kawai a Burtaniya ya rufe har abada.
Sakamakon da aka samu a kan manyan jiragen ruwa na fasinjoji ya kasance ba a taɓa gani ba.
An rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da yawa.
Cutar ta haɗu da Chunyun, wani muhimmin lokaci don yin tafiya don hutun Sabuwar Shekarar Sin.
Yawancin ayyukan da jama'a ke halarta sun dakatar da su ta hanyar gwamnatoci na ƙasa da na yanki, gami da bukukuwan Sabuwar Shekara, inda kamfanoni masu zaman kansu suka rufe shagunan su da kuma wuraren yawon shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland sun rufe.
Yawancin bukukuwan Sabuwar Shekara da wuraren shakatawa masu ban sha'awa an rufe su don kauce wa taron jama'a, ciki har da Forbidden City a Beijing da kuma bikin gargajiya na masallatai.
A cikin jihohi 24 daga cikin 31 na kasar Sin, manyan birane da yankuna, hukumomi sun kara hutun sabuwar shekara zuwa 10 ga Fabrairu, suna ba da umarnin cewa wuraren aiki da yawa ba za su sake buɗewa ba har zuwa wannan ranar.
Waɗannan yankuna suna da kashi 80% na GDP da 90% na fitarwa.
Hong Kong ta kara tsawaita matakan yaki da annobar, ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta dakatar da bikin Sabuwar Shekara. Kasuwancin da aka shafa gaba ɗaya, ta rage lokacin buɗe shaguna ko kuma ta rufe na ɗan lokaci.
Kashi 40% na yawan masu ziyartar wuraren kasuwanci a Turai da Kudancin Amurka sun ragu.
Kasuwancin Arewacin Amirka da Gabas ta Tsakiya sun ragu da kashi 50-60%.
Wannan kuma ya haifar da raguwar 33-43% a cikin yawan masu shiga cikin wuraren kasuwanci a watan Maris idan aka kwatanta da Fabrairu.
Dillalai a manyan shagunan duniya sun kara daukar matakai, kamar kara tsaftacewa, sanya na'urorin zafin jiki don auna wutar masu amfani da kuma dakatar da ayyukan bukukuwa. A cewar Hukumar Kula da Tattalin Arzikin Kasashen Kudancin Amurka ta Majalisar Dinkin Duniya, annobar za ta bar mutane miliyan 14 zuwa 22 a Kudancin Amurka cikin matsananciyar talauci fiye da yadda za su kasance idan ba a yi hakan ba.
A cikin watan Janairu da Fabrairu na 2020, yayin da annobar ta kasance mafi muni a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin ma'aikatan kasar Sin miliyan 300 da ke aiki a karkara an tsare su daga gidajensu a lardunan cikin gida ko Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu suna neman taimakon gwamnati.
A cewar Federal Reserve Bank of St. Louis, annobar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi zai iya kaiwa 32%. A Indiya, Tsarin Rage gida ya bar miliyoyin Indiyawan baƙi (marasa aikin yi) marasa aiki. Wani binciken da Angus Reid ya gudanar ya nuna cewa kashi 44% na iyalai a Kanada sun fuskanci matsalar rashin aikin yi. Kimanin ma'aikata 900,000 sun rasa a Spain tun lokacin da aka fara Tsarin Rage gida a tsakiyar watan Maris na 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi amfanin rashin aikin yi na wucin gadi kuma ma'aikata miliyan 1 na Burtaniya sun nemi shiga cikin tsarin bashi na jama'a. Kimanin rabin miliyan na kamfanoni a Jamus sun tura ma'aikatansu zuwa shirye-shiryen wucin gadi da gwamnati ke tallafawa da ake kira Kurzarbeit.
Ƙasar Faransa da Ingila sun soma amfani da tsarin biyan kuɗi na ɗan lokaci a Jamus.
Masana'antu da al'adun gargajiya sun sha wahala sosai daga annobar, saboda ta shafi ayyukan kamfanoni da kuma mutane (masu amfani da masu zaman kansu) a duniya.
Kungiyoyin al'adu da fasaha sun yi ƙoƙari su kula da alhakinsu (galibi da tallafin jama'a) na kula da al'adu, kula da lafiyar ma'aikata da al'umma da kuma taimaka wa masu fasaha inda zai yiwu.
A watan Maris na 2020, a duk faɗin duniya, da kuma a hanyoyi daban-daban, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran wuraren tarihi sun rufe har abada kuma an dakatar da ko kuma an sake dawo da nune-nunen su, bukukuwa da abubuwan baje kolin su.
Don magance matsalar, an dauki matakan samar da ƙarin sabis na fasaha. Wani babban matakin da aka ɗauka kwanan nan kuma yana hanzarta rage cutar shine dakatar da duk ayyukan gani, manyan wasanni da sauran ayyukan haɗin jama'a ciki har da wasan kwaikwayo na kiɗa, shawarwari na fasaha da kuma abubuwan da suka shafi hasken zamani.
A lokacin da aka yi bikin, an dakatar da bikin mako mai tsarki a Roma, wanda ke faruwa a makon ƙarshe na lokacin tuba na Kirista a Gisibo.
Yawancin majami'u sun ba Kiristoci tsofaffi umurni su zauna a gida maimakon zuwa coci a ranar Lahadi; wasu ikilisiyoyi sun yi nazarin taro ta rediyo, Intane, ko talabijin yayin da wasu suka yi amfani da motocin su saurari taron.
Yayin da cocin Katolika ya rufe majami'u da kuma ɗakin ibada da kuma babban filin St. Peter's, sauran cocin sun dakatar da taron jama'a kuma sun rage yawan taro a majami'u, masallatai, majami'u, da kuma sauran wurare.
Ma'aikatar Lafiya ta Iran ta sanar da cewa an dakatar da sallar Juma'a a wuraren da cutar ta shafa da kuma wuraren ibada daga baya, yayin da Saudiyya ta hana baƙi masu zuwa haikalin addini shiga da kuma hana mazauna yankin shiga wuraren ibada a Makka da Madina.
Cutar ta haifar da mummunan rikici a cikin wasanni na duniya tun bayan yakin duniya na biyu.
An dakatar da ko kuma an dage wasanni da yawa, ciki har da gasar zakarun Turai 201920, gasar zakarun Ingila 201920, gasar zakarun Turai 2020, gasar zakarun Amurka 201920, da kuma gasar zakarun Turai 201920.
A ranar 24 ga Maris, kwamitin wasannin Olympics na duniya ya ba da sanarwar cewa wasannin "za a sake ƙaddamar da su zuwa ƙarshen 2020 amma ba kafin lokacin bazara na 2021 ba".
Wannan ya haifar da yawan masu caca da yawa zuwa Intanet, inda yawancin shafukan caca ke ba da rahoton cewa adadin rajista ya ƙaru sosai. Hakanan nishaɗi ya shafar, inda ƙungiyoyin kiɗa da yawa suka dakatar ko kuma suka jinkirta tafiye-tafiyen su.
Babban gidajen wasan kwaikwayo kamar na Broadway sun dakatar da duk wasan kwaikwayo.
Wasu masu fasaha sun nemi hanyoyin ci gaba da samar da kayayyaki da kuma raba ayyukan su ta yanar gizo a matsayin hanyar maye gurbin abubuwan da suka faru na gani na ainihi, gudanar da zanga-zangar yanar gizo, ko gudanar da "ƙungiyoyi" na yanar gizo don masu fasaha, don haka yadawa, har ma da tallata ayyukansu.
A cikin intanet, akwai hotunan ban dariya da ke mai da hankali kan coronavirus saboda mutane da yawa suna so su yi dariya da kuma nishadi kafin su fahimci inda lamarin yake.
Tun lokacin da cutar ta COVID-19 ta fara, an sami ƙiyayya mai yawa, ƙiyayya da baƙi, da nuna bambanci tsakanin mutanen da ke fitowa daga China da Gabashin Asiya, da kuma waɗanda ke fitowa daga wurare masu haɗari a Turai, Amurka da sauran ƙasashe.
Tsoro, nuna bambanci, da kuma faɗa sun yi yawa a ƙasashe da yawa, musamman a Turai, Gabas ta Asiya, da Arewacin Amirka, da kuma Asiya-Pacific.
Rahotanni na watan Fabrairu (lokacin da yawancin marasa lafiya ke cikin China) sun nuna halin nuna wariya a cikin kungiyoyi daban-daban a duniya, suna cewa Sinawa sun cancanci cutar ko kuma za a hukunta su.
Wasu ƙasashen Afirka ma sun nuna ƙiyayya da ake yi wa Sinawa.
Yawancin mazauna Wuhan da Hubei sun ce an nuna musu wariya bisa ga asalin su.
An samu goyon baya ga 'yan kasar Sin, a zahiri da kuma ta yanar gizo, da kuma wadanda ke yankunan da cutar ta shafa.
Yayin da annobar ke yaduwa zuwa sababbin ƙasashe, mutanen Italiya, ƙasa ta farko a Turai da ke da yawan adadin masu kamuwa da COVID-19, na iya fuskantar ƙiyayya da ƙiyayya game da baƙi. Mutanen ƙasashe kamar Malaysia, New Zealand, Singapore da Koriya ta Kudu a kan takarda sun sanya hannu kan takardar gargaɗi ga sauran ƙasashe don hana Sinawa shiga ƙasashensu don hana yaduwar annobar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
Kasashen Sin da kuma wasu 'yan Asiya a Birtaniya da Amirka sun ce an samu karuwar nuna bambanci da kuma kai hare-hare.
Shugaban Amurka Donald Trump ya fuskanci mummunan zargi saboda kiran coronavirus "Cinese Virus", kalmar da masu sukar ta dauki nuna wariya da kuma adawa da Sinawa.
Masu zanga-zangar na Ikreeniya sun tashi da bas din da ke dauke da 'yan gudun hijira da kuma kasashen waje daga Wuhan zuwa Novi Sanzhary.
Dalibai daga arewa maso gabashin Indiya, iyakar da ke da ita da China, suna karatu a manyan biranen Indiya don fuskantar cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a West Bengal, Dilip Ghosh, ya ce, kasar Sin ta lalata muhalli "saboda haka Allah ya hukunta su".
Ofishin jakadancin kasar Sin a Kolkata ya yi watsi da wannan lamarin, yana mai da shi "abubuwan da ba su dace ba". A kasar Sin, ƙiyayya da baƙi da kuma nuna wariyar launin fata sun kasance a cikin annobar, inda baƙi ake kira "ƙazanta na baƙi" kuma ya kamata a zubar da su.
Yawancin jaridu da ke da shafukan yanar gizo da ke cajin masu ziyartar sun cire wasu ko duk farashin da ake cajin su akan labaran coronavirus.
Masu rubutun kimiyya sun wallafa littattafan kimiyya game da annoba kuma kowa zai iya samun su.
Wasu masana kimiyya sun zaɓi raba abubuwan da suka samu daga binciken kwanan nan tare da sabobin aikace-aikace kamar bioRxiv.
Cutar da ke faruwa - Cutar da ke faruwa ta hanyar kwayar cuta, sau da yawa sabon abu ne a cikin bayyanar ko kuma hanyar kamuwa da cutar
Tattalin Arziki da Cututtuka - Hanyar Tattalin Arziki da Yadda Cututtuka Suke Yaduwa
Jerin cututtuka da annoba  Jerin mutuwar cututtuka
Cin Hanci da Rashawa da Cututtuka Daga Dabbobi - Sakamakon Cinikin Dabbobi
Gwajin dakin gwaje-gwaje na cutar coronavirus 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa ya haɗa da gano ƙwayoyin cuta da gano tsarin garkuwar jiki.
Ana tabbatar da kwayar cutar a cikin gwajin da aka ɗauka ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da waɗanda suka kamu da cutar ko waɗanda suka warke.
Ana iya amfani da ganewar asali na jiki (binciken jini) don tantancewa da kuma lura da al'umma.
Gwajin rigakafi na jiki yana nuna yawan mutanen da ke da cutar, gami da waɗanda ke da alamun da ba su da yawa don sanar da masu kula da cutar ko ba su da alamun cutar.
Ana iya tantance ainihin adadin mutuwar cutar da matakin rashin tsaro a cikin al'umma daga sakamakon wannan gwajin.
Saboda karancin adadin masu gwajin, a watan Maris na 2020, babu wata ƙasa da ke da tabbacin gaskiyar cutar a cikin al'ummarta.
A ranar 23 ga watan Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3 cikin 100 na yawanta, kuma akwai bambancin da ya sa an yi gwajin a kowace ƙasa.
Wannan canjin zai iya shafar yawan mutuwar, wanda zai iya zama mafi muni a wasu ƙasashe.
Ta hanyar yin amfani da saurin daukar hoto da kuma nazarin gwajin kamuwa da cuta (rRT-PCR), ana iya yin gwajin cutar ta hanyar gwajin numfashi na iska wanda aka samo ta hanyar amfani da hanyoyi daban-daban, ciki har da gwajin ƙuƙwalwa ko na hanji.
A cikin 'yan sa'o'i kadan zuwa kwanaki biyu, ana samun amsoshin.
Gwajin RT-PCR na ƙwayoyin cuta shine kawai hanyar da za a iya amincewa da ita a farkon makon kamuwa da cuta.
Daga nan, kwayar cutar za ta iya shiga cikin hanci yayin da ta ci gaba da yaduwa cikin huhu.
Ga mutanen da aka gano suna da cutar a mako na biyu, zai fi kyau a sake gwada su da wasu gwaje-gwaje na gwaji.
Wani gwajin PCR na ƙarshe da aka yi a Charité a Berlin a watan Janairun 2020 ya yi amfani da saurin yin amfani da saurin yin amfani da gwajin rigakafi (rRT-PCR) da kuma kayan aikin 250,000 da Hukumar Lafiya ta Duniya ta bayar.
A ranar 28 ga Janairu, 2020, Kamfanin Kogenebiotech na Koriya ta Kudu ya shirya gwajin na'urar gano SARS-CoV-2 ta PCR (PowerChek Coronavirus).
Yana gano kwayar cutar "E" da ke yaduwa ta hanyar nau'in coronavirus da ke cikin jikin mutum, da kuma kwayar cutar RdRp da ke bayyana a cikin SARS-CoV-2. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da aka amince da su ta hanyar Cibiyar Kula da Kayan aikin Likita ta Kasa don amfani da kayan aikin gwajin SARS CoV-2 na PCR. A Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) tana haɓaka kayan aikin RT-PCR Diagnostic da ake amfani da su don gwada sabon Coronavirus 2019 (2019-nCoV) a cikin dakin gwaje-gwaje na duniya ta hanyar Cibiyar Nazarin Kayan aikin Kayan aikin Kayan aiki ta Duniya (International Reagent Resource).
Daya daga cikin gwaje-gwaje uku na ƙwayoyin halitta a cikin tsohuwar sigar na'urar gwaji ta haifar da sakamako mai ban mamaki saboda ƙarancin magungunan da aka yi amfani da su, da kuma ƙalubalen gwaji a Cibiyar Kula da Cututtuka (CDC) a Atlanta; wanda ya haifar da matsakaicin gwajin gwaji na 100 a kowace rana a cikin Fabrairu 2020.
Ba a sa ran gwajin gwaji na biyu ya zama abin dogaro ba har zuwa 28 ga Fabrairu, 2020, kuma har zuwa wannan lokacin an ba da izinin fara gwajin ga dakunan gwaje-gwaje na tarayya da na yanki.
Hukumar Abinci da Magunguna ta amince da gwajin kuma ta ba da izinin gaggawa. Labs na kasuwanci a Amurka sun fara gwajin a farkon Maris 2020.
Har zuwa 5 ga Maris, 2020, LabCorp ta ba da sanarwar cewa an sami tsarin gwajin COVID-19 na ƙasa-da-kasa dangane da RT-PCR.
Quest Diagnostics ta kuma gudanar da gwajin COVID-19 a duk faɗin ƙasar da aka samu daga 9 ga Maris, 2020.
Babu wani iyakar adadin da aka bayyana; tattarawa da sarrafa samfurori da aka ɗauka dole ne a yi su daidai da bukatun Cibiyar Kula da Cututtuka (CDC).
A Rasha, gwajin COVID-19 ya kasance wanda Cibiyar Nazarin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwa
A ranar 11 ga Fabrairu, 2020, Cibiyar Kula da Lafiya ta Jiha ta fara gwajin cutar. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Asibitin Mayo ya haɓaka na'urar gwajin COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izinin FDA don ƙirƙirar na'urar gwajin cutar da ke buƙatar samar da sakamako a cikin awanni 3.5 a matsakaicin lokaci, wanda ke ba da damar na'ura ɗaya don gwada mutane 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin Amfani da gaggawa (EUA) ga Laboratory na Abbott don gudanar da gwaji akan tsarin Abbott na m2000; FDA ta ba da izinin kama da Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, an ba Cepheid izinin amfani da hanyar gaggawa daga FDA don gwajin minti 45.
FDA ta amince da gwajin da ke amfani da fasaha don ƙara yawan zafin jiki na nucleic acid maimakon PCR.
Tun da wannan ba ya buƙatar jerin sauyawa na zafin jiki, wannan hanyar na iya samar da sakamakon mai ƙazanta a cikin mintuna biyar da kuma sakamakon mai tsabta a cikin mintuna 13.
A halin yanzu akwai kimanin na'urori 18,000 na wannan nau'in a Amurka kuma Abbot na shirin haɓaka ƙarfin zuwa gwaje-gwaje 50,000 a kowace rana. A Taiwan ana yin gwajin da ke amfani da rigakafin jiki na N-Coronaviruses, kuma ana fatan zai iya samar da sakamako tsakanin minti 15 zuwa 20 kamar na'urar gano mura mai sauri.
A watan Maris na shekarar 2020, takardun bincike sun kammala cewa "fara-fara shiga cikin na'urar daukar hoto ta hanta ba shi da amfani sosai a gwajin, kuma ana iya samun bayanan CT [computing tomography] tun kafin bayyanar cututtuka ta fara".
Abubuwan da ke cikin CT na lantarki na ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙ
Ƙarƙashin ƙananan huhu, ƙuntatawa na sassan huhu yana ƙaruwa yayin da cutar ta ƙaru.
Wani bincike da aka gudanar don kwatanta gwajin PCR da CT a Wuhan don gano asalin cutar ya nuna cewa alamun sun nuna cewa cutar ta kasance mai tsanani a Wuhan saboda an haɗu da wasu cututtukan numfashi.
A watan Maris na 2020, Cibiyar Nazarin Cututtuka ta Amurka ta ba da umarnin cewa "ba za a sake amfani da hanyoyin da ake amfani da su a Wuhan don bincika CoronavirusCOVID-19 ba". Daga Maris na 2020, Cibiyar Kula da Cututtuka (CDC) ta ba da shawarar cewa PCR ya zama farkon gwajin.
Wani abu mai ban mamaki da ke tattare da rigakafin jiki shine samar da tsarin rigakafi na jiki wanda ya haɗa da IgM da IgG.
Wannan zai iya taimakawa wajen gano kamuwa da cuta a cikin mutane daga rana ta 7 ko bayan gano alamun farko, don tantance matakin kariya da kuma gudanar da bincike na al'umma. Ana iya yin nazarin gwaji a cikin dakin gwaje-gwaje na yau da kullun (CLT) ko kuma wani wuri na gwaji (PoCT).
Ana amfani da ƙwaƙwalwar da aka yi amfani da ita don gwada mutane da yawa a cikin dakunan gwaje-gwaje na likitanci da yawa don bincike, amma samun sakamakon zai dogara da saurin aiki.
A cikin dakin gwaje-gwaje na yau da kullum, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfurori masu yawa don bin tsarin jiki.
A wani wuri kuma, an samu jini ɗaya da aka samu a jiki.
Ba kamar PCR ba, ba a buƙatar samfurin farko na samfurin kafin gwaji. A ranar 26 ga Maris, 2020, FDA ta sanar da cewa kamfanoni 29 sun sanar da shi a matsayin mai buƙata kuma yanzu suna iya samar da gwajin rigakafin jiki na yau da kullun.
Tun daga ranar 7 ga Afrilu, 2020, gwajin guda ɗaya ne kawai FDA ta amince da shi don yin aiki tare da izinin gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostic sun sami takardar izini ta Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA masu rigakafi a cikin ƙwayoyin cuta a cikin gwajin jini.
Ana iya gwada gwajin kamuwa da cuta da yawa a cikin sa'o'i kuma yana da sauri fiye da gwajin PCR da aka saba amfani da shi don gwada RNA na kwayar cuta.
A cikin watan Afrilu, Burtaniya ta gano cewa babu wani kayan aikin da ke auna yawan masu kare lafiyar da ta saya kuma ba za a iya amfani da su yadda ya kamata ba.
Hong Kong ta kafa tsarin da zai ba da damar kowa da kowa da ke da kamuwa da cutar ya zauna a gida, kuma hukumar agaji ta ba shi "na'urar da ta dace", ta yi bincike sannan ta mayar da su don ba da amsa daga baya. Hukumar Lafiya ta Burtaniya (NHS) ta sanar da cewa tana shirin kafa tsarin gwajin gida ga waɗanda ake zargi da kamuwa da cutar, wanda zai kawar da haɗarin kamuwa da cutar yayin da ake asibiti, ko kuma buƙatar yin maganin kashe kwayoyin cuta a cikin motar da ta kawo mai haƙuri. A yayin gudanar da gwajin COVID-19, likita yana yin hakan a cikin tsari na yau da kullun.
Cibiyar gwajin mutane a cikin motocin ta taimaka wa Koriya ta Kudu ta gudanar da wasu gwaje-gwaje mafi sauri, kuma mafi girma a duniya. A Jamus, a ranar 2 ga Maris, Hukumar Kula da Lafiya ta Likitoci ta ba da sanarwar cewa tana da damar yin gwajin kusan 12,000 a kowace rana ta hanyar gaggawa kuma an gwada kusan 10,700 a makon da ya gabata.
Asusun inshorar lafiya ne ke biyan kuɗin idan likita ya umurce ku.
A cewar shugaban kamfanin Robert Koch, Jamus na da damar yin gwajin mutum 160,000 a mako.
Tun daga ranar 19 ga Maris, an gudanar da gwajin a yawancin manyan birane.
Har zuwa 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, saboda an ba da rahoton kamuwa da cutar kawai.
Wani bincike na farko da dakin gwaje-gwaje ya yi ya bayyana cewa a cikin makon 12/2020 an gwada aƙalla mutane 483,295 ciki har da ranar 12/2020, daga cikinsu 33,491 (6,9%) sun kamu da SARS-CoV-2. A Isra'ila, masu bincike a asibitin Technion da Rambam sun gano kuma sun gwada hanyar gwada marasa lafiya 64 a lokaci guda, inda suke yin gwaji da kuma sake gwadawa a baya idan wani ya kamu da cutar. A Wuhan, dakin gwaje-gwaje na agaji mai girman murabba'in mita 2000 da ake kira "Huo-Yan" 火眼 a Gwiwa, ko "Ido mai wuta" a Kinyarwanda, an buɗe shi a hukumance a ranar 5 ga Fabrairu 2020 da cibiyar BGI, wanda ke iya gwada fiye da mutane 10,000 a kowace rana.
Wanda ya kafa BGI, Wang Jian ne ya gudanar da aikin kuma ya dauki kwanaki 5, samfurori sun nuna cewa kamuwa da cutar a Hubei zai karu da kashi 47% kuma farashin magance keɓewa zai ninka idan ba a samu wannan damar ba.
Labarin Wuhan ya biyo bayan dakin gwaje-gwaje na Huo-Yanmu Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 a duk ƙasar Sin.
Har zuwa 4 ga Maris, 2020, ana yin allurai 50,000 a kowace rana. Hanyar da ta fi sauri da kuma amfani da kowa da kowa da Origami Assays ta gabatar ta iya gwada gwajin COVID19 na marasa lafiya 1,122 tare da gwaji 93 kawai. Ana iya yin wannan tsari mai kyau a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar robobi mai sarrafa sinadarai ba.
Har zuwa watan Maris, raguwa da rashin ingancin allurar rigakafi a cikin dakin gwaje-gwaje ya kasance babban ƙalubale ga gwajin mutane a cikin Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu marubuta suka rubuta game da shirye-shiryen yin gwaji inda ake buƙatar dumama su zuwa 98 °C (208 °F) a cikin minti 5 don bayyana ƙwayoyin da ke haifar da sake gwadawa. A ranar 31 ga Maris, an sanar da cewa Tarayyar Larabawa ta kasance a saman matsayi na iya gwada yawan jama'arta fiye da sauran ƙasashe, tare da shirin gwada kusan dukkanin mazaunan ta.
Wannan ya faru ne saboda haɗuwa da ikon gwada mutane a cikin motocin su, da sayen dakunan gwaje-gwaje masu iya gwada mutane da yawa a lokaci guda a cikin Group 42 da BGI (wanda ya dogara da dakunan gwaje-gwaje na sauri na Huo-Yan).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje na iya gudanar da gwaje-gwaje na RT-PCR sama da dubu goma a rana kuma shine na farko a duniya a irin wannan matakin da ke aiki a wajen China.
Ana gudanar da gwaje-gwaje daban-daban kan sassa daban-daban na sifofin cutar coronavirus da aka kafa a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da tsarin da Jamus ta bayar na samar da kayan aiki da aka tura wa ƙasashe masu talauci da ba su da damar yin amfani da su.
A ranar 17 ga Janairu, 2020, Jamus ta ba da sanarwar tsarin su, tsarin da Hukumar Kula da Cututtuka ta Amurka ta tsara bai kasance a wurin ba har zuwa ranar 28 ga Janairu, wanda ya haifar da jinkirin gwaji a Amurka. China da Amurka suna da matsaloli game da rashin amincewa da amincin kayan aikin gwaji da ke akwai, kuma waɗannan ƙasashe da Ostiraliya ba su da ikon gamsar da kasuwar kayan aikin da ke da su da kuma bin shawarar masana kiwon lafiya.
Amma masana sun ce, gabatar da Koriya ta Kudu a cikin tsarin gwaji mai yawa ya taimaka wajen rage yaduwar sabon kwayar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina ikon yin gwaje-gwaje, musamman a cikin dakunan gwaje-gwaje masu zaman kansu, a tsawon shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga ƙasashe da yawa don ƙara yawan allurai da shirye-shiryen da ke tattare da wannan aikin a matsayin hanya mafi kyau don rage yaduwar cutar COVID-19. Ƙarin buƙatar kayan aikin gwaji na cutar saboda yaduwar cutar, ya sa yawancin su su kasance a cikin dakin gwaje-gwaje na Amurka, wanda ya haifar da babbar matsala wajen samar da kayan aiki da magunguna masu mahimmanci don magance cutar.
A watan Maris na shekarar 2020, kasar Sin ta bayyana cewa akwai wasu matsaloli game da ingancin kayan aikinta na gwaji.
A Amurka, kayan aikin da Cibiyar Kula da Cututtuka ta Kasa ta Amurka ta samar sun zama masu lahani, kuma yanzu gwamnati ta kawar da matsalolin da ke hana gudanar da bincike mai zaman kansa. Spain ta sayi kayan daga Shenzhen Bioeasy Biotechnology Co Ltd, wani kamfani na kasar Sin amma ta gano cewa ba su da inganci.
Cibiyar ta bayyana cewa sakamakon da ba daidai ba zai iya faruwa ba saboda rashin tattara jarrabawa ko rashin amfani da kayan aiki.
Ma'aikatar kasar Spain ta ce za ta cire kayan aikin da ke samar da sakamako mara kyau daga kasuwa kuma za ta maye gurbin na Shenzhen Bioeasy. 80% na kayan aikin da Czech ta sayi daga China sun samar da sakamako mara kyau.Slovakia ta sayi kayan aiki miliyan 1.2 daga China wanda aka gano ba daidai ba.
Firayim Minista Matovič ya bukaci a jefa su cikin kogin Danube. Ateş Kara, Ministan Lafiya na Turkiyya ya ce kayan aikin gwajin da aka saya a China ba su da kyau kuma ba za a iya amfani da su ba. Birtaniya ta sayi kayan aikin gwaji miliyan 3.5 daga China amma kwanan nan a watan Afrilu 2020 sun sanar da cewa ba za a iya amfani da su ba.
Gwajin, tare da keɓewa da kuma bincika waɗanda suka kamu da SARS-CoV-2, sun kasance masu tasiri.
Masu bincike a garin Vò na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun yi gwajin sau biyu na yawan jama'a 3,400 a cikin kwanaki goma.
Kusan rabin waɗanda aka gano sun kamu da cutar ba su nuna alamun cutar ba, kuma an ware duk waɗanda suka bayyana.
Dakatar da zirga-zirga zuwa wasu yankuna ya dakatar da sabon kamuwa da cutar gaba ɗaya.
Saboda tsauraran matakan lura da kamuwa da cutar, hana zirga-zirgar mutane, yin gwaji da keɓewa, cutar ta Coronavirus 2020 a Singapore ta kasance ƙasa da sauran ƙasashe masu tasowa kuma an yi hakan ba tare da rufe gidajen abinci da shagunan kasuwanci ba.
An dakatar da ayyuka da yawa, kuma Singapore ta fara ba da shawarar jama'a su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutu a ranar 23 ga Maris.
Yawancin ƙasashe da suka yi fama da cutar sun kuma kafa tsarin gano masu kamuwa da cutar, hana shiga cikin ƙasa, gwaji, keɓewa, da kuma kasancewa a gida amma ba tare da matsananciyar ƙarfi ba, kamar Iceland da Koriya ta Kudu.
Ƙididdigar ya nuna cewa ƙasashen da suka yi gwajin mafi yawan mutane, idan aka kwatanta da yawan mutuwar, suna da ƙananan adadin mutuwa, wataƙila saboda waɗannan ƙasashe suna da ikon gano waɗanda ke da ƙananan alamomi ko marasa alamomi.
Hukumar Lafiya ta Duniya ta bukaci kasashen da ba su da isasshen ƙarfin gwaji da kuma dakin gwaje-gwaje masu iyawa don gwada COVID-19 su aika da gwajin su na mutane biyar na farko da aka tabbatar da cewa suna da cutar da kuma mutane goma na farko da aka tabbatar da cewa ba su da cutar COVID-19 a cikin dakunan gwaje-gwaje 16 na WHO don tabbatar da gwajin.
Daga cikin dakunan gwaje-gwaje 16 na samfurin, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Ostiraliya.
A cikin teburin da ke gaba, "Cutar da ta kai kashi kashi 100 na masu gwajin" na iya canzawa dangane da manufofin gwajin cutar na ƙasar.
Kasar da ke yin gwajin asibiti kawai za ta sami mafi yawan adadin kamuwa da cutar a cikin gwajin, idan aka kwatanta da ƙasar da ke yin gwajin ga dukan jama'a, ko suna da alamun cutar ko a'a, idan ba a sami wani canji ba.
Wanke hannu, ko kuma wanke hannu, aiki ne na wanke hannu don kawar da ƙura, man fetur, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Yin wanka a kai a kai a "lokaci na musamman" na rana yana hana yaduwar cututtuka da yawa kamar tari, cutar kolera, da ke kamuwa da cutar ta hanyar hanci.
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko mura, misali, idan ba su wanke hannayensu kafin su taɓa fuska, hanci ko baki ba (watau, sassan da ke da kumburi).
Abubuwa biyar masu muhimmanci na rana da ba a bukatar wanke hannu da sabulu ba sun hada da: kafin da bayan wankewa, bayan ka shafa ko ka canza masa kafafu, kafin ka ciyar da yaro, kafin ka ci da kuma bayan ka shirya abinci ko ka kama nama mai naman kaza, kifi, ko kaza.
Idan babu sabulu da ruwa, za a iya wanke hannuwanka da toka. Hukumar Lafiya ta Duniya ta bukaci mutane su wanke hannu:
Kafin, lokacin da kake dafa abinci, da kuma bayan ka dafa.
Kafin ka kula da wani mai ciwo da kuma bayan ka kula da shi.
Bayan an canza wa jariri kayan shafa ko bayan an wanke jariri bayan amfani da tawul.
Bayan ka numfashi, ka yi tari ko ka yi gumi.
Bayan ka taɓa dabba, ka ciyar da ita, ko kuma ka tsabtace ta.
Tsabtace hannu a likita yana nufin ayyukan tsabtace jiki.
Yin wanka kafin a yi magani ko kuma a kula da mai haƙuri zai iya hana ko rage yaduwar cutar sosai.
Babban manufar wanke hannu na likita shi ne wanke hannuwan da suka kamu da cututtuka (kwayar cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta) da kuma magungunan da ke da tasiri ko kuma cutar.
Wannan yana da mahimmanci ga masu shirya abinci ko ma'aikatan kiwon lafiya, amma kuma yana da kyau ga kowa.
Wanke hannu yana da fa'idodi masu yawa na kiwon lafiya, wanda ya haɗa da rage yaduwar mura, coronavirus, da sauran cututtukan annoba; hana wasu dalilai na cututtukan zuciya; rage cututtukan huhu;
kuma sun rage yawan mutuwar jarirai da aka haifa a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu sosai zai taimaka wa yara da ba su kai shekara biyar ba su yi girma sosai.
A ƙasashe masu tasowa, ana iya rage mutuwar yara daga cututtukan numfashi da kuma rashin hankali ta hanyar sauƙaƙe hanyoyin sauya halaye, kamar wanke hannu da sabulu.
Wannan hanya mai sauƙi na iya rage yawan mutuwar da ke tattare da cututtukan da kusan kashi 50%.
Yin amfani da wanke hannu na iya rage kashi ɗaya bisa uku na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Ragewar cututtukan da ke tattare da cutar kumburi da kashi 48% na iya kasancewa tare da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da arha don hana kumburi da cututtukan numfashi masu tsanani (ARI), wanda ya kamata ya zama al'ada a gida, makaranta da kuma cikin babban iyali.
Cutar huhu, wadda ta fi tsanani, ita ce babbar cuta da ke kashe yara 'yan ƙasa da shekara biyar, da ke kashe kusan yara miliyan 1.8 a kowace shekara.
A kowace shekara, ƙwayoyin cuta da kuma ciwon daji suna kashe yara miliyan 3.5 a duniya.
Bisa ga rahoton UNICEF, amfani da sabulu kafin cin abinci da kuma bayan amfani da tabarau na iya ceton rayuka fiye da kowane rigakafi ko magani, kuma zai rage kusan rabin mutuwar rashin hankali da kashi hudu na mutuwar rashin numfashi.
Yin wanka hannu sau da yawa yana cikin wasu ayyukan tsabtace ruwa, tsabtace jiki, da kuma tsabtace jiki (WASH).
Yin wanka a hannu yana kāre ka daga kamuwa da cututtukan fata da ke tattare da yin aiki tare da wasu.
Ƙananan sakamako na wanke hannu shi ne cewa wanke hannuwan sau da yawa zai iya haifar da lalacewar fata saboda yawan bushewar fata.
Wani bincike a Denmark a shekara ta 2012 ya nuna cewa wanke hannu sosai zai iya haifar da tsananin, rashin lafiyar fata, wanda ake kira cututtukan fata na hannu, wanda ya fi yawa a cikin ma'aikatan kiwon lafiya.
Yin wanka sosai a hannu ma alama ce ta rashin lafiyar mutum (OCD).
Akwai lokatai guda biyar na rana inda wanke hannu da sabulu ke da muhimmanci wajen rage kamuwa da cututtukan da ke gudana ta hanyar safa da bakin: bayan amfani da kayan shafa (tsabtace, wankewa), bayan motsawa (canza safa), kafin ciyar da yaro, kafin cin abinci da / bayan shirya abinci ko shan naman kaza, kifi, ko kaji.
A wasu wurare, ya kamata a yi amfani da wanke hannu don hana kamuwa da cuta, kamar kafin da bayan da aka warkar da rauni ko rauni; bayan da aka yi gumi, tari, ko numfashi; bayan da aka taɓa shara ko kula da dabba; da kuma bayan da aka taɓa shara.
A ƙasashe da yawa, an rage yawan wanke hannu da sabulu.
Binciken wanke hannu a cikin ƙasashe 54 a shekarar 2015 ya nuna cewa a matsakaita kashi 38.7% na gidaje sun yi amfani da sabulu don wanke hannu. Binciken 2014 ya nuna cewa Saudiyya tana da mafi girman kashi 97%; Amurka kusan 77%; kuma China tana da mafi ƙasƙanci kashi 23%. A halin yanzu akwai hanyar canza tunani don farkawa da wanke hannu tare da sabulu a cikin mawuyacin yanayi. Wanke hannu a lokaci guda ga yara a makaranta a cikin ƙayyadaddun lokutan yau da kullun yana ɗaya daga cikin hanyoyin da za a iya amfani da su a cikin ƙasashe masu tasowa don koyar da yara al'adar wanke hannu.
Shirin Kula da Lafiya na Muhimmanci da Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne mai kyau na ayyukan da ke inganta lafiyar yara da ilimi.
Yin maganin shan maciji sau biyu a shekara, tare da wanke hannuwanmu kullum da sabulu, da kuma wanke hakora kullum da fuliwore, shine tushen wannan shirin na kasa.
An yi amfani da shi sosai a Indonesia.
Ana iya ƙara ƙwayar cuta ta jiki ta hanyar ƙara sabulu ko kuma maganin tsabta.
Babban amfani na sabulu da kuma maganin tsabtace jiki shine rage hana kashewa da kuma inganta ƙarfin kashewa.
Ruwan da yake da kyau kawai ba ya tsabtace fata saboda man fetur da kitse, kamar su na ƙasa, ba su narke cikin ruwa ba.
Don tsabtace jiki, dole ne a yi amfani da ruwa mai yawa.
Sabulu mai tsabta yana iya riƙe da ƙwayoyin cuta daga waɗanda suka yi amfani da shi a dā.
Ƙananan bincike sun bincika yadda kwayoyin cuta ke kamuwa da cuta daga sabulu mai ƙazanta kuma an gano cewa ba zai yiwu ba saboda an wanke ƙwayoyin cuta daga kumburi.
Cibiyar Kula da Cututtuka (CDC) ta ce "sabar ruwa da kuma wurin da za a yi amfani da shi ba tare da yin amfani da shi ba shi ne hanya mafi kyau".
Sabulu mai kashe ƙwayoyin cuta ya yi wa waɗanda suke kula da lafiyarsu yabo sosai.
Har zuwa yanzu, babu wata alama da ta nuna cewa amfani da maganin rigakafi ko maganin kashe kwayoyin cuta ya fi dacewa da maganin ƙwayoyin cuta da aka sani don hana maganin kashe kwayoyin cuta.
Amma, sabulu mai kashe ƙwayoyin cuta yana ɗauke da maganin kashe ƙwayoyin cuta kamar triclosan, wanda ke da tarin ƙwayoyin cuta da ba za a iya ƙonewa ba.
Saboda haka, ko da yake maganin rigakafi ba a haɗa shi da sabulu ba, zai iya yin aiki da kyau kamar yadda ake faɗa.
Baya ga kare yanayin da ke cikin ƙasa da fata, miyagun ƙwayoyi na iya ƙunsar acid (acetic acid, acetic acid, lactic acid) kamar su isrogenic acid, benzoic acid wanda ke hana kwayoyin cuta da sauran magungunan fata (tabarci, ƙwayoyin cuta, menthol, da sauran magungunan shuka). Wani bincike mai zurfi na Jami'ar Oregon School of Public Medicine ya nuna cewa sabulu yana da ikon hana cututtuka na yau da kullun da kuma kawar da ƙwayoyin cuta a kan yatsunansu kamar sabulu wanda aka tsara don magance ƙwayoyin cuta.
Ruwan zafi da za a iya amfani da shi wajen wanke hannu ba shi da zafi don kashe ƙwayoyin cuta.
Kwayar cuta tana girma da sauri a zafin jiki (37 ° C).
Amma, ruwan zafi da sabulu suna da amfani sosai fiye da ruwan sanyi, wato sabulu don kawar da ƙwayoyin ƙasa da ƙwayoyin cuta.
Sabanin abin da mutane da yawa suka gaskata, binciken kimiyya ya nuna cewa ruwan zãfi ba shi da amfani wajen rage yawan kwayoyin a hannayenku.
Maganin wanke hannu ko maganin hana kamuwa da cutar hannu magani ne na wanke hannu wanda ba shi da ruwa.
A ƙarshen 1990s da kuma farkon karni na 21, wanke hannu da maganin kashe ƙwayoyin cuta (wanda aka fi sani da maganin wanke hannu) ya zama sananne da kuma sananne.
Ana yin su ne da yawa daga isopropyl ko ethanol da aka yi ta hanyar haɗuwa da Carbomer a cikin mai mai mai, ko kuma ƙara ƙanshi kamar giris zuwa kayan shafawa ko kayan shafawa don sauƙaƙe amfani da su da kuma rage tasirin ƙwayoyin cuta.
Ƙara isrogen peroxide a buɗe yana haɓaka ƙwayoyin cuta. Magungunan tsabtace hannu waɗanda ke ƙunshe da aƙalla 60 zuwa 95% na glucose na iya zama masu tasiri wajen kashe ƙwayoyin cuta.
Magungunan wanke hannu suna ƙunshe da maganin kashe ƙwayoyin cuta, ƙwayoyin cuta masu yawa (MRSA da VRE), tarin fuka, da sauran ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura, da cutar hanta) da kuma ƙwayoyin cuta na cutar kumburi.
Magungunan wanke hannu suna kashe kashi 70% na 99,97% (3.5 na raguwa, daidai da raguwar 35 decibels) na kwari a cikin dakika 30 bayan amfani da kashi 99,99% zuwa 99,999% (ƙara tsakanin 4 zuwa 5) na kwari a cikin minti 1 bayan amfani. Magungunan wanke hannu suna da tasiri sosai wajen hana ƙwayoyin cuta amma ba su da ƙarancin ƙwayoyin cuta.
Magungunan wanke hannu ba su da tasiri a kan cutar Norwalk, wadda ke haifar da cututtukan hanji. Magungunan wanke hannu dole ne a yi amfani da su a hankali ko kuma a rarraba a hannayen biyu.
A gaban da bayan hannuwanku da kuma tsakiyar da kuma ƙarshen hannuwanku, ku yi ta ta taƙama na kusan dakika 30 har sai ruwa, ruwa ko kuma maganin wankewa sun bushe.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka ta ba da shawarar cewa a wanke hannu da maganin kashe ƙwayoyin cuta musamman idan an gano cewa hannu sun kamu.
Ci gaba da amfani da wannan hanyar ya dogara da sauƙin amfani da saurin kashe ƙwayoyin cuta; amma, wannan ba zai maye gurbin aikin wanke hannu ba sai dai idan sabulu da ruwa ba su da shi.
Yin amfani da tsabtace hannu da aka yi amfani da su a kai a kai zai iya sa fata ta bushe sai dai idan an ƙara su don su sa fata ta yi sanyi ko kuma su yi sanyi.
Wannan ƙarancin fata na fata na iya ragewa ko kuma kawar da shi ta hanyar glycelin ko wani magani na fata.
A cikin binciken likita, maganin wanke hannu yana dauke da ƙura amma kuma yana dauke da maganin da ke sa fata ta kasance mai laushi fiye da sabulu ko maganin kashe kwayoyin cuta.
Ba a yawan samun saurin fata, saurin fata, ko kuma saurin jiki da aka yi a hannu ba.
Saboda rashin haɗarin lalacewar fata, wannan hanya ta fi amfani da shi fiye da wanke hannu da sabulu da ruwa.
Ko da yake suna da kyau, tsabtace hannu ba tare da ruwa ba ba, ba sa tsabtace hannuwanmu don su kawar da duk wani gurbatawa, amma suna kawar da ƙwayoyin cuta kawai.
Wannan shine dalilin da ya sa kayan wanke hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta da yawa, saboda ƙwayoyin cuta suna kasancewa a hannunka.
A dā, maganin wanke hannu da ba shi da ƙwaya ba ya da kyau kamar ƙwaya da sauran ƙwayoyin ƙwaya.
Kwanan nan, maganin benzodiazepine ya nuna cewa yana da inganci mai kyau na maganin rigakafi bayan amfani, ba kamar maganin ƙwayoyin cuta ba, wanda ya nuna cewa yawan amfani da shi bayan amfani da shi sau da yawa, saboda yiwuwar tasirinsa akan fata.
Mutane da yawa a cikin talakawa ba su da sabulu kuma suna amfani da toka ko ƙasa.
Yin amfani da toka ko ƙasa yana da amfani fiye da yin amfani da ruwa kawai, amma kuma ba shi da amfani kamar yin amfani da sabulu.
Wani abin damuwa shi ne, ƙura ko ƙasa suna da ƙananan ƙwayoyin cuta waɗanda za su iya gurɓata su kuma hakan zai kara yaduwar cutar fiye da yadda zai rage.
Kamar sabulu, toka tana kashe ƙwayoyin cuta domin tana yin sinadarai a lokacin da ta haɗu da ruwa.
Idan babu sabulu, Hukumar Lafiya ta Duniya ta bukaci yin amfani da toka ko yashi.
Tsarin wanke hannu da aka tsara ta Hukumar Kula da Cututtuka da Cututtuka ta Amurka don hana yaduwar cutar shine kamar haka:
Ka wanke hannunka da ruwa mai zafi ko sanyi.
Ya kamata a yi amfani da ruwan da ke gudana saboda ruwan da ke cikin bututun yana da haɗari, kuma zafin jiki na ruwa ba ya canzawa sosai.
Ka wanke hannunka da aka wanke, ka yi wanka da sabulu mai yawa, ka wanke bayan hannunka, tsakanin hannunka da kuma ƙarƙashin fam.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannuwansu da sabulu fiye da wanke su da ruwa.
Ka yi haƙuri da hannunka na akalla dakika 20.
Yin tafin hannu sosai yana sa a yi tawaye, yana taimaka wa a cire ƙwayoyin cuta daga fata, kuma yana kawar da ƙwayoyin cuta da yawa.
Ka wanke hannunka da ruwa mai gudana.
Rashin hannayenka a cikin kwandon yana iya sake gurɓata hannayenka.
Ka shafa hannunka da wani abu mai tsabta ko kuma iska mai bushewa.
Hannun da suka lalace ko kuma suka bushe suna iya samun sauƙi su sake kamuwa da cutar. Abubuwan da ake manta da su sau da yawa shine yatsunsu, a cikin tsokoki, a tsakanin hannayen hannu, har ma a ƙarƙashin yatsunsu.
Ƙarƙashin ƙwayoyin cuta ko ƙwayoyin cuta masu launi suna iya zama masu yawa.
Ana ba da shawarar yin amfani da man shafawa mai laushi don hana hannayen su yin aiki; fata mai bushewa na iya lalacewa kuma hakan yana ƙara haɗarin yaduwar cutar.
Ana iya amfani da wasu ƙananan hanyoyi don sauƙaƙe aikin wanke hannu idan babu kayan aiki na roba ko sabulu, kamar zuba ruwa ta hanyar gyaran gefen itace (kandirukraba) ko ƙarfe mai ƙunshe da ruwa ko amfani da ƙasa idan ya cancanta a ƙasashe masu tasowa. A cikin yanayin matsalar ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin ruwa na ruwa kamar karkara da sauran hanyoyin da ba su da tsada.
Kada ku yi amfani da shi don yin amfani da kayan aiki masu sauƙi, kamar su sa ruwa a ƙafa, wanke hannayenku da sabulu.
Yin sallama da kyau yana da muhimmanci sosai wajen tsabtace hannu, amma ana iya yin muhawara a kan yadda za a yi sallama a wuraren da ake wanka.
Yawancin bincike sun nuna cewa takarda mai tsabta ta fi tsabta fiye da na'urorin wanke hannu masu amfani da wutar lantarki a cikin ɗakunan da yawa.
A shekara ta 2008, Jami'ar Westminster a London, da taimakon wani kamfani mai suna "The European Tissue Symposium", ta gudanar da bincike da ya kwatanta yadda tsabtace hannu da na'urar wanke hannu take.
Bayan wanke da kuma wanke hannu tare da na'urar wanke hannu ta hanyar iska mai zafi, an gano cewa yawan kwayoyin cutar da ke haifar da cutar ya karu da kimanin 194% a hannun hannu da kuma 254% a tsakiyar hannu.
Yin amfani da iska mai iska ta hannu ya kara yawan kwayoyin cutar da ke tattare da cutar da kashi 42% a matsakaiciyar hannu da kuma kashi 15% a matsakaiciyar hannu.
Bayan wanke hannu da kuma wankewa ta hanyar takarda na musamman, an rage adadin ƙwayoyin cuta ta matsakaici da kashi 76% a kan yatsun hannu da kuma kashi 77% a kan hannayen hannu. Masana sun kuma gudanar da bincike don ganin ko akwai kamuwa da cuta tsakanin masu amfani da gidan wanka da kuma kewaye da shi saboda kowane nau'in wankewa.
Kayan wanka, wanda ke fitar da iska a saurin 180m/s (650km/h; 400mph), zai iya cire ƙwayoyin cuta daga hannayen hannu da sauran sassan da kuma iya cutar da sauran masu amfani da wanka da kuma fitar da ƙwayoyin cuta daga nesa har zuwa mita 2.
Yin amfani da iska mai zafi don numfashi yana hana ƙwayoyin cuta su shiga mita 0.25 daga wurin da ƙarfe yake.
Gwajiyar da muka yi a kan takarda ta nuna cewa ba za mu iya yada kwayoyin ba. A shekara ta 2005, a cikin binciken TÜV Produkt und Umwelt, an bincika hanyoyi daban-daban na yin sallama.
Wadannan canje-canje sun bayyana a cikin adadin kwayoyin cuta bayan an yi musu sallama:
Wasu masana'antun sun yi amfani da kayan wanke hannu da yawa, kuma an kwatanta kayan wanke hannu da takarda mai wanke hannu.
Yin wanka da hannu da aka yi amfani da shi a hannu yana da kyau idan kana tafiya ba tare da ruwa ko sabulu ba.
Dole ne a yi amfani da akalla kashi 60% na kayan aikin wanke hannu.
Bayan da Ignaz Semmelweis, wani likita a ƙasar Hungary ya gano (a shekara ta 1846) cewa wanke hannu yana da amfani wajen hana kamuwa da cuta a asibiti, sai aka kafa dokar.
Wasu na'urori na zamani suna tunatar da ma'aikatan kiwon lafiya su wanke hannuwansu idan sun manta.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cutar.
Ka wanke hannuwanka na tsawon minti 15 a cikin magani, tare da sabulu da ruwa ko kuma maganin da aka yi amfani da shi don yin kumburi kuma ka haɗa hannuwanka.
Dole ne a haɗa hannayen hannu a kusa da juna.
Idan akwai ƙazanta a ƙarƙashin yunwa, ana iya cire shi daga cikin ƙazanta.
Tun da yake kwari masu kamuwa da cuta suna zama a cikin ruwa a hannu, yana da muhimmanci a tsabtace hannuwanmu sosai kuma a yi amfani da tufafi masu tsabta.
Bayan wanke hannu, dole ne a yi amfani da takarda don rufe ruwa (har ma da buɗe ƙofar fita idan ya cancanta).
Wannan yana hana hannu sake kamuwa da cutar ta hanyar abin da ya shafa.
Ana amfani da wanke hannu a cikin asibiti don kawar da ƙwayoyin cuta da ke haifar da cututtuka da kuma hana su yadawa.
Jaridar The New England Journal of Medicine ta ce wanke hannu a asibitoci yana da wuya, domin yawancin likitoci da ma'aikatan jinya suna manta da wanke hannu kafin su taɓa marasa lafiya, kuma hakan yana sa ƙwayoyin cuta su yi yawa.
Wani bincike ya nuna cewa wanke hannu da wasu hanyoyin da suka dace na iya rage yawan cututtukan da ke gudana ta hanyar jini da kashi 66%. Hukumar Lafiya ta Duniya ta wallafa takardun da ke nuna yadda za a wanke hannu da kuma amfani da maganin wanke hannu a fannonin kiwon lafiya.
Za a iya samun takardar shawarwari game da tsabtace hannu ta hanyar dandalin yanar gizon kamfanin don yin tsokaci.
Whitby da sauransu sun yi wani babban gyara.
Kayan aiki na kasuwanci na iya gwadawa da tabbatar da tsabtace hannu idan an nemi a nuna buƙatu da umarni.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" na wanke hannu:
bayan samun haɗuwa da jini / zubar jini
kafin aikin likita, da
Bayan kula da mai haƙuri. Ƙara maganin kashe cuta zuwa sabulu (sabulu "mai amfani da magani" ko "mai kashe ƙwayoyin cuta") yana taimakawa wajen wanke hannu don kashe ƙwayoyin cuta.
Ana iya buƙatar wannan maganin kashe kwayoyin cuta kafin tiyata ko a cikin yanayin da ke da yawa ga masu haƙuri da maganin rigakafi. Don samun tsabta a hannu kafin tiyata, yana da mahimmanci a sami rufi wanda za'a iya rufewa da buɗewa ba tare da amfani da hannu ba, chlorhexidine ko iodine mai tsabta, wani kayan shafa mai tsabta don wanke hannu bayan wanke su, da kuma wanke hannu mai tsabta da kuma wani kayan tsabta don wanke hannu.
Dole ne ka cire duk kayan da ke jikinka.
Wannan aikin yana bukatar wanke hannuwanka zuwa kugu, yawanci na tsawon minti 2 zuwa 6.
Ba lallai ba ne a yi dogon gaisuwa (na minti 10)
Idan kana wanke hannuwanka, ka mai da hankali don kada ruwa ya koma hannunka.
Bayan sun gama wanke hannuwansu, sai su wanke tufafi masu tsabta kuma su saka tufafin da ke cikin dakin shan magani.
Don rage ƙwayoyin cuta, yana da kyau a wanke hannuwanku ko kuma a yi amfani da maganin wanke hannu kafin da bayan kula da mai haƙuri.
A cikin binciken asibiti na maganin cututtukan da ake kira "staph", an gano cewa mafi yawan amfanin wanke hannu ya fito ne daga kashi 20% na wanke hannu na farko, kuma mafi ƙarancin amfanin ya fito ne daga yawan wanke hannu ya tashi sama da 35%.
Wanke da sabulu na yau da kullun yana ba da sakamako mai yawa sau uku na cututtukan cututtukan abinci fiye da wanke da sabulu mai kashe ƙwayoyin cuta. Idan aka kwatanta da amfani da sabulu mai kashe ƙwayoyin cuta a cikin dakika 30, duk sun nuna cewa amfani da sabulu mai tsabtace hannu yana rage ƙwayoyin cuta da kashi 26% idan aka kwatanta da sabulu mai kashe ƙwayoyin cuta.
Amma wanke hannu da sabulu da ruwa ya fi amfani da maganin wanke hannu don rage yawan cutar A/H1N1 da sauran ƙwayoyin cuta da ke cikin hannayen hannu. Ayyukan wanke hannu a asibitoci na iya haɗawa da koyar da ma'aikata su wanke hannu, ƙara yawan wanke hannu da kuma tunatar da ma'aikata a rubuce da kuma a baki.
Akwai bukatar bincike mai yawa don tabbatar da yadda wannan taimakon yake da amfani sosai a fannoni daban-daban na kiwon lafiya.
A ƙasashe masu tasowa, wanke hannu da sabulu ana ganin su hanya ce mai mahimmanci da kuma araha don samun lafiya, da kuma abinci mai gina jiki.
Amma rashin samun ruwa, sabulu ko kayan wanke hannu a gidaje, makarantu, da kuma wuraren aiki na yau da kullum yana da matukar wuya a hana kowa yin wanke hannu.
Alal misali, a yankuna da yawa na ƙauyuka a Afirka, ana samun ƙananan rufi don wanke hannu a kusa da wuraren wanke hannu ko kuma a wuraren zaman kansu, ko da yake akwai wasu hanyoyin da za su iya samun kuɗin yin wanke hannu.
Amma, ƙarancin yawan wanke hannu zai iya faruwa ne saboda rashin wanke hannu maimakon rashin sabulu ko ruwa.
Ingantawa da kuma karfafawa mutane su wanke hannu da sabulu na iya kawo canji a matakin da ya kamata, ya haifar da fahimtar amfanin wanke hannu da kuma kawo canji na dogon lokaci ga al'umma.
Don yin wannan, dole ne a bi da su kuma a bincika su.
Binciken binciken 70 ya gano hanyar da ta dace da al'umma ta ƙara yawan wanke hannu a cikin LMICs, yayin da tallata ayyukan a kan kafofin watsa labarun ba ta da amfani. Misali ɗaya shine yadda ake inganta ayyukan wanke hannu a makarantu a cikin "Hanyar Star Star 3" ta UNICEF ta hanyar ƙarfafa makarantu su yi amfani da sauƙi, mai araha ta hanyar tabbatar da cewa ɗalibai suna wanke hannu tare da sabulu, da sauran kayan aikin Tsabta.
Idan aka cika ka'idodin, makarantu na iya zama daga taurari ɗaya zuwa uku.
Gina wuraren wanke hannu na iya zama ɗayan hanyoyin da za a ci gaba da inganta wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya misali ne na wani motsi na inganta wanke hannu don cimma burin sauya halaye. Saboda annobar coronavirus ta 2019-20, UNICEF ta haɓaka emojis na wanke hannu.
Kadan daga cikin binciken da aka yi sun nuna yawan amfani da wanke hannu a ƙasashe masu tasowa idan aka kwatanta da DALYs.
Duk da haka, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi amfani da ruwa da kuma tsabtace jiki.
Muhimmancin wanke hannu a rayuwar mutum; musamman ga marasa lafiya kamar jarirai masu haihuwa ko sojoji da aka ji rauni a yaki a asibiti, ya bayyana a tsakiyar karni na 19 ta hanyar biyu masu kirkiro tsabtace hannu: Ignaz Semmelweis, wani likitan Hungary da ke aiki a Vienna, Austria da Florence Nightingale, wani Ba'amurke "wanda ya kirkiro sabon tsarin aikin jinya".
A lokacin, mutane da yawa suna ganin cewa miyagun ƙwayoyi ne suke haddasa cututtuka masu yaduwa.
A cikin shekarun 1980, cututtukan abinci da cututtukan cututtuka na likita sun sa Cibiyar Kula da Cututtuka ta Amurka ta ci gaba da ƙarfafa farkawa ga tsabtace hannu a matsayin muhimmin hanyar hana yaduwar cutar.
Cutar cutar sankara ta 2009 da annobar COVID-19 ta 2020 sun ba wa ƙasashe damar fahimtar mahimmancin wanke hannu da sabulu don hana kamuwa da cututtukan cututtukan cututtukan.
Alal misali, an rataye manyan takardu game da "hanyar wanke hannu" a kusa da ɗakunan wanke hannu a cikin wuraren shakatawa na gine-gine da filayen jirgin sama a Jamus.
Kalmar nan "wanke hannu" tana nufin rashin son mutum ya yarda da abin da ya yi ko kuma ya yi niyyar yin abin da ya yi.
Ya fito ne daga littafin Matta inda Bilatus ya wanke hannayensa bayan ya yanke shawarar giciye Yesu Kristi, amma wannan furcin ya ci gaba da amfani da shi a cikin harshen Turanci.
A cikin wasan kwaikwayo na Shakespeare na Macbeth, Madam Macbeth ta fara wanke hannayenta don kawar da tabo da ta ɗauka tana da shi, yana nuna cewa zuciyarta ta yi ta fushi saboda zunubanta da abin da ta sa mijinta ya yi.
An gano cewa mutane, bayan sun tuna ko sun yi tunanin yin wani abu da bai dace ba, suna ƙoƙari su wanke hannuwansu fiye da sauran mutane, kuma suna daraja kayan wanke hannu fiye da kowa.
Kuma waɗanda aka ba da izinin wanke hannu bayan sun yi tunani game da waɗannan ayyukan marasa kyau ba sa son yin wasu ayyuka na "tsabtace" da suka tuba kamar yin aikin da ba shi da kyau.
Wasu addinai suna buƙatar masu bi su wanke hannu don tsabtace jiki da kuma nuna al'adun addini. Yin wanke hannu yana nuna al'adun addini, ta amfani da ruwa kawai ba tare da sabulu ba kuma wanke hannu, wani ɓangare ne na al'adun addinai da yawa, ciki har da Baha'i, Hindu, Baha'i, da kuma al'ummar Yahudanci, da kuma addinin Buddha. Addinai suna kuma buƙatar mabiyan su wanke hannuwansu, musamman bayan ayyuka na musamman.
Addinin Hindu, Yahudawa, da kuma Islama suna ba da umurni a wanke hannuwanka bayan ka fita daga gidan wanka.
Addinai kamar su Hindu, Buddha, Sikh, Yahudawa, da Islamawa sun koyar da yin wanka kafin da kuma bayan cin abinci.
Matakan yaki da cutar COVID-19 a wuraren aiki
Matakan rigakafin COVID-19 a wuraren aiki suna da mahimmanci don tabbatar da aminci da lafiya a wuraren aiki don hana cutar coronavirus ta 2019 (COVID-19).
Ingantaccen matakan yaki da cutar a wuraren aiki ya dogara da yanayin aiki da yanayin aiki, dangane da tasirin tasirin cutar, kamuwa da cutar a cikin al'umma da haɗarin da ma'aikatan da ke da rauni ke da shi na kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya a Aiki ta Amurka (OSHA), aiki mai ƙarancin haɗarin kamuwa da cutar shine aiki inda ma'aikata ke da dangantaka mai kyau da mutane da sauran ma'aikata, inda aka ba da umarnin matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su kasance a gida yayin rashin lafiya, umarnin rigakafin cutar numfashi da tsaftacewa na yau da kullun da kuma amfani da maganin kashe cututtuka a wurin aiki.
Aikin da ke da haɗarin kamuwa da cutar yana nufin aiki da ke buƙatar haɗuwa ko kusanci da mutane da ba a san su ba ko kuma waɗanda ake zaton suna da cutar COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar kamuwa da juna ko tafiya a ƙasashen waje.
Akwai ma'aikatan da ke aiki tare da jama'a a cikin gidajen karatu, da kuma wuraren da ake aiki da yawa da kuma wuraren da ake sayarwa da yawa.
Yin amfani da cutar a kan ma'aikata ya fi dacewa da ƙa'idodin rigakafin cutar, gami da samar da isasshen iska ta hanyar iska, kayan kariya daga fashewa da kuma samar da tufafin kariya na musamman don saduwa da wani wanda ya kamu da COVID-19.
OSHA ta ba da shawarar cewa ma'aikatan kiwon lafiya da na hutu waɗanda suka haɗu da ko kuma ake zaton suna da haɗarin kamuwa da COVID-19 suna da haɗari sosai, wanda ke ƙara haɗarin yayin da ma'aikatan ke gudanar da ayyukan hawan iska, ɗaukar ko bincika gwajin mutum wanda aka sani ko ake zaton yana da COVID-19.
Hanya mafi kyau don hana cutar ga ma'aikatan ita ce ta amfani da kayan aiki na musamman kamar ɗakunan iska da kuma tufafin kariya na musamman don aikin su.
Cutar COVID-19 na iya yin tasiri sosai a wurin aiki.
Ma'aikata suna iya yin jinkiri don rashin lafiya, bukatar kula da wasu, ko kuma tsoron kamuwa da cuta.
Yanayin kasuwanci na iya canzawa, ko dai game da yadda ake shigo da kayayyaki da kuma yadda ake sayen kayayyaki (misali sayen kayayyaki a cikin sa'o'i masu rahusa ko sabis na gyara ko jigilar kayayyaki ta mota).
Bayan haka, ana iya dakatar da jigilar kayayyaki daga wuraren da cutar COVID-19 ta shafa. Ana iya amfani da shirin shirye-shirye don magance cututtukan cututtuka don yin rigakafi.
Shirye-shiryen haɗari a wurare da yawa na aiki da kuma aiki da kansa, ciki har da haɗarin kamuwa da cuta, haɗarin gida da haɗarin al'umma da haɗarin da ma'aikata ke fuskanta saboda tsufa ko rashin lafiya mai tsanani.
Suna nuna mahimman matakan da za a bi don kawar da cutar ta hanyar kawar da waɗannan haɗarin da sauran matakan da za a yi amfani da su idan ba a yi nasara ba yayin annobar.
Ana iya aiwatar da shirye-shiryen shirye-shirye da kuma hana cututtukan cututtuka a matakin ƙasa ko yanki.
Matakan rigakafin cutar a cikin wasu mutane sun haɗa da rage kamuwa da cuta tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da wasu cututtuka, ci gaba da buɗe kasuwancin da rage tasirin sauran kamfanoni a cikin sarrafawa da sarrafa kayayyaki.
Yawan kamuwa da cutar a cikin al'ummomin da ke da zaman kansu na iya shafar matakan da aka ɗauka.
Ana amfani da jerin matakan rigakafin cutar da aka fi amfani da su wajen magance cutar don kare aminci da lafiya a wuraren aiki dangane da sakamakon da suke samarwa.
Inda ba za a iya magance cutar COVID-19 ba, hanyar da za a iya amfani da ita wajen magance cutar ita ce ta amfani da kayan aikin da aka tsara, sannan kuma ta bi matakan gudanarwa da kuma kayan kariya.
Yin amfani da kayan aiki na musamman don hana ma'aikata haɗarin aiki ba tare da dogaro da halayyar ma'aikaci ba kuma yana iya zama mai sauƙi a aiwatar da shi.
Tsarin gudanarwa shine canji a cikin tsarin aiki ko aiki wanda mai aiki ko ma'aikaci ke buƙatar aiwatar da shi.
An yi la'akari da tufafin kariya na musamman (PPE) wanda ba shi da tasiri kamar na baya, amma yana iya taimakawa wajen hana kamuwa da cutar.
Dole ne a zaɓi kowane nau'in PPE bisa ga haɗarin da ma'aikaci ke ciki, daidai da aikinsa (misali: numfashi), a sa shi a kai a kai da kuma yadda ya kamata, a duba shi akai-akai, a kula da shi da kyau, a canza shi kamar yadda ya dace kuma a cire shi, a tsabtace shi, a adana shi ko a zubar da shi don hana shi gurɓatawa.
A cewar OSHA a Amurka, aiki mai ƙarancin haɗarin kamuwa da cuta shine aiki mai ƙarancin haɗari ga mutane ko abokan aiki.
Dole ne a bi ƙa'idodin rigakafin kamuwa da cuta a duk wurin aiki kuma ya haɗa da wanke hannu sau da yawa, ƙarfafa ma'aikata su kasance a gida yayin rashin lafiya, umarnin rigakafin cutar numfashi sun haɗa da rufe kai yayin da kake motsawa ko motsawa, samar da wuraren da za a iya tsabtace da kuma sanya su, shirya sadarwa ta hanyar fasaha, hana ma'aikatan maye daga shiga ko fita daga aiki sau ɗaya idan ya cancanta, hana ma'aikatan yin amfani da kayan aiki na abokan aiki da kuma tsabtace da kuma amfani da maganin kashe ƙwayoyin cuta a wuraren aiki.
Ganowa da killace masu kamuwa da cutar nan take yana da mahimmanci wajen kare ma'aikata, abokan ciniki, baƙi da sauransu a wurin aiki.
Cibiyar CDC ta Amurka ta bukaci ma'aikatan da ke da alamun cutar ta numfashi mai tsanani su zauna a gida har sai sun daina yin wuta, alamun wuta da sauran alamun rashin lafiya, su zauna a gida har tsawon awanni 24 ba tare da yin amfani da maganin rage wuta ko wasu magungunan magance alamunsu ba kuma su sauƙaƙe aikace-aikacen neman izinin rashin lafiya, su ba ma'aikatan izinin zama a gida tare da wani danginsu mai rashin lafiya da kuma sanar da ma'aikatan waɗannan matakan.
A cewar OSHA, aiki mai daidaitaccen haɗarin kamuwa da cutar aiki ne wanda ke buƙatar haɗuwa ko kusanci da yawa a cikin nesa na ƙasa da mita 1.8 da mutane da ba a san su ba ko kuma waɗanda ake zargin suna da cutar COVID-19, amma waɗanda zasu iya kamuwa da cutar SARS-CoV-2 saboda kamuwa da cutar tsakanin mutane a wuraren kasuwanci ko saboda mutane sun yi tafiya kwanan nan a wuraren da COVID-19 ke kamuwa da cutar.
Ya hada da ma'aikata masu saurin saduwa da jama'a kamar ma'aikata a makarantu, masu aiki a wuraren da jama'a ke da yawa da kuma wuraren da ake karɓar masu amfani da yawa. Yin amfani da kayan aiki don magance kamuwa da cuta ta hanyar amfani da kayan aiki da aka tsara don waɗannan ma'aikata da sauran rukunin masu haɗarin kamuwa da cuta da suka haɗa da masu motsa jiki, ƙara yawan masu motsa jiki, da kuma sanya alamun da ba a taɓa amfani da su ba don kare mutum daga cutar ta filastik, da kuma sanya windows don masu amfani da su don taimakawa wajen rage haɗarin kamuwa da cuta. Matakan da ake amfani da su don hana kamuwa da cuta ta hanyar amfani da su da kayan aiki da yawa da ke da haɗari da yawa na ma'aikata sun haɗa da ƙarfafa ma'aikatan da ke da cutar ta gida, sauya tarurruka na ma'aikata don amfani da na'urori masu amfani da filastik, hana ma'aikata da ke da amfani da na'urori masu amfani da kayan aiki da ke da amfani da su don taimakawa wajen hana cutar ta COVID-19, da kuma rage yawan haɗarin cutar, da kuma ba da amfani da kayan aiki na yau da kullun da kullun don taimakawa wajen hana cutar, da kuma ba da amfani da kayan aiki na yau da kullun, da ke da kullum, da ke da ke da amfani da kayan aiki da kayan aiki da kayan aiki da ke da ke da amfani da kayan aiki da kayan aiki da kayan aiki da ke da kayan aiki da ke da ke da amfani da su don taimakawa wajen hana cutar COVID-19, da ke da ke da ke da ke da ke da amfani da ke da amfani da su don taimakawa wajen hana cutar.
Ma'aikata a cikin wannan rukunin masu haɗari ba su da buƙata ta amfani da numfashi.
Idan mutum yana cikin jirgin sama, dole ne a yi matakan tsaro na musamman don kare ma'aikatan jirgin sama da sauran fasinjoji, ciki har da sanya mai haƙuri a cikin keɓewa daga sauran mutane a cikin nesa na mita 2, sanya ma'aikaci a cikin jirgin sama ɗaya don ba da abin da mai haƙuri yake buƙata, ba shi abin rufe fuska ko kuma ya nemi rufe bakinsa da hanci da sutura yayin da yake hawa ko motsawa.
Ma'aikatan jirgin sama suna bukatar su saka kayan aikin likita na asibiti da aka yi amfani da su bayan sun taimaka wa mai haƙuri a cikin jirgin sama ko sun taɓa ruwan jiki ko kuma sun yi aiki a cikin yanayin da zai iya zama mai ƙazanta kuma su saka kayan kariya na musamman idan mai haƙuri yana cikin jirgin sama yana da wuta, ƙonawa ko rashin numfashi.
Dole ne a saka kayan aiki da kayan aiki da aka yi amfani da su a cikin kayan aiki na musamman kuma dole ne a share wuraren da suka lalace kuma a yi maganin kashe kwayoyin bayan amfani da su. A kan jiragen ruwa masu jigilar mutane, gami da jiragen ruwa masu yawon shakatawa da sauran jiragen ruwa masu jigilar mutane, maganin cutar ya haɗa da jinkirta tafiya idan wani yana rashin lafiya da kewaye da shi da kuma sanar da asibitin jirgin nan da nan idan akwai wuta ko wasu alamun bayyanar a cikin jirgin.
A cikin gidajen ilimi da kuma wuraren kula da lafiya, CDC ta ba da shawarar cewa a tsare shi na ɗan lokaci don tsaftacewa ko maganin kashe kwayoyin cuta idan mutum mai cutar ya bayyana a cikin ɗakin makaranta ba tare da la'akari da cutar ba.
Duk da ƙananan ko manyan adadin kamuwa da cuta tsakanin mutane, ana iya ɗaukar matakan guje wa kusanci tare da dakatar da makarantu da taron jama'a kamar motsa jiki ko darussan waƙa a cikin kora ko cin abinci a kantin, ƙara sarari tsakanin kujerun, barin sarari ga masu shiga ko fita, hana ziyartar da ba dole ba da kuma amfani da asibiti a wani wuri don yara da ke nuna alamun cutar.
Idan akwai kamuwa da cutar a cikin al'umma, sai dai idan ana iya yin la'akari da matakan guje wa kusanci da rufe makarantu na dogon lokaci. Ga ma'aikatan tsaro da ke aiki a yau da kullum, haɗarin kamuwa da cutar nan take yana da ƙasa, a cewar CDC.
Jami'an tsaro da suka sadu da mutumin da aka tabbatar da cewa yana da cutar ko kuma ake zargin yana da COVID-19 ana buƙatar bin wasu umarnin kamar na likitocin da ke aiki a cikin yanayin gaggawa, gami da sanya tufafin kariya na musamman.
Idan akwai kusanci yayin kama mutum, ma'aikata dole ne su wanke da kuma sanya maganin kashe kumburi a belun da suke sawa da kuma kayan aikin su kafin su sake amfani da su ta hanyar amfani da kayan wanke gida ko kayan wanke kuma su bi ka'idodin da aka saba da su na adana da zubar da tufafin kariya na musamman da aka yi amfani da su don adana da wanke tufafi.
OSHA ta ba da shawarar cewa wasu ma'aikatan kiwon lafiya da kuma nishaɗi suna da haɗarin kamuwa da cutar.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da ma'aikatan kiwon lafiya, dakunan gwaje-gwaje, da masu jigilar kaya waɗanda suka haɗu da wani wanda aka sani ko kuma ake zaton yana da cutar COVID-19.
Waɗannan mutane suna da haɗarin kamuwa da cutar yayin da ma'aikatan ke gudanar da ayyuka waɗanda suka haɗa da ƙara yawan numfashi, ɗaukar ko bincika gwajin mutum wanda aka sani ko ake zaton yana da COVID-19.
Ayyukan da ke taimakawa wajen samun numfashi sun hada da saka numfashi a jiki, motsa jiki, shigar da numfashi, wasu ayyukan hakora da kuma duba ko kuma daukar matakan jiki.
Mafi yawan haɗarin kamuwa da cuta a lokacin hutu yana tare da ma'aikatan da suka san ko kuma ake zaton sun kamu da COVID-19 a lokacin mutuwa; suna da haɗarin haɗari yayin gwajin gwajin mutum. Kuma maganin kamuwa da cuta tare da kayan aiki na musamman ya haɗa da rukunin haɗari ciki har da ɗakunan ɓoye ga marasa lafiya da aka sani ko ake zaton suna da COVID-19, gami da gudanar da ayyukan hawan iska ga marasa lafiya.
Wani na'urar kwantar da iska ta musamman na iya zama mai dacewa ga wasu likitoci da ke aiki a lokacin hutu.
Dole ne a yi gwaji bisa ga matakan tsaro na likita na 3.
WHO ta bukaci a yi wa marasa lafiya da ke zuwa asibiti keɓewa don jiran su saboda zargin COVID-19. Kuma ko dai rigakafin kariya ne, OSHA ta ba da umarnin yin amfani da rigakafin numfashi ga waɗanda ke aiki a cikin nesa ƙasa da mita 2 na waɗanda aka sani ko ake zargin suna da cutar, waɗanda ke da cutar SARS-CoV-2 da waɗanda ke yin aikin hawan jini.
A Amurka, ana buƙatar amfani da N95 ko mafi ƙarancin nau'in numfashi na NIOSH a cikin tsarin kulawa da rigakafi na yau da kullun, wanda ya haɗa da gwajin tufafi, horo da gwajin likita.
Sauran nau'ikan rigunan numfashi na iya kare masu sa tufafi da kuma sa ma'aikaci ya ji dadi. WHO ba ta buƙatar ma'aikata su sa tufafi saboda COVID-19 cuta ce ta numfashi maimakon cuta ta hanyar jiki.
Hukumar ta WHO ta bukaci a sanya masks na likita kawai ga ma'aikatan da ke karbar marasa lafiya.
Ga masu gwajin iska, masu kula da marasa lafiya, ko masu ɗaukar COVID-19 waɗanda ba su da iskar iska, WHO ta ba da shawarar sanya abin rufe fuska na asibiti, fitilu ko kasusuwa, rigar hannu da takalma.
Idan an yi aikin ƙara numfashi, ana maye gurbin abin rufe fuska na asibiti da N95 ko FFP2 na numfashi.
Saboda rashin isasshen kayan kare lafiyar mutum (PPE) a duniya, WHO ta bukaci rage yawan abubuwan da ke haifar da kayan kare lafiyar mutum ta hanyar amfani da maganin cirewa, kafa hanyoyin hana mutane yin taro kamar windows na gani, da kuma sanya masu ba da sabis na kai tsaye su shiga cikin dakin da COVID-19 ke ciki, amfani da PPE lokacin da ya zama dole kawai don aiki na musamman, ci gaba da amfani da numfashi ɗaya ba tare da cirewa ba yayin kula da marasa lafiya da yawa a cikin yanayin rashin lafiya ɗaya, sa ido da daidaita ayyukan aiki da magance PPE da hana amfani da masks ga marasa bayyanar cututtuka.
AN rubuta ta: Katherine Maher, Shugaba na Gidauniyar Wikimedia
AHA: Duk ma'aikatan Wikimedia Foundation
MAI TAMBAYA: [Covid-19] Rage nauyi da kuma shirya don nan gaba
Lokacin da aka kammala: 14 ga Maris 2020, 00:24 UTC
RUSHYA: CC0: Babu haƙƙin mallaka na musamman
Muna cikin yanayi na musamman a wannan watan.
Cutar COVID-19 alama ce mai kyau cewa duniya ta zama birni kuma muna buƙatar taimaka wa juna.
Ba mu taɓa fuskantar waɗannan ƙalubale ba, amma mun san cewa magance cutar a hanya mai kyau yana nufin fahimtar matsalolin duniya, haɗin kai da kasancewa cikin haɗin kai a cikin wannan al'umma.
Abokantaka da kulawa da muka samu daga dukkan abokan aikinmu ta hanyar imel, kira da tattaunawa suna nuna halin da muke da shi na musamman da muka samu damar aiki tare da ku sosai.
Ba ni da wata magana da za ta nuna godiya gare ku, ko kuma in faɗi yadda nake taƙama da ku duka, da yake muna aiki tare.
A makon da ya gabata, wani ya nuna mini yadda yake jin daɗin aikinmu.
Ya tunatar da ni yadda Wikipedia ta zama mai amfani a duniya a yau, wanda ke nuna cewa ita ce cibiyar sadarwa mai amfani da kuma kasancewa a kan layi da kuma samuwa ga kowa.
Aikin da kuke yi ne zai sa hakan ya yiwu, ko don ci gaba da yin amfani da dandalin, ko don biyan abokan aiki, ko kuma don kiyaye wuraren aiki.
Duniya tana bukatar bayanai na Wikipedia fiye da kowane lokaci.
Wannan lokaci ne da za mu yi amfani da shi wajen yin canji mai muhimmanci a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kake takawa, za mu yi canje-canje masu muhimmanci ga yadda muke aiki, daga mako mai zuwa.
Yin canje-canje a cikin ayyukanmu shine lokacinmu
Kamar yadda Robyn ta ce, ƙungiyarmu ta haɗu a daren jiya don tattauna yadda za mu yi amfani da lokaci na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna abin da muka yi tunanin zai zama amsar da ta dace ga abin da muke fuskanta da kuma hanya mafi kyau na ci gaba da kasancewa cikin iyali a wannan lokacin.
Muna son mu kawar da matsaloli kuma mu ci gaba da hidimarmu.
Idan kana son yin kira, ba kome.
Ga waɗanda suke aiki, waɗanda suke da alkawari, da waɗanda suke cikin alkawari:
Sa'o'i masu zuwa da ake sa ran aiki a kullum su ne sa'o'i 4 ko 20 a mako har sai an ba da ƙarin umarni.
Ba za mu ce hutu ba ne; idan za ka iya yin aiki, za mu iya amfani da shi a matsayin aikinmu.
Amma, a yau, yanayin duniya yana daɗa muni kuma idan kana bukatar ka kula da ƙaunatattunka, ka sayi abinci, ko kuma ka je wurin zama, kana bukatar ka mai da hankali ga lafiyarka.
Ba za mu lura da lokacin da kake aiki ba.
Idan kana rashin lafiya, kada ka je aiki.
Ba a bayyana ba, amma muna da tabbaci.
Ba lallai ne ku nemi izinin rashin lafiya ko izinin biya ba, ku sanar da shugabanninku kuma ku taimaka wa ƙungiyar ku sake duba jadawalin lokaci don ci gaba da aikin farko.
(Idan an gano COVID-19 a cikin gwajinku, ku sanar da Bryan daga T&amp;C Ops don T&amp;C ya ba ku taimako game da matsalarku kuma ku sami kulawa ta hanyar gudanarwa).
Wanda aka biya a sa'a za a biya shi dukan kuɗin.
Mun sake yin hakan kuma mun sake yin alkawarin cika hakkokinmu ga waɗanda muka yi aiki tare da su.
Kowa zai sami albashinsa bisa ga ainihin sa'o'in da ya yi aiki a lokutan yau da kullum.
A wasu lokatai kana rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kana son yin aiki, muna tare da kai.
Mutane da yawa suna amfani da aiki a matsayin hanyar kawar da damuwa a wannan duniyar.
Abubuwan da muke yi suna da muhimmanci sosai musamman a wannan lokacin.
Ƙari ga haka, ka kula da kanka.
Shirye-shiryenmu shine ka tuntubi shugabanka don sanin abin da za mu iya tsammani da kuma daidaita tsarin yadda ya kamata.
Akwai wasu ayyuka da ake ɗauka da muhimmanci.
Akwai abubuwa da ya kamata mu ci gaba da yi.
An kafa ƙungiyoyin SRE, HR Ops, Trust &amp; Safety don tara kuɗi (da sauransu) don yin aiki mai mahimmanci wanda ke buƙatar ƙarin taimako.
Za mu fara duba kowane reshe don bincika manufofin da ke akwai kuma mu daidaita abubuwan da muke mayar da hankali ga su don taimakawa manyan abubuwan da muke da su.
Akwai abubuwa masu muhimmanci da dukanmu za mu yi, amma akwai abubuwa masu muhimmanci da za mu mai da hankali ga su.
Yin aiki kaɗan a yanzu ba zai kawo sakamako ba.
Ba mu da niyyar aƙalla maimaita aikinmu don dawo da lokacin da muka rasa  bayan an kammala annobar.
Ba a bukatar ka yi aiki fiye da sa'o'i da yawa don kada lokacinka ya wuce, domin ba za ka iya yin hakan ba a yanzu.
Mun yarda cewa abubuwa sun canza kuma za mu yi aiki don kafa maƙasudai da kuma sababbin yanayi a inda ya dace.
Menene zai faru da shirin shekara-shekara?
Don daidaitawa da yanayin da ya rage na sa'o'in aiki na yau da kullun, muna son canza jadawalin shirin na 2020-2021.
Manufarmu ita ce a ba da shawarar tsawaita lokacin tsarawa na 2019-2020 don ba da lokaci don tsara kasafin kuɗi ta hanyar sa ma'aikata su mai da hankali kan aiki na farko, kula da kansu da kula da ƙaunatattunsu yayin da muke tallafawa waɗanda suke son ko kuma waɗanda suke son yin aiki na ɗan lokaci a cikin makonni masu zuwa.
Irin wannan tsawaita lokaci yana rage yawan aikin da aka shirya a matsayin matsi ga dukan iyalin.
Za mu gabatar da shawarwarinmu ga Hukumar Kula da Ayyukanmu a mako mai zuwa kuma zan ba da sabon bayani ga sauran wakilan da kuma kungiyoyi game da umarnin da ke gaba da wuri-wuri da zarar an amince da su.
Ƙungiyar da ke shirin shirin ta yi nasara a kan ikon gudanarwa da ta nuna.
Yanayin jiki, yadda mutane ke kamuwa da cuta da kuma tsabtace jiki
A makon da ya gabata, mun sami labarin cewa ɗaya daga cikin abokan aikinmu a SF ya sadu da wani wanda zai iya kamuwa da COVID-19.
Amma, saboda muna da hankali sosai, mun ɗauki ƙungiyar tsabtace tsabtace muhalli don samar da maganin kashe kumburi a ko'ina a ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafin cutar a asibiti kuma sun kashe ci gaba a duk wuraren da mutane ke shiga da kuma a cikin masu ba da bayanan banki zuwa bene na aiki.
Ginin yana amfani da umarnin rigakafin cutar ta amfani da kayan aikin tsaro na masu amfani.
Muna da tabbacin cewa ofishin zai kasance a shirye idan muka zaɓi sake yin hakan.
Ofishinmu na DC a WeWork, ya raba tsarin COVID-19 tare da mu da duk ma'aikatanmu na DC.
Har zuwa makon da ya gabata, ofishinmu na DC ya daidaita aikinsa ta hanyar amfani da nesa don bin umarnin San Francisco.
Kamar yadda wasu abokan aikina da ke aiki a birnin New York suka sani, mun soma tattauna batun haya a Brooklyn.
Wannan tattaunawar tana ci gaba amma tana iya jinkiri.
Wasu abokan aikina za su yi aiki a nesa a karon farko.
Abokan aikinmu da ke amfani da nesa sun san cewa za a iya canzawa kuma muna so mu ba su shawara:
Ka rage tsawon lokacin da za ka yi taro, ka rage tsawon sa'a ɗaya ko biyu idan ka yi jinkiri.
Idan ba a bukatar ƙarin lokaci, ku yi tunani game da yadda za ku rage yawan darussan da ake yi a cikin kwanaki da yawa.
Bayyana shawara a fili, samun bayanin da ya dace da abin da za a yi nazari da kuma aika da takardun da aka rubuta a gaba.
Ka bar yin amfani da bidiyo ya zama babban abu ta amfani da aikace-aikace kamar Google Docs da Zoom don sauƙaƙe sadarwa da raba bayanai cikin sauri.
Idan an bar shugaban kasa ya jagoranci kowane taro, an ba da mai kula da tattaunawar da aka yi tambaya da kuma jerin abubuwan da aka yi magana da wanda ya dauki bakuncin taron (ko kuma ya shiga cikin rubutun taron).
Aika imel zuwa masu ba da taimako na fasaha idan kana buƙatar kwamfutar da ke magana da kyau.
Ka ci abinci mai sauƙi don ka kasance da koshin lafiya.
Ka shiga dandalin #remoties a Slack don bayyana matsalolin da kake fuskanta wajen yin aikinka
Ayyukan ƙungiyar ma'aikata suna nazarin tsarin horo na kan layi don karɓar taimako da haɓaka aikin da aka bayar a cikin Ƙungiyar.
A makon da ya gabata, mun nemi duk cibiyoyin da ke tallafawa su dakatar da ayyukan da ake yi na neman tallafin Wikimedia a matsayin wani shiri na horar da sababbin masu rubutun ra'ayin yanar gizo, har sai WHO ta sanar da cewa annobar ta ƙare.
Mun gaya musu cewa mun san cewa yin musu gargaɗi su daina waɗannan ayyukan da kuma bin wasu dokoki yana sa ya yi wuya su kammala aikin tara kuɗi da suka yi niyya kuma babu wanda zai hukunta su don jinkirin su ko kuma canja burinsu.
A mako mai zuwa, za mu bi wasu umarni a Wikimania da kuma wasu tarurruka na musamman na yanki.
Ra'ayoyin da aka samu game da kungiyoyin duniya suna da damuwa game da dakatar da ayyukan amma akwai ta'aziyya, fahimtar da kuma ikon mayar da hankali ga kungiyoyin kansu, Wikimedia da sauransu.
Don haka, CRT tana kafa shafi a kan Meta-Wiki don ba da damar ƙungiyar don bin diddigin tasirin da kuma bayanan da muke hulɗa da su.
Ci gaba da sadarwa kan matsalolin COVID-19
Za mu aika da gayyatar zuwa gajerar ku a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don kawo muku sabon labari, amsa tambayoyinku, da kuma ciyar da sauran lokaci don sadarwa.
Dukanmu mun shiga cikin annobar kuma muna nan don yin aiki tare da iyakar ƙarfinmu.
A halin yanzu, zaku iya ci gaba da samun cikakken bayani game da wannan imel ɗin da sauran mahimman bayanai game da COVID-19 a cikin Wiki Office.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma duk bayanan za su kasance a wuri ɗaya.
Muna neman hanyoyin da za mu ci gaba da sadarwa da ma'aikatan da ke zaune a ƙasashen da ke fuskantar cutar.
Idan kuna da wata tambaya game da tafiya, ayyuka, aiki ko matsalar Intanet ko wani abu da kuke buƙatar taimako, kada ku yi jinkirin sanar da mu da kuma tuntuɓar CRT.
Muna nan don taimaka maka ka daidaita ayyukan yadda ya kamata.
Idan kana da wata matsala ta sirri ko kuma kana bukatar a kula da ita, ka aika da imel zuwa Bryan Judan, Shugaba na Ayyuka da Ayyuka na Duniya.
Babu wani canji da ya kamata a ɗauka a matsayin barin aikinmu ko kuma hakkinmu.
Maimakon haka, yana nuna cewa a yau, ayyukanmu da kuma hakkokinmu suna iya canja fiye da dā.
Waɗannan su ne matakan da muka yi imanin suna da muhimmanci wajen taimaka wa juna don ci gaba da aiki, yin aikin da aka ba mu bisa ga taimakon da suke bukata da kuma samar da sabis na duniya.
Za mu yi aiki da muka shirya har sai lokacin ya yi.
A yanzu haka, muna cikin lokaci na taimaka wa juna da kuma samun lokaci don yin aiki mai muhimmanci a cikin makonni masu zuwa kuma mai yiwuwa a cikin watanni masu zuwa.
Muna bukatar ku duka don wannan ya faru kuma muna bukatar ku kula da kanku da kuma iyalanku don ku sami lafiya idan ya cancanta.
Yanzu ya kamata ku wanke hannuwanku kuma ku guji taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran mambobin kungiyar (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
A2 (ACE2) shine furotin da ke aiki da ƙwayoyin cuta na waje (kwayoyin ƙwayoyin cuta) na huhu, jijiyoyin jini, zuciya, koda, da hanji.
ACE2 yana daidaita aikin furotin mai canza angiotensin (ACE) ta hanyar rage adadin angiotensin-II da haɓaka Ang(1-7) zuwa ingantaccen magani don maganin cututtukan zuciya.ACE2 kuma yana taimakawa wajen shiga cikin kwayar cutar ta kwayar cutar ta coronaviruses.
An fi kiran fasalin ɗan adam na furotin mai gina jiki hACE2.
Protein mai aiki na angiotensin-con 2 shine zinc wanda ke dauke da metalloenzyme wanda ke cikin endothelial surface da sauran kwayoyin halitta.
Protein ACE2 yana dauke da N-terminal na peptidase M2 da kuma C-terminal collectrin na daukar kwayoyin acid daga kwakwalwa.
ACE2 wani nau'in furotin ne mai nau'i ɗaya na nau'i I, wanda ke da wani ɓangare na furotin mai aiki wanda ke aiki a saman ƙwayoyin cuta da sauran ƙwayoyin halitta.
A cikin ƙwayoyin halitta, an cire wani ɓangare na ACE2 daga cikin ƙwayoyin cuta kuma ya shiga cikin wani furotin mai ƙwayoyin cuta wanda ake kira sheddase, kuma furotin mai ƙarancin ƙwayoyin cuta ya shiga cikin hanyar ƙwayoyin cuta sannan ya fita cikin kwayar cuta.
ACE2 yana samuwa a cikin kwayoyin halitta da yawa: ACE2 yana aiki ne don ƙwayoyin halitta da yawa na ƙwayoyin cuta na nau'in II na jijiyoyin huhu, ƙwayoyin cuta, ƙwayoyin jini da jijiyoyin jini da ƙwayoyin jijiyoyin jiki na ƙananan sassan jiki.
Ana samun ma'anar ACE2 mRNA a cikin ƙwaƙwalwar kwakwalwa, a cikin striatum, a cikin hypothalamus, da kuma a cikin kwakwalwa.
Aikin farko na ACE2 shine daidaita daidaitattun matakan ACE.
ACE na jini na angiotensin I zuwa angiotensin II yana haifar da ƙananan jijiyoyin jini da rage karfin jini.
ACE2 kuma yana samar da phenylalanine na amino acid carboxyl-terminal a cikin angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) da hydrolyses a cikin angiotensin wanda ke haifar da manyan huhu masu ɗaukar jini (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
Hakanan ACE2 na iya raba peptides kamar [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 yana taimakawa wajen karɓar amino acid mai aiki wanda ke haifar da SLC6A19 kuma yana taka rawa wajen cututtukan Hartnup da ke haifar da ƙwayar cuta.
A matsayin furotin mai wucewa, ACE2 yana aiki azaman babban hanyar shiga cikin kwayar halitta don samar da wasu coronaviruses, wato HCoV-NL63; SARS-CoV (virus mai haifar da SARS); da SARS-CoV-2 (virus mai haifar da COVID-19).
A bayyane yake, alaƙar haɓakar ƙwayoyin cuta S1 na SARS-CoV zuwa SARS-CoV2 zuwa sashi na ƙwayoyin cuta na ACE2 a cikin ƙwayoyin cuta yana ba da tsarin endocytosis da kuma ƙaurawar ƙwayoyin cuta daga ƙwayoyin cuta zuwa ƙwayoyin cuta na cikin ƙwayoyin cuta.
Wannan hanyar shiga tana shirya furotin S don aiki ta hanyar rarraba TMPRSS2, kuma ana binciken yadda za a hana shi aiki a matsayin babban hanyar magani. Wannan ya haifar da ra'ayin cewa rage matakan ACE2 a cikin kwayoyin halitta na iya taimakawa wajen hana cutar.
Duk da haka, yawancin kamfanoni masu sana'a da kuma cibiyoyin kula da aiki sun nemi ci gaba da hana ACE aiki a allurai da aka yarda da su tare da maganin ARB.
Wani bincike mai zurfi da aka sake nazari da aka buga a ranar 11 ga Yuli, 2012, ya gano cewa "sanya maganin hana ACE yana da alaƙa da raguwar 34% na haɗarin kamuwa da cutar sankara idan aka kwatanta da waɗanda aka bincika".
Bugu da ƙari, "hadarin kamuwa da cutar ta kumburi ya ragu a cikin marasa lafiya da ke da haɗarin kamuwa da cutar da aka yi amfani da su ta hanyar maganin hana ACE musamman ga marasa lafiya na zuciya, wato marasa lafiya na zuciya.
Ana samun raguwar amfani da maganin ACE kuma an rage yawan mutuwar kamuwa da cutar sankara, duk da cewa sakamakon bai fi haɗarin kamuwa da cutar sankara gaba ɗaya ba".
ACE2 (rhACE2) an yi la'akari da shi a matsayin sabon magani don cutar cututtukan huhu, kuma yana da kyau don inganta haɓakar jini a cikin huhu da kuma ƙara isasshen iska a cikin wuraren da ke da cutar huhu.
Rashin lokaci na rayuwa na rhACE2 a cikin mutum shine awanni 10 kuma yana farawa bayan minti 30 fiye da lokacin da tasirin tasirin ya fara bayyana (lokacin) cikin awanni 24.
Yawancin bincike sun gano cewa rhACE2 na iya zama magani mai amintacce ga mutanen da ke fama da rashin haƙuri na tsarin renin-angiotensin (RAS inhibitors) ko kuma cutar da ke da babban adadin angiotensin II. An ƙayyade rhACE2 a cikin gwaji na asibiti don maganin cututtukan huhu.
COVID-19 aikace-aikacen wayar hannu ne da aka tsara don gano waɗanda suka sadu da su don neman amsar cutar coronavirus 2019-20, misali, a cikin aikin gano mutane ("lambar") wanda zai iya haɗuwa da mai cutar.
Yawancin shirye-shiryen sun kasance ko kuma an nemi masu amfani da su da yawa, gwamnatoci suna tallafawa su a wasu jihohi da yankuna da suke gudanarwa.
An kafa dandamali da yawa na yin amfani da tsarin sadarwa.
An nuna damuwa game da ɓoye bayanan sirri na sirri, musamman game da tsarin gano wuri na masu amfani da aikace-aikacen.
Wani zaɓi na musamman na sauyawa na amfani da Bluetooth don shiga cikin wayar hannu ta hanyar aikace-aikacen da ke kusa.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa wannan aikace-aikacen don tallafawa aikace-aikacen da ke dogara da sanarwar Bluetoothigah da za a shigar nan take a cikin tsarin Android da iOS.
A kasar Sin, Gwamnatin China, tare da Alipay, ta ƙaddamar da aikace-aikacen da ke ba da damar 'yan ƙasa su sami damar tuntuɓar mutanen da ke da cutar COVID-19.
Ana amfani da shi a cikin birane sama da 200 na kasar Sin. A Singapore, ana amfani da TraceTogether.
An gabatar da wannan app ɗin a matsayin wata hanyar sadarwa ta kowa da kowa da kuma ta gwamnati. Arewacin Macedonia ta fitar da "StopKorona!", wani app wanda ke amfani da Bluetooth don ganewa da kewaye da mutanen da ke da cutar sosai kuma ya ba da amsa mai sauri ga hukumomin lafiya.
An tsara wannan shirin ne ta ma'aikatar sadarwa da fasaha da ma'aikatar kiwon lafiya.
Daga ranar 14 ga Afrilu, 2020, ana jiran karɓar aikace-aikacen a cikin Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce an riga an shirya shirin don samun damar yin amfani da shi a cikin makonni masu zuwa, kuma ana shirin yin irin wannan shirin a Ireland da Faransa ("StopCovid").
Ostiraliya da New Zealand suna tunanin yin aikace-aikacen wayar hannu bisa ga misalin Singapore TraceTogether da kuma Rasha BlueTrace. Rasha na shirin ƙaddamar da aikace-aikacen da zai hana yawan masu cutar COVID-19 da ke zaune a Moscow, wanda ya tabbatar da cewa ba su bar gida ba.
Ross Anderson, Farfesa a fannin aiwatar da tsare-tsaren tsaro a Jami'ar Cambridge, ya lissafa yawan matsalolin da tsarin da aka kafa ta hanyar aikace-aikacen wayar hannu ke haifar, gami da waɗanda ke nuna rashin lafiya da lafiya da rashin aiwatar da abin da aka tsara idan amfani da waɗannan aikace-aikacen ya kasance ga ƙananan al'umma.
Don magance wannan damuwar game da yaduwar waɗannan aikace-aikacen da ke yaudarar ko lalata masu kula da coronavirus, Apple ya sanya iyakancewar nau'ikan aikace-aikacen da ke tattare da coronavirus a cikin App Store, yana ba da izinin kawai "halattaccen" ko kuma amintaccen ƙungiyoyi.
Google da Amazon sun kafa irin wannan takunkumin.
Mutane sun nuna damuwa game da yawan jama'a da ke amfani da wayar hannu, musamman idan za a kawar da matakan da aka kafa don sarrafa cutar coronavirus lokacin da cutar ta ƙare.
Amnesty International da fiye da kungiyoyi 100 sun wallafa takarda da ke kira ga rage amfani da tsarin kula da mutane.
Wadannan kungiyoyin sun bayyana abubuwa takwas da gwamnati za ta bi don gudanar da ayyukanta:
Dole ne a yi bincike bisa doka, dole ne kuma a daidaita shi da manufar sa. "
tsawaita lokacin bita da duba ya kamata ya hada da takardun da ke nuna lokacin da za a kammala;
ya kamata a yi amfani da bayanan ne kawai don dalilai na COVID-19;
tsaro da kuma sirri na bayanan da dole ne a kare su kuma a bayyana su domin a kiyaye su bisa ga hujjoji;
Dole ne a yi amfani da fasaha don yin nazari ba tare da nuna bambanci ba;
duk wani bayani da ya kamata ya kasance bisa doka;
ya kamata a samar da hanyoyin da za a magance zalunci da kuma taimakawa jama'a su hana shi;
"Ana buƙatar haɗin gwiwar  na kowane  na abokan hulɗa , gami da ƙwararrun likitocin jama'a da ƙungiyoyin  na mutanen da suka rage a Cibiyar Fasaha ta Jamus (CCC) da kuma  'Yan Jarida ba tare da iyaka ba (RSF) sun kuma ba da jerin abubuwan da za a kula da su.
Tsarin Google/Apple wanda ke nuna matsalar sa ido na yau da kullun ya yanke shawarar cire hanyoyin gano masu kamuwa da cutar daga na'urorin su lokacin da ba a buƙatar wannan hanyar ba.
Wasu ƙasashe sun yi amfani da hanyar bincike ta hanyar yin amfani da keɓaɓɓun hanyoyin bincike na gida maimakon amfani da fasahar wayar hannu, suna kawar da sha'awar sanya wannan fasahar ta wayar hannu da kuma yiwuwar guje wa bincike.
A Isra'ila, an tabbatar da hanyar gano wadanda suka kamu da cutar ta hanyar mai bincike.
Tsarin bincike na masu bincike wanda ke da damar samun bayanan sirri na mutum game da wurin zama yana da manyan batutuwan sirri.
Amma, ba duk hanyoyin adana bayanai bane na fasaha amma dole ne su sami damar samun bayanan sirri na sirri dangane da wurin; akwai hanyoyin da yawa da aka tsara don kiyaye bayanan sirri na sirri wanda ke amfani da bayanan kawai lokacin da ake buƙatar daidaitaccen bayani (duba sashin da ke ƙasa).
A Koriya ta Kudu, an yi amfani da hanyar da ba ta da fasaha ta wayar hannu don gano waɗanda suka kamu da cutar.
Maimakon amfani da fasahar wayar hannu ta musamman, an tattara bayanai ta hanyar amfani da wayoyin hannu, ayyukan katin kuɗi da kuma sanar da mutane da ke da matsala mai tsanani ta hanyar saƙonnin rubutu zuwa wayoyin salula.
Baya ga amfani da wannan bayanan don sanar da waɗanda suka kamu da cutar, gwamnati ta kuma samar da damar samun damar kowa zuwa bayanan yanki, sakamakon canje-canje a cikin dokokin bayanan sirri bayan barkewar cutar MERS a ƙasar.
Kowa na iya samun wannan bayanin ta hanyar sadarwa ta hanyar sadarwa da kuma shafukan yanar gizo daban-daban. Kasashe ciki har da Jamus sun yi amfani da duka hanyoyin a matakin ƙasa duk da cewa suna ba da bayanan sirri.
Tun daga ranar 6 ga Afrilu, 2020, babu wani bayani.
A ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyi 12 na masana sun bincika abin da za a yi don hana ɓoye sirrin mutum, kamar amfani da tsarin ɓoye-ɓoye (BLE) wanda ke ba mai amfani damar sadarwa tare da wayoyin salula na kusa.
Duk da haka, PEPP-PT wani tsari ne na haɗin kai na tsarin kasa da na al'umma wanda ba ya aiki daidai. Tsarin al'umma ya haɗa da tsarin gano masu kamuwa da cutar ta hanyar bayanan sirri na mutum (DP-PPT), Ƙididdigar ɗan lokaci na masu kamuwa da cutar (TCN), Ƙididdigar Ranar Bikin (CEN), Tsarin gano masu kamuwa da cutar ta sirri (PACT) da ƙari.
A wannan hanyar, bayanan sirri na mutane da aka gano ba a fitar da su ba, kuma yana da alaƙa da gano waɗanda aka sadu da su ta hanyar fasaha.
Ƙungiyar bayanan sirri ta MIT Media Lab tana ci gaba da neman ingantaccen tsarin ɓoye bayanai, hanyoyin da za a kiyaye bayanan sirri na mutum da kuma amfani da hanyar gano masu kamuwa da cutar ta hanyar asalin su don samun bayanai game da yaduwar COVID-19.
Wannan ya dogara ne akan binciken da Apps Gone Rogue: Tsare Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sirrin Sir
Tabbatar da hanyar gano masu kamuwa da cutar ta amfani da na'urorin fasaha don taimakawa masu amfani da su sadar da bayanan lafiya da na lafiya ba tare da keta sirrin mutum ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyi masu haɗin kai da yawanci suna fuskantar rikice-rikice game da abin da ya kamata a bi sun kafa TCN Forum na Duniya, wanda ke nufin haɗa kai da samar da hanyar sadarwa ta duniya game da fasahar wayar hannu don gano masu kamuwa da cutar, wanda zai haifar da ƙarin amfani.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta kafa hanyar gano wadanda suka kamu da cutar ta hanyar amfani da fasahar gwamnati.
A ranar 10 ga Afrilu, 2020, kamfanonin sarrafa wayar hannu na Android da iOS, Google da Apple, sun ba da sanarwar cewa suna da hanyar gano masu kamuwa da cutar, hanyar da kamfanonin suka ce sun bi ƙa'idodin sirrin sirri, wanda ya dogara da haɗin fasahar sanyaya mai suna Bluetooth Low Energy da sauran hanyoyin kwamfuta waɗanda ke ba da damar ɓoye bayanan sirri.
Sun kuma sanar da yadda wannan fasaha za ta yi aiki a wannan shirin.
Google da Apple sun ba da sanarwar cewa ana amfani da wannan hanyar a matakai uku:
tattara kayan aiki don taimakawa gwamnati ta samar da fasaha mai dacewa da ka'idodin sirrin mutum wanda zai taimaka mata gano wadanda suka kamu da cutar
Google da Apple suna shirin ƙaddamar da wannan aikace-aikacen a cikin iOS da Android don magance matsalolin sarrafawa ta hanyar haɓaka wannan aikace-aikacen zuwa sauran fasahohin da ke akwai, sannan za a cire wannan hanyar bayan annobar ta ƙare.
Maganin da ba a yi amfani da shi ba, wanda aka sani da shi a Turanci drug repurposing, re-profiling, re-tasking or therapeutic switching, shi ne tsarin da ake amfani da shi wajen magance wani magani na musamman da ya bambanta da wanda aka yi amfani da shi ko kuma wanda ya bambanta da yanayin da aka yi amfani da shi.
Wannan shine hanyar da ake ci gaba da samar da magani mai aminci da inganci don magance COVID-19.
Wani bincike na musamman game da samar da allurar rigakafin COVID-19 da kuma maganin jini. SARS-CoV-2 yana da alluran gwaji guda 66 a wurare daban-daban.
Binciken wurin ya ba da shawarar yin maganin da zai iya magance cutar COVID-19.
Wasu daga cikin manyan kwayoyin SARS-CoV-2 da ake bincike a kansu sune waɗanda aka samo a cikin hatsi na papaya, waɗanda ke da alaƙa da RNA, helicase, S protein, da ADP ribophosphatase.
Hussein A, da abokan aikinsa, sun gudanar da bincike kan magunguna waɗanda suka nuna cewa suna da kamanceceniya da magungunan yau da kullun don hanzarta samar da magungunan da ke da ikon magance SARS-CoV-2 a cikin binciken farko don sanya su a cikin jerin magungunan da za a yi nazari.
Chloroquine magani ne na malaria amma yana iya magance wasu cututtukan da ke tattare da tsarin garkuwar jiki.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine na iya kasancewa cikin jerin magunguna huɗu da ke ci gaba da bincike ta hanyar gwajin magunguna da aka sani da Solidarity.
Gwamnan New York Andrew Cuomo ya ba da sanarwar cewa jihar New York za ta fara gwajin chloroquine da hydroxychloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate idan babu wani magani a cikin littafin Emergency Use Authorization (EUA) a Turanci.
Ba a tabbatar da wannan magani ba a cikin gwajin FDA, don amfani ne kawai a cikin EUA, a matsayin magani mai bincike don amfani a cikin asibiti amma marasa lafiya ba za a iya magance su ba maimakon gwajin magani.
CDC ta ce an yi amfani da shi, a cikin adadin, ko lokacin da mutum zai iya yin amfani da hydroxychloroquine don rigakafi ko magani na SARS-CoV-2 kafin a sanar da shi.
Likitoci sun bayyana cewa ana amfani da wannan magani ne a lokacin da "babu wani zaɓi".
Ƙungiyar masu bincike na Turkiyya a Istanbul suna gudanar da wani bincike mai sauƙi game da amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Oxford.
Makarantar likitancin NYU Langone tana gudanar da gwaje-gwaje kan inganci da kuma tasirin hydroxychloroquine a cikin maganin mutum.
Gwajin China a lardin Wuhan da Shenzhen ya bayyana cewa favipiravir yana da "matsayin da ba a tabbatar da shi ba don magance cutar.
Marasa lafiya 35 a Shenzhen sun warke cikin kwanaki 4, yayin da marasa lafiya 45 da ba a ba su maganin ba sun dauki kwanaki 11 don warkewa.
A cikin binciken da aka yi a Wuhan a kan marasa lafiya 240 da ke fama da matsalar numfashi, rabin sun karɓi favipiravir kuma wani ɓangare sun karɓi umifenovir.
Cibiyar Magunguna ta Italiya ta tunatar da mutane cewa tushen tabbatar da wannan magani bai kamata a yi la'akari da shi ba kuma har yanzu yana cikin binciken farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta iya siyan wannan magani daga China kuma ta ajiye shi a cikin shagon ta, sannan ta yi amfani da sojoji don isar da shi zuwa asibitin Jami'ar, inda za a yi amfani da maganin don magance marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya ba da shawarar gwamnatin Trump game da sayan maganin. Wannan magani na iya nuna rashin iyawar warkarwa ga mutanen da suka kamu da cutar a yankunan da ke da yawan adadin masu kamuwa da cutar.
ba a bada shawarar yin amfani da wannan magani ga mata masu ciki ko waɗanda ke shirin yin ciki ba.
Binciken lopinavir/ritonavir (Kaletra), cakuda lopinavir da ritonavir ya tabbatar da cewa "ba a samu sakamako ba".
An tsara wannan magani don hana kwayar cutar AIDS.
Wani rukuni na masu bincike a Jami'ar Colorado na kokarin inganta wannan maganin don samar da maganin hana kwayar cutar SARS-CoV-2. Akwai masana da yawa da suka soki shawarar amfani da wannan maganin da aka yi don cutar AIDS.
Hukumar kula da lafiya ta duniya ta sanya lopinavir/ritonavir a jerin magunguna da ake gwadawa a duniya
Remdesivir ya samo asali ne daga Cibiyar Nazarin Kimiyya ta Gilead, wanda aka tsara don magance cutar Ebola da cutar Marburg. Gilead Sciences ya kuma gano cewa Remdesivir na iya magance ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta na cuta, ƙwayoyin cuta, ƙwayoyin cuta, ƙwayoyin cuta, da kuma ƙwayoyin cuta na corona.
Matsalar da ake fuskanta a maganin cututtukan da ke tattare da kwayar cuta ita ce yadda ake iya watsi da magani yayin da yake canzawa a hankali wanda ke sa cutar ta zama mai tsanani da kuma kamuwa da cuta.
Binciken da aka yi kwanan nan ya nuna cewa remdesivir na iya samun ƙarancin ƙwayar cuta. Akwai bincike da yawa a kan shi, ciki har da biyu na asibitin Jami'ar Clevaland; ɗaya don marasa lafiya na farko da kuma wani don gaggawa.
Akwai gwaje-gwaje guda uku na maganin Vitamin C mai jinin jini, wanda ake gudanarwa a cikin asibiti don cutar COVID-19; na farko ana gudanar da gwaje-gwaje (China, Kanada) kuma na biyu ba a gudanar da su ba (Italiya).
A ranar 24 ga Maris, jihar New York ta soma gwajin maganin kashe ƙwayoyin cuta mai suna azithromycin.
Cibiyar Kula da Lafiya ta Japan (NCGM) tana shirin gwada maganin Teijin's Alvesco (ciclesonide ), wanda ke magance cutar asma don magance marasa lafiya marasa cutar Coronavirus.
Hanyar 2 na jini, gwaji ne a kan marasa lafiya 200 da za a yi amfani da su a asibitoci a Denmark, Jamus, da Austria don nuna tasirin maganin.
Masu bincike a Cibiyar Montreal Heart a Kanada suna nazarin maganin colchicine don rage zafi da kuma matsalolin numfashi a cikin marasa lafiya da ke da alamun COVID-19.
Binciken, wanda ake kira COLCORONA, yana neman mutane 6,000 masu shekaru 40 zuwa sama da COVID-19 da ke nuna alamun cutar amma ba su buƙatar zuwa asibiti ba.
Mata masu ciki ko masu shayarwa ko waɗanda ba su yi amfani da hanyoyin hana haihuwa ba ba a cikin binciken da ake yi a yanzu.
Ana gwada wasu magunguna da ke hana jini a Italiya.
Ana amfani da maganin hana jini mai ƙarancin nauyi mai suna Low-molecular-weight heparin a cikin harshen Ingilishi, wanda ya haɗa da matsa lamba a kan cibiyoyin kiwon lafiya a Italiya don yin umarni game da amfani da wannan magani.
A ranar 14 ga Afrilu a Italiya an sanar da wani bincike na cibiyar sadarwa na 300 na marasa lafiya game da amfani da sodium enoxaparin a matsayin kariya da kuma maganin maganin cututtuka.
Tun lokacin da aka gano SARS-CoV-2 a matsayin kwayar cutar, yawancin bincike sun ci gaba da mai da hankali kan magungunan da aka tabbatar da warkar da cututtukan cutar da aka yi kafin barkewar cutar kamar MERS, SARS, da West Nile.
Ribavirin: ribavirin a cikin takaddun shaida na 7 na kasar Sin, an bayar da rahoton cewa ana iya amfani dashi don maganin COVID-19
Umifenovir: wani magani ne na cutar a cikin takaddun shaida na 7 na kasar Sin, wanda aka bayyana a matsayin magani na COVID-19
An bayar da rahoton cewa ana iya amfani da wasu maganin rigakafi don magance COVID-19:
Tocilizumab (mai karɓar maganin IL-6): An amince da shi a kasar Sin.
Har ma da gwajin Italiya. Duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 shine shawarar neman allurar rigakafin cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu allurar rigakafi, ana gudanar da bincike mai zurfi game da sakamakon.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ba da sanarwar cewa babu allurar rigakafin SARS-CoV-2, wanda ke haifar da cutar, kafin watanni 18.
Ana ci gaba da gwajin kashi biyar na allurar rigakafi a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Ya fara yaduwa a duniya a cikin 2020 wanda ya haifar da babban kashe kuɗi da kuma ƙaddamar da bincike don gano allurar rigakafi.
Yawancin cibiyoyin da ke amfani da magungunan yau da kullun suna cikin samar da allurar rigakafin SARS-CoV-2.
Tun daga watan Afrilu, CEPI ta mai da hankali kan samun allurar rigakafi a cikin sauri, samarwa, neman ma'aikata, da kuma isar da ita a duniya.
A watan Afrilu, masana CEPI sun ba da sanarwar cewa ana gudanar da bincike da ci gaba da fasahar fasahar fasaha daban-daban guda 10 a farkon 2020 don samar da allurar rigakafin COVID-19.
Tsarin da ake aiwatarwa a cikin Phase I na binciken ya hada da:
Kwayoyin jini (DNA da RNA) na mataki na I na binciken rigakafi sune: Moderna, mRNA-1273)
Kwayoyin kwayar cuta (ƙwarewar farko na binciken allurar: CanSino Biologics, adenovirus type 5 vector)
A cewar masana CEPI a watan Afrilu, kimanin bincike kan alluran rigakafi 115 ba su fara ba, daga cikinsu 78 sun tabbatar da cewa an fara shirye-shiryen su (79, kamar yadda Cibiyar Milken ta ruwaito), kuma 37 sun sanar, amma ba a san cikakken bayani ba (ana zaton akwai shirye-shirye ko kuma ana sarrafa su).
Gwajin I-II yana auna daidaito da inganci, ana yin shi gaba ɗaya, ana bin sa ido sosai, ana yin shi a wurare da yawa, idan akwai guje wa kuskure, kuma ana gano adadin da za a iya amfani da shi.
Gwajin Mataki na III yana ɗaukar mutane da yawa, gami da ƙungiyar kulawa, da kuma kimanta tasirin rigakafin kwayar cutar, yayin da yake ƙunshe da kimantawa cewa ana rage sauran tasirin kwayar zuwa matakin jurewa.
Daga cikin alluran 79 da ake aiwatarwa (wanda aka amince da su a farkon Afrilu 2020), 74 ba a fara gwajin su a cikin mutane ba (har yanzu suna cikin binciken farko).
A ranar 24 ga Janairu, 2020, Jami'ar Quensland ta bayyana cewa tana gudanar da bincike kan allurar da za ta iya canza tsarin kwayar cutar don taimakawa tsarin rigakafin jiki.
A ranar 24 ga Janairu, 2020, a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta ba da sanarwar cewa an fara aikin samar da allurar, kuma za a fara gwajin mutum a 2021.
A ranar 26 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta kasar Sin ta sanar da shirye-shiryen gaggawa, kuma Jami'ar Hong Kong ta sanar da hakan a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanonin Magunguna da Hanneke Schuitemaker ke jagoranta, sun ba da sanarwar cewa sun fara aikin samar da allurar rigakafi.
Janssen kuma, tare da abokin aikinta Vaxart, suna samar da allurar da za a iya ba ta baki.
A ranar 18 ga Fabrairu, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don samar da allurar.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya buga wani bincike na kwayar halitta tare da fasahar da ta dace da maganin kansa.
A ranar 25 ga watan Maris, mai kula da cibiyar ta sanar da cewa ta kammala muhimman abubuwan da suka shafi allurar, kuma za ta fara gwajin ta.
A ranar 27 ga Fabrairu, 2020, kamfanin Generex, NuGenerex Immuno-Oncology, ya ba da sanarwar cewa zai fara aikin samar da allurar rigakafi don gano allurar da ke dogara da kwayoyin halitta da za ta iya tsayayya da COVID-19.
Manufarsu ita ce samar da allurar rigakafi da za a iya gwadawa a cikin mutane a cikin kwanaki 90
A ranar 25 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryen samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Nazarin Kiwon Lafiya da Kayan Soja ta Amurka a Fort Detrick da Makarantar Nazarin Kayan Soja ta Walter Reed, duka a yammacin Maryland, sun ba da sanarwar cewa suna aiki kan allurar.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta fara haɗin gwiwa tare da Novavax Inc.
a cikin aikin yin allurar rigakafi.
Hakanan, abokan hulɗar sun sanar da cewa suna da shirin gwada allurar kuma fara gwajin sa na Tier I a watan Yuli 2020.
A ranar 5 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta ba da sanarwar cewa tana samar da allurai 11 kuma a farkon lokacin zai ɗauki aƙalla shekara ɗaya zuwa shekara ɗaya da rabi zuwa shekaru biyu don samar da allurar.
A ranar 5 ga Maris, 2020, kamfanin kiwon lafiya na Quebec City, Quebec, ya sanar da wani samfurin maganin coronavirus mai inganci wanda aka tallafawa ta Cibiyar Nazarin Kiwon Lafiya ta Kanada.
Har yanzu ana gudanar da bincike kan allurar a dakin gwaje-gwaje, kuma ana shirin samar da ita ga mutane a watan Yuli ko Agusta 2020.
A farkon makon nan, jaridar The Guardian ta ba da sanarwar cewa Shugaban Amurka Donald Trump ya ba da babban kuɗi don kawai aikin samun allurar rigakafin COVID-19, wani abu da gwamnatin Jamus ta ƙi.
A ranar 5 ga Maris, 2020, Kamfanin Pharmaceutical Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don samar da allurar rigakafi bisa ƙwayoyin mRNA.
An yi gwaji da allurar mRNA mai suna BNT162 kuma ana shirin fara gwajin ta a watan Afrilu 2020.
A ranar 17 ga Maris, 2020, a Italiya, Kamfanin Kiwon Lafiya na Takis Biotech, ya ba da sanarwar cewa zai sami sakamakon gwajin da aka ɗauka a watan Afrilu na 2020 sannan kuma gwajin rigakafin zai fara nan da nan.
A ranar 19 ga Maris, 2020 a Faransa, Cibiyar Kula da Rigakafin Bala'i (CEPI) ta ba da sanarwar kashe dala miliyan 4.9 don binciken rigakafin COVID-19 da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh ke gudanarwa, wanda ya kawo adadin kuɗin da CEPI ta kashe don neman rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI da suka ba da kuɗi don samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A watan Maris na 2020, jami'an kiwon lafiya a Rasha sun sanar da cewa masana sun fara gwajin dabbobi a gwajin allurar esheshtu.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin COVID-19 ta hanyar ƙwayoyin jini.
An yi allurar ne cikin kwanaki 14 bayan da kasar Sin ta kawo kayan aikin.
A ƙarshen Maris, gwamnatin Kanada ta ba da sanarwar dala miliyan 275 don tallafawa ayyukan 96 na matakan COVID-19, gami da yin allurar rigakafi a cikin cibiyoyin ilimi da jami'o'i na Kanada, gami da na Medicago da Jami'ar Saskatchewan.
A daidai wannan lokacin, gwamnatin Kanada ta ba da sanarwar cewa an ba da C$192 miliyan kawai don samar da allurar COVID-19 , don ƙirƙirar Rukunin allurar rigakafi wanda ke adana ƙarin allurar rigakafi don amfani da ita yayin da wani sabon barkewar cutar coronavirus ya barke.
A ranar 2 ga Afrilu, 2020, masu bincike a Kwalejin Likita ta Jami'ar Pittsburgh sun ba da sanarwar cewa suna gwaji a cikin beraye na allurar PittCoVacc, wanda zai iya haifar da allurar COVID-19, suna ba da sanarwar cewa ɓangarorin SARS-CoV-2 S1 na kwayoyin halitta na MNA sun nuna ikon samar da rigakafin jiki [a cikin beraye], wanda ya fara bayyana tun farkon mako 2 bayan amfani da shi. "
A ranar 16 ga Afrilu, 2020, Kwalejin Magunguna ta Jami'ar Waterloo ta sanar da cewa suna haɓaka allurar rigakafin DNA wanda za'a iya amfani da shi ta hanci.
Ta amfani da maganin kashe kwayoyin cuta, za a yi amfani da DNA don shigar da kwayoyin halitta zuwa kwayoyin halitta masu kama da ƙwayoyin cuta, waɗanda za su iya haɓaka tsarin garkuwar jiki don ƙirƙirar rigakafin jiki na SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun tattara bayanai don samun damar kwamfutocin IBM na musamman, da sauran kayan aikin kwamfutar Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu kwayoyin cutar suna da sakamako masu illa, sau da yawa ana kiran su sakamako marar kyau.
Wannan yana nufin cewa suna iya inganta lafiyar jiki.
Wani gwaji a Ostiraliya yana neman likitoci 4,170 da za su taimaka musu.
Ana iya ganin cewa alluran da ake yi ba su da inganci ko kuma ba su da inganci.
Wani binciken da aka yi kwanan nan na gwajin cutar ta hanyar amfani da kwayoyin cutar COVID-19, kamar ACE2 da kuma tsuntsaye, ya nuna cewa akwai buƙatar matakan kiyaye lafiyar matakin 3, don magance cutar da ke akwai, da haɗin gwiwar duniya don bin ƙa'idodin lafiya.
An gwada alluran rigakafin SARS da MERS a kan dabbobi.
Har zuwa 2020, babu magani ko allurar rigakafin SARS da MERS da aka tabbatar da inganci da inganci a jikin mutum.
A cewar wani bincike na shekara ta 2005 da 2006, ganowa da kuma samar da alluran rigakafi da magungunan SARS sun kasance gaggawa a cikin tsarin gwamnati da cibiyoyin kiwon lafiya a duniya. Babu tabbacin rigakafin MERS.
A lokacin da cutar ta MERS ta bazu, ana tsammanin cewa binciken da ake yi zai iya samar da hanyoyin da za a iya amfani da su wajen samar da alluran rigakafi da magunguna don hana kamuwa da cutar ta MERS-CoV.
A watan Maris na 2020, an kammala gwajin gwajin mutum na farko na allurar rigakafin MERS (DNA) da kuma wasu uku da ake aiwatarwa, dukansu a cikin nau'in kwayar cuta, biyu daga cikin nau'in kwayar cuta Adenoviridae (ChAdOx1-MERS, BVRS-GamVac), da kuma daya daga cikin nau'in MVA (MVA-MERS-S).
Kafofin watsa labarun sun yada jita-jita cewa COVID-19 ya riga ya zama sananne kuma akwai allurar rigakafin.
Abubuwan da aka gano a shafukan sada zumunta sun shafi kasancewar kwayoyin halitta da alluran rigakafi don sauran cututtukan coronavirus kamar SARS.
Cutar coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa wacce ke haifar da kwayar cutar ta hanyar cutar ta hanyar numfashi ta SARS-CoV-2 (SARS-CoV-2).
Alamomin da ake nunawa a yau su ne yawan zafin jiki, kumburi, da kuma rashin numfashi.
Sauran alamun cutar sun haɗa da gajiya, ciwon jijiya, rashin ƙarfi, ciwon hanci, rashin numfashi da kuma jin dadi, da kuma ciwon ciki.
Alamun cutar suna bayyana a cikin kwanaki biyar amma suna iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Duk da yake yawancin waɗanda suka kamu da cutar suna nuna alamun bayyanar cututtuka, wasu suna fama da matsalar numfashi da jin rauni a cikin wasu sassan jiki.
A ranar 17 ga Afrilu, 2020, mutane sama da miliyan 2,24 sun kamu da cutar a ƙasashe 210, wanda ya haifar da mutuwar kusan 153,000.
Fiye da mutane 568,000 sun warke. Wannan kwayar cutar tana kamuwa da juna ta hanyar haɗuwa, galibi ta hanyar zubar da jini wanda ke fitowa daga hawaye yayin da mutum yake ta ihu, taɓawa, ko magana.
Idan an yi numfashi, yawanci waɗannan ruwan za su sauka a ƙasa ko a wani abu maimakon su yi wa mutum illa a wani wuri mai nisa.
Mutane na iya kamuwa da cutar ta hanyar yin aiki da wurin da cutar ke ciki sannan kuma ta shafi fuska, hanci ko baki.
Kwayar cutar tana iya rayuwa a waje har tsawon awanni 72.
Ana iya samun kamuwa da cutar sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake yana iya kamuwa da cutar kafin bayyanar cututtuka da kuma lokacin da kamuwa da cutar ba ta da tsanani. Hanyar da ta fi dacewa don kimantawa ita ce ta hanyar real-time reverse transcription polymerase chain reaction (rRT-PCR) wanda aka yi ta hanyar gwajin hanci.
Yana da muhimmanci mutum ya saka abin rufe fuska idan ana zarginsa da kamuwa da cutar.
Dokokin da suka shafi saka abin rufe fuska a kan kowa suna bambanta, wasu shugabannin suna ba da shawarar kada a saka shi, wasu kuma suna ba da shawarar cewa a saka shi.
Har yanzu babu wani magani ko magani na musamman da za a iya amfani da shi don magance COVID-19.
An samu kamuwa da cutar tsakanin mutane a cikin yanki guda a duk yankuna shida na WHO.
Masu kamuwa da cutar na iya zama marasa bayyanar cututtuka ko kuma suna nuna alamun cutar kamar su ƙonawa, tari, gajiya, da rashin numfashi.
Alamomi masu tsanani sun haɗa da wahalar numfashi, ciwon ciwo ko ciwon kirji, fuska mai ƙyama, rashin iya tafiya, ja a fuska ko a baki; wanda zai zama dole a nemi likita nan da nan idan an nuna waɗannan alamun.
Ba a yawan samun alamun bayyanar cututtuka ba, kamar su kumburi, cizon safa, ko kuma ciwon hanci.
Alamun yanayin da ke cikin matasan da ke da ƙarfi kamar yin tawaye, tsalle, da kuma yin tawaye suna bayyana a kan allon da ke sama.
A China, marasa lafiya sun nuna alamun fashewar kirji da bugun zuciya na farko.
A wasu, rashin lafiya zai iya zama da tsanani har ya kai ga rashin numfashi, rashin aiki na gabobin jiki, har ma da mutuwa.
Wannan shi ne lokacin bayyanar cututtuka.
Lokacin bayyanar COVID-19 yawanci kwanaki shida ne amma yana iya kasancewa tsakanin 2 zuwa 14.
97.5% na mutane suna nuna alamun cutar a wannan lokacin na iya zama a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun ce duk wanda ya ci ba ya nuna alamun cutar.
Har yanzu ba a san irin tasirin da masu kamuwa da cutar ba za su iya yi ba; duk da haka, akwai bayanai na asali cewa suna iya kamuwa da wasu.
Ba a san adadin mutanen da ba su da alamun cutar ba tukuna amma ana nazarin su, bisa ga rahoton da Hukumar Kula da Cututtuka ta Koriya (KCDC) ta bayar, kashi 20% na mutanen da ke da cutar suna jiran a kwantar da su daga asibiti ba tare da alamun cutar ba.
Hukumar kula da lafiya ta kasar Sin ta fara sanya wadannan mutane a cikin bayanan kamuwa da cuta na yau da kullum a ranar 1 ga Afrilu; daga cikin mutane 166 da aka ruwaito a wannan ranar, 130 (78%) ba su nuna alamun cutar ba lokacin da aka gwada su.
Abubuwan da aka yi da kwayoyin halitta na iya ɗaukar ƙwayoyin cuta da yawa.
Yin magana sosai yana sa a yi ruwa fiye da yin magana a hankali.
Wani bincike a Singapore ya nuna cewa yin tari a bakin mutum zai iya sa ruwa ya kai tsawon mita 4.5 (15 feet).
Ko da yake cutar tana yaduwa cikin iska, Cibiyar Kimiyya ta Kasa ta ce yana yiwuwa kuma an gwada iska daga ɗakunan da aka tattara don gano cutar.
Hanyar magani kamar ta hanyar shigar da iska a cikin hanci da kuma ƙara iska (CPR) na iya haifar da iska mai iska wanda zai iya haifar da kamuwa da cutar.
Idan akwai wasu tambayoyi game da yiwuwar mace ta kamu da cutar a cikin jariri, babu tabbaci mai yawa. Kwayar cutar tana iya kamuwa da cutar idan mutane sun nuna alamun cutar; idan akwai yiwuwar kamuwa da cutar kafin bayyanar cututtuka.
Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kula da Cututtuka (ECDC) ta ce ko da yake ba a san yadda za a iya samun ƙwayar cutar ba, mutum zai iya kamuwa da mutane biyu zuwa uku.
A cikin ƙayyadaddun bayanai, kwayar cutar ta kasance kwana ɗaya a kan allon, kusan kwana uku a kan filastik (polypropylene) da ƙarfe mai ƙarfi (AISI 304), da sa'o'i huɗu a kan ƙarfe mai sauƙi 99%.
Amma, yanayin zai iya canzawa a lokacin sanyi da zafi.
Sabulu da magungunan kashe ƙwayoyin cuta, idan aka yi amfani da su yadda ya kamata, na iya kashe ƙwayoyin cuta; sabulu yana lalata ƙwayoyin cuta, yana hana su aiki da kuma cire su daga jiki ko kuma daga cikin ƙwayar cuta.
Sauran sun hada da benzankonium chloride da chlorhexidine gluconate (a cikin wani magani mai suna chlorhexidine gluconate), amma ba su da tasiri sosai. A cikin wani binciken Hong Kong, an yi gwajin ƙwayoyin cuta a cikin kwanaki biyu bayan asibiti.
Biyar daga cikin marasa lafiya shida, gwajin farko ya raba yawan adadin ƙwayoyin cuta, sannan na shida ya raba yawan ƙwayoyin cuta a cikin allurai na rana ta biyu.
Cutar Coronavirus ta 2 SARS-CoV-2 sabon kwayar cuta ce mai ɗaukar numfashi, wanda aka fara ganowa a Wuhan a cikin mutane uku da ke fama da matsalolin numfashi da ke tattare da cututtukan numfashi.
Dukkanin alamun cutar SARS-CoV-2 suna bayyana a cikin nau'in coronavirus.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, yana kashe rigakafin kwayar cutar. SARS-CoV-2 yana da alaƙa da SARS-CoV na farko.
COVID-19 yana shafar huhu musamman, saboda kwayar cutar tana wucewa ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda ke bayyana a cikin huhu.
Kwayar cutar tana amfani da sashin ta na baya mai suna spike (mai kama da ƙahon) don haɗuwa da ACE2 kuma ta shiga cikin kwayoyin halitta.
Kashi 12 cikin 100 na wadanda suka kamu da cutar da aka kwantar a Wuhanm, China, sun kamu da cututtukan zuciya masu tsanani kuma wannan yana faruwa a cikin cututtuka masu tsanani.
Yawan cututtukan cututtukan zuciya a cikin mutane yana da girma, saboda kumburi da kuma lalacewar garkuwar jiki suna faruwa a cikin yanayin da cutar ta ci gaba, amma cututtukan cututtukan zuciya na iya kasancewa da alaƙa da cututtukan zuciya na ACE2.
Kwayar cutar ACE2 tana shiga cikin zuciya kuma tana da hannu a cikin aikin zuciya.
Marasa lafiya a ICU da ke da COVID-19 sun nuna matsaloli Rashin jini (31%) da kuma lalata hanyoyin jini (25%), wanda ke da alaƙa da rashin yiwuwar warkewa. Gwaje-gwajen da aka yi a cikin mutanen da suka mutu daga COVID-19 sun nuna lalacewar tsarin numfashi (DAD), da kuma cututtukan huhu.
Ko da yake SARS-COV-2 na iya kasancewa tare da ACE2 a cikin jiki da kuma a cikin ƙwayoyin numfashi, marasa lafiya na COVID-19 suna nuna alamun ciwon kumburi mai tsanani.
Musamman, an gano ƙwayoyin T na cutar GM-CSF suna aiki tare da IL-6-mai haifar da kumburi a cikin marasa lafiya na COVID-19.
An gano kwayoyin rigakafi a jikin wanda cutar ta kashe.
Hukumar lafiya ta duniya WHO ta sanar da wasu hanyoyin gwajin cutar.
Hanyar tabbatarwa ta tabbatar da cutar ita ce ta hanyar amsawar sarkar polymerase ta hanyar juyawa ta ainihi (rRT-PCR).
Ana yin gwajin gwajin a cikin matattarar numfashi ta hanyar amfani da nasal decanoids; duk da haka, ana iya amfani da maganin shafawa da kuma maganin shafawa .
Za a iya samun amsoshin a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya yin gwajin jini, amma ana buƙatar gwajin jini biyu a cikin makonni biyu daban-daban kuma sakamakon ba shi da mahimmanci a nan take.
Masana kimiyya a kasar Sin sun sami damar ware kwayoyin cutar coronavirus sannan su fitar da sakamakon dakin gwaje-gwaje a duniya don samar da kwayoyin halitta (PCR) da za a iya amfani da su wajen tantance kamuwa da cutar.
Har zuwa ranar 4 ga Afrilu, 2020, ana gudanar da gwaje-gwaje a kan jami'an tsaro (wanda zai iya nuna kamuwa da cutar a jiki ko kuma idan mutum ya kamu da cutar a baya), amma ba a yi amfani da su a wurare da yawa ba.
Kwarewar gwajin kasar Sin ta nuna cewa an samu nasarar yin gwajin a kashi 60% zuwa 70%.
Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta amince da wani wuri na gwaji a ranar 21 ga Maris, 2020 wanda za a fara amfani da shi a ƙarshen watan. Jagorancin gwaji da aka bayar ta asibitin Zhongnan na Jami'ar Wuhan ya ba da shawarar hanyar gwajin kamuwa da cuta bisa ga tabbacin likita da kuma sakamakon cutar.
A farkon kamuwa da cuta yawanci ta hanyar ɓoyewar ƙwayoyin cuta, tattara su, ware su daga jikin da suka shiga sannan su yada su ko'ina.
Yayin da cutar ke ci gaba, ta bazu cikin hanyoyin numfashi, ta samar da hanyoyi (ta zurfafa hanyoyin numfashi ta hanyar rufe hanyoyin numfashi) da kuma haɗuwa.
Akwai wasu bayanai game da hotunan hoto da kuma yanayin COVID-19.
Abubuwan da suka faru na binciken kwayar cutar da aka yi a jikin mutum sune:
Abubuwan da ke gani: kumburi a cikin numfashi, kumburi a cikin zuciya, rufe hanyoyin numfashi
Akwai nau'ikan cututtuka guda uku na rashin lafiyar da ke tattare da cutar:
Rashin iskar iska mai sauƙi: ƙwayoyin cuta a cikin huhu, ƙwayoyin cuta na numfashi, ƙwayoyin cuta na numfashi, ƙwayoyin cuta da ƙwayoyin cuta daban-daban
Ƙarfin ƙwayar cuta: yaduwar cutar ta hanyar iska (DAD) da kuma yaduwar ƙwayar cuta.
DAD shine babban abin da ke haifar da cututtukan cututtukan numfashi (ARDS) da kuma toshewar jini.
Rashin lafiyar numfashi yana farawa da sauƙi: tarin haɗuwa a cikin numfashi da huhu
Jinin jini: zubar da jini (DIC); samar da sababbin kwayoyin halitta a cikin jini
Matakan rage yaduwar cutar sun hada da zama a gida, guje wa zuwa wuraren da jama'a ke taruwa, wanke hannuwanka da sabulu da ruwa akai-akai kuma a yi shi na akalla dakika 20, tsabtace wuraren numfashi da guje wa taɓa fuska, hanci ko bakinka ba tare da wanke hannu ba.
CDC ta ba da shawarar cewa a rufe bakinka da sutura mai tsabta lokacin da kake taɓawa ko cirewa ko kuma a rufe bakinka da hannun gaba na gwiwoyi lokacin da babu sutura.
Yana da muhimmanci a wanke hannuwanka a duk lokacin da ka tari ko ka yi gumi.
CDC ta ba da shawarar cewa mutane su sa abin rufe fuska a lokacin da suke fita daga gida, don hana yaduwar cutar ta hanyar mutanen da ba su da alamun cutar. Tsarin sasantawa yana nufin rage yawan mutanen da ke da lafiya da waɗanda ke da cutar ta hanyar rufe makarantu, wuraren aiki, dakatar da tafiya da hana mutane haɗuwa a wuri ɗaya.
Dokokin sun ce dole ne a yi nisa da mita 6.
Babu wata sanarwa da za ta magance COVID-19. Tun da ana sa ran samun allurar rigakafi a kusan shekara ta 2021, hanya mafi kyau don magance cutar ita ce ta samar da hanyoyin da za su rage sabon kamuwa da COVID-19 wanda ake kira "flattening the curve" a cikin harshen Turanci.
CDC ta shawarci mutane su wanke hannayensu akai-akai da sabulu da ruwa kuma su yi haka na akalla dakika 20, musamman bayan sun fita daga ɗakin wanka ko kuma a lokacin da aka ga hannu suna da tsabta, kafin cin abinci, bayan numfashi, tari ko ɗagawa.
CDC kuma tana ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na musamman idan ya kai kashi 60 cikin ɗari, wanda ake amfani da shi a lokacin da babu ruwa ko sabulu. A yankunan da ke da wahalar samun waɗannan magungunan, WHO ta ba da wasu nau'ikan magungunan magani guda biyu.
Wannan maganin yana dauke da maganin kashe kwayoyin da ake kira ethanol ko isopropanol.
Hydrogen peroxide yana kashe ƙwayoyin cuta; ba " magani ba ne na hannu.
Hakanan ana ƙara glycerol zuwa magani.
Ana amfani da hanyoyin da dama na magani, ciki har da amfani da ruwa, karfafa iska, da kuma karfafa sauran sassan da suka kamu da cutar.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa masu kamuwa da cutar su sa abin rufe fuska.
Ana ci gaba da amfani da tsarin haɓaka iska (ECMO) don magance matsalar rashin iska, kuma har yanzu ana samun karbuwa.
Ana ƙarfafa mutane su kasance da tsabta, kula da lafiyarsu, da kuma cin abinci mai gina jiki don ƙara ƙarfin jiki.
Ana iya amfani da wasu hanyoyin da za a iya amfani da su a cikin magani ga mutanen da ke da ƙananan alamun kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun ba da sanarwar yadda za a kula da marasa lafiya da ke cikin asibiti na COVID-19.
Masana ilimin likitancin da ke kula da cututtukan numfashi a Amurka sun tattara bayanan likita na cututtukan daga cibiyoyin bincike na duniya (IBCC) kuma sun bayyana su.
A watan Afrilu na 2020, babu maganin COVID-19 da aka sani.
Don magance bayyanar cututtuka, masana sun bada shawarar maye gurbin ibuprofen da acetaminophen (paracetamol) a farkon kwanakin rashin lafiya.
Ya kamata a dauki matakan rage yaduwar kamuwa da cuta, musamman a asibitoci yayin da suke gudanar da ayyukan da za su iya fitar da iska, kamar sanya kayan numfashi a cikin iska ko ƙara numfashi da hannu ga marasa lafiya.
CDC ta shawarci likitocin da ke kula da marasa lafiya na COVID-19 su sanya su a cikin wani ɗaki na musamman da ake kira , Airborne Infection Isolation Room (AIIR) tare da ci gaba da bin umarnin da aka bayar, guje wa kusanci da sanya abin rufe fuska. CDC ta ba da jerin umarni da za a bi don amfani da kayan kariya na musamman (PPE) don rigakafin cutar.
Irin wannan tufafi sune: PPE, numfashi ko mask, sutura, har ma da sutura. Zai fi kyau a yi amfani da numfashi, idan akwai, maimakon sanya masks.
An yarda da N95 don amfani a masana'antu, amma FDA ta amince da masks don amfani da magani (EUA).
An tsara mu ne don kare masu amfani da iska mai tsabta amma ba a tabbatar da tasirinsa na hana kamuwa da cutar ba.
Idan babu abin rufe fuska, CDC ta ba da shawarar cewa mutane su yi amfani da suturar rufe fuska, ko, a kan sutura, suturar rufe fuska da mutane suka yi.
Yawancin marasa lafiya na COVID-19 ba za su gamsu da shi sosai don samun ƙarin numfashi ko kuma wasu hanyoyin numfashi ba, amma wasu suna buƙatar hakan.
Ana gudanar da bincike a asibiti kan nau'ikan kayan aikin da za a iya amfani da su don ƙara numfashi ga COVID-19, wanda ke ba da damar hana amfani da matatun numfashi ko wasu kayan shafawa don numfashi.
Ba a sani ba ko waɗannan hanyoyin suna da sakamako iri ɗaya a shekara.
Wasu likitoci sun fi son ci gaba da amfani da na'urorin numfashi idan sun kasance saboda wannan hanyar ta hana fitar da iska fiye da na'urorin numfashi. Wannan cutar tana faruwa a cikin manya (sama da shekaru 60 musamman ma sama da shekaru 80).
Yawancin ƙasashe masu tasowa suna da matsalar rashin gado, wanda ke haifar da matsalar magance ƙaruwar yawan mutanen da ke fama da COVID-19 waɗanda ke cikin rashin lafiya kuma suna buƙatar zuwa asibiti.
Wani bincike a kasar Sin ya nuna cewa kashi 5 cikin 100 na mutanen da aka kai asibiti, kashi 2.3 cikin 100 na mutanen da suka bukaci karin iska kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30% na mutanen da ke da cutar COVID-19 a asibiti suna samun kulawa ta ICU.
Ana ci gaba da amfani da hanyoyin samar da iska saboda matsalolin rashin iska da COVID-19 ke haifar da su.
Ana buƙatar ƙarin kayan aikin PEEP don taimakawa marasa lafiya su sami iska don rage matsalolin rauni da kuma rufe hanyoyin numfashi.
Ba a amfani da kayan aikin PEEP a cikin kayan aikin da suka gabata ba.
Binciken magungunan da ke da tasiri a kan cutar ya fara ne a watan Janairun 2020, kuma an fara gwajin magunguna da yawa.
Remdesivir magani ne mai ba da bege.
Ko da yake zai iya zuwa shekara ta 2021 don samun sababbin magunguna, ana gwada magunguna daban-daban don amfani da su a cikin wasu cututtuka ko kuma ana gudanar da bincike na yau da kullun.
Ana iya gwada maganin rigakafin cutar a kan marasa lafiya.
WHO ta gayyaci masu aikin sa kai su shiga cikin binciken da ke tabbatar da inganci da amincin magungunan da ake gwaji. FDA ta ba da izinin jinkirin amfani da magungunan da ke ƙarfafa lafiyar marasa lafiya a lokacin da lafiyarsu ke cikin haɗari.
Babu wani bincike da aka gudanar da shi na FDA don tabbatar da tasirin wannan magani na rashin lafiya ko rashin lafiya.
A watan Fabrairun 2020, kasar Sin ta ƙaddamar da fasahar wayar hannu don magance yaduwar cutar.
Ana buƙatar masu amfani da wannan hanyar su shigar da sunayensu da lambar ID.
Wannan fasaha tana iya gano ko akwai kamuwa da cutar a wurin da kake amfani da shi ta amfani da bayanan kulawa don samun kamuwa da cutar a kusa.
Kowane mai amfani da wannan fasahar zai iya lura da matsayin sauran masu amfani da shi.
Singapore Idan an gano cutar a yankin, ban da cewa fasahar tana ba da shawarar keɓewa, tana sanar da hukumomin kiwon lafiya na yankin. Kasashen Koriya ta Kudu, Taiwan da sauransu suna amfani da fasahar nazarin bayanan wayar hannu, na'urorin lura da mutane ta fuskar mutum , binciken bayanai ta wayar hannu da kuma amfani da na'urorin daukar hoto, a cikin tsarin gano mutane da suka kamu da cutar.
A watan Maris na 2020, gwamnatin Isra'ila ta bai wa cibiyoyin fasaha damar bincika wayoyin salula na mutanen da ake zargi da kamuwa da cutar.
An yanke wannan shawarar ne don aiwatar da tsarin hanawa da kuma kare wadanda zasu iya saduwa da wadanda suka kamu da cutar.
A watan Maris na 2020, Deutsche Telekom ta ba da damar yin amfani da cibiyar bincike ta Robert Koch ta Jamus don gudanar da bincike da hana yaduwar cutar.
Rasha ta inganta fasahar duba fuska don gano wadanda suka taka dokar hana yin jima'i.
Kwamishinan lafiya na Italiya Giulo Gallera ya shaida wa masu amfani da wayar tarho cewa "kimanin kashi 40 cikin 100 na mutanen ƙasar suna tafiya bisa ga tsarin da suka samu".
Gwamnatin Jamus ta gudanar da taron tsawon sa'o'i 48 da masana kimiyyar kwamfuta sama da 42,000.
Shugaban Estonia, Kersti Kaljulaid, ya yi kira ga al'ummar duniya da su nemi hanyoyin magance yaduwar cutar coronavirus.
Mutane na iya fuskantar matsanancin damuwa saboda keɓewa, hana tafiya, sakamakon magani, ko kuma tsoron cutar kanta.
BBC ta wallafa wani bayani na Rory O'Connor, inda ta ce "keɓewa, kadaici, damuwa da lafiya, tunani mai yawa da talauci suna da tasiri sosai a kan lafiyar kwakwalwa da zamantakewar jama'a".
Cutar na iya nuna alamun bayyanar cututtuka kaɗan ko kaɗan, wanda ya yi kama da sauran cututtukan numfashi ko mura.
Mutane da ke da rashin lafiya mai sauƙi suna iya warkewa a cikin makonni biyu, yayin da waɗanda suke da rashin lafiya na iya ɗaukar makonni uku zuwa shida.
Mata masu ciki suna iya kamuwa da COVID-19 kamar yadda bayanai suka nuna dangane da wasu ƙwayoyin cuta, kamar SARS da MERS, amma ba a san bayanan COVID-19 a cikin mata masu ciki ba. COVID-19 na iya haifar da cutar numfashi ga wasu mutane.
Wasu mutanen da suka kamu da COVID-19 na iya samun cututtukan numfashi masu tsanani (ARDS) wanda zai iya haifar da rashin numfashi, rashin jin daɗi da kuma rashin ƙarfi na sassan jiki daban-daban.
Matsalolin COVID-19 sun haɗa da ciwon jiki, tarin jini, da cututtukan zuciya, koda, da kuma rashin ƙarfi.
Ana samun zubar da jini, musamman a cikin duhu, a cikin kashi 6% na marasa lafiya na COVID-19 da aka kwantar a asibiti, yayin da rashin lafiyar koda ya kasance a cikin kashi 4%.
Kashi 20-30% na masu cutar COVID-19 sun nuna karuwar ƙwayoyin transaminases a cikin duhu.
Rahoton ya kuma nuna cewa, lokacin da aka samu tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, kuma ana daukar biyar daga cikinsu zuwa asibiti.
Duk da haka, marasa lafiya da aka kwantar a ICU sun yi kwana bakwai a asibiti kafin su mutu.
A cikin binciken da aka yi a kan waɗanda suka kamu da cutar kwanan nan, an yi nazarin tsawon lokaci tsakanin bayyanar cututtuka da mutuwa a cikin kwanaki 14, a tsakanin kwanaki 6 zuwa 41.
A wani binciken da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar, mace-mace a kasar Sin ta kai kashi 2.8 cikin dari a cikin maza, yayin da mata ke da kashi 1.7 cikin dari.
Gwaje-gwajen da aka yi a kan mutanen da suka mutu sakamakon cututtukan huhu sun nuna rashin lafiyar ƙwayoyin huhu na huhu.
Matsalar numfashi ta nuna cewa cutar tana canzawa.
Hanyar huhu ta kasance ta kashe kanta da matsaloli masu tsanani na numfashi (ARDS).
A cikin kashi 11,8% na mutuwar kamar yadda Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an sami ƙuntatawa na jijiya ko asarar zuciya.
Rahotanni na Maris a Amurka sun nuna cewa kashi 89% na waɗanda aka kwantar da su asibiti suna da wasu matsaloli.
Yawan mutuwar cutar ya bambanta daga yanki zuwa yanki, amma kuma daga matsalolin da suka shafi yadda ake amfani da ita.
rashin kula da kididdigar marasa lafiya na iya haifar da ƙarin mutuwar cutar.
Amma, yawan mutuwar da ake yi a wasu lokatai na iya sa a yi watsi da yawan mutuwar.
Masu shan taba sun ninka sau 1.4 cikin waɗanda ke da alamun COVID-19 mai tsanani kuma kashi 2.4 cikin ɗari daga cikinsu suna kamuwa da rashin lafiya ko mutuwa idan aka kwatanta da waɗanda ba su shan taba ba.
Jami'an asibitin Hong Kong sun gano cewa ruwa ya rufe tsakanin kashi 20 zuwa 30% na huhu na mutanen da suka warke, kuma hotunan da aka nuna ta hanyar na'urar likita sun nuna lalacewar huhu.
Wannan kuma yana nufin cewa dole ne a ci gaba da kula da su bayan sun bar asibitin gaggawa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar ta haifar da rashin lafiyar jiki na dogon lokaci na mutanen da suka tsira daga cutar ba.
Wannan ya zama kamar wannan kariya ta kasance, dangane da yanayin sauran cututtukan coronavirus, amma akwai wasu mutane da suka kamu da COVID-19 bayan an sanar da samun nasarar warkewa daga coronavirus.
Waɗannan mutane za su yi baƙin ciki sosai da zafin jiki da ya rage a jikinsu fiye da yadda za su yi baƙin ciki sau biyu.
Ana iya ɗauka cewa ba a yi maganin cutar ba kuma dabbobi ne suke jawo ta, kuma ana iya kamuwa da ita ta hanyar kwayoyin halitta.
Ba a san ainihin asalin cutar ba, amma har zuwa Disamba 2019 cutar ta yadu daga mutum zuwa mutum.
Binciken da aka yi kan marasa lafiya 41 na COVID-19, wanda aka buga a watan Janairun 2020 a cikin Lancet, ya bayyana alamun cutar da suka fara bayyana a ranar 1 ga Disamba, 2019.
Hukumar ta WHO ta sanar da cewa alamun cutar sun fara bayyana a ranar 8 ga Disamba, 2019.
An dauki matakai da yawa don ƙidaya yawan mutuwar.
Wannan adadi yana canzawa ta hanyar yanki, lokaci da kuma yawan allurai, ikon cibiyoyin kiwon lafiya, hanyoyin da ake amfani da su, lokacin da cutar ta fara bayyana da kuma yanayin al'umma ta hanyar shekaru, jinsi da lafiyar su gaba ɗaya.
A ƙarshen 2019, WHO ta ba da lambar cutar ICD-10 U07.1 ga marasa lafiya waɗanda aka tabbatar da mutuwar su ta hanyar dakin gwaje-gwaje ta SARS-CoV-2 da lambar U07.2 ga marasa lafiya waɗanda aka tabbatar da COVID-19 amma ba a tabbatar da cutar ta hanyar dakin gwaje-gwaje ta SARS-CoV-2 ba.
Bisa ga kididdigar da Jami'ar Johns Hopkins ta fitar, yawan mutuwar duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Ƙididdigar ta bambanta da na yanki. Sauran matakan sun haɗa da ƙididdigar Mutuwa (CFR), wanda shine adadin mutanen da suka kamu da cutar da cutar, da kuma yawan mutanen da suka mutu daga cutar (IFR), wanda shine adadin mutanen da suka kamu da cutar (masu gwadawa da marasa gwadawa) da suka mutu daga cutar.
Wadannan kididdigar ba su da lokaci kuma suna tafiya tare da wasu al'ummomin da suka kamu da cutar ta hanyar kulawa.
Idan duk masu kamuwa da cutar ba su fara yin rigakafin jiki ba, bayyanar waɗannan masu kamuwa da cutar na iya ba da labari game da yawan mutanen da suka kamu.
A cikin cibiyoyin cutar da ta kai ga Italiya, Castiglione d'Adda, wani karamin yanki da ke da yawan mutane 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar ta karfafa ta hanyar bukukuwan Carnival, wanda matasa ke kamuwa da ita, yana haifar da raguwar yawan jama'a, amma ba a ba da rahoton mutuwar COVID-19 gaba ɗaya ba.
Bugu da ƙari, hukumomin kiwon lafiya na Jamus ba su yi sanyin gwiwa ba.
A Netherlands, kusan kashi 3 cikin dari na mutane na iya samun rigakafin jiki, kamar yadda aka nuna a cikin masu ba da jini.
An samu rahoton mutuwar 69 (0.004% na yawan jama'a) sakamakon COVID-19.
Sakamakon cutar da kuma yawan mutuwar sun bambanta ga maza da mata.
Yawan mutuwar maza yana da girma; kamar yadda binciken da aka yi a China da Italiya ya nuna.
Maza a cikin shekaru 50 suna da haɗari mafi girma, kuma akwai bambanci tsakanin maza da mata a cikin shekaru 90 kawai.
A kasar Sin, mace-mace sun kashe mutane kusan kashi 2.8 cikin 100 a cikin maza da kuma 1.7 cikin 100.
Ba a san dalilin da ya sa ake samun bambancin jinsi ba, amma zai iya kasancewa saboda yanayin jiki da halayensu.
Bambancin rigakafin jiki tsakanin maza da mata, rashin shan taba na mata da kuma cututtukan da ke shafar maza, wanda ke haifar da bugun zuciya a cikin matasan da suka fi mata, na iya haifar da ƙaruwar yawan mutuwar maza.
A Turai, kashi 57% na mutanen da suka kamu da cutar maza ne kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
A watan Afrilu na shekarar 2020 Gwamnatin Amurka ba ta fara tattara bayanan jima'i game da kamuwa da COVID-19 ba.
Binciken cututtukan cuta na kwayar cuta kamar Ebola, HIV, mura da SARS yana shafar maza da mata a hanyoyi daban-daban.
Yawancin likitoci, musamman ma masu maganin rigakafi, mata ne, kuma suna da haɗarin kamuwa da cutar.
A ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta sanar da sunan cutar a matsayin COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO ya ƙunshi corona, cutar VI, cutar D, kuma 19 ya nuna lokacin da cutar ta fara bayyana: 31 ga Disamba, 2019.
An zaɓi sunan don hana shi ba da sunan yankin (misali China), nau'in dabba ko rukuni na mutane, bisa ga ƙa'idodin ba da suna na duniya don magance rashin girmamawa ko rashin daraja.Covid-19 shine cutar coronavirus ta 2 mai cutarwa ta hanyar cutar ta hanyar numfashi (SARS-CoV-2).
WHO ta kuma yi amfani da "COVID-19" da "COVID-19" a cikin sadarwa ta gwamnati.
Ko dai cutar ko kuma kwayar cutar biyu ana kiranta "coronavirus".
A Wuhan, China, an gano cewa cutar da cutar guda biyu suna da suna "coronavirus" da "coronavirus Wuhan".
A watan Janairun 2020, WHO ta bayyana 2019-nCov da 2019-nCoV a matsayin sunayen gajeren lokaci na cutar cutar don girmama dokar 2015 da ta hana amfani da sunayen yanki a cikin sunayen cutar cutar.
An sanar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda rashin wadatar da ake samu, wasu masana'antun fasaha suna samar da kayan aikin kiwon lafiya kamar su kayan aikin gwajin hanci, da kuma kayan numfashi.
Alal misali, sa'ad da asibitoci a Italiya suka bukaci na'ura mai sanyaya iska sosai kuma mai ba mu magani ya kasa yin hakan, masana'antar da ke wurin ta yi aiki da na'ura 100 a dare ɗaya.
Bayan an fara gano mutum na farko game da COVID-19, jita-jita, ɓatarwa, ɓatarwa, asalin, asalin, ci gaba, hanawa, magani da sauran abubuwan da suka shafi cutar sun fara magana da sauri a kan hanyoyin sadarwar jama'a.
Mutane na iya kamuwa da cutar ga wasu dabbobi.
Binciken ya kasa gano asalin kwayar cutar a cikin alade, naman kaza da kaza.
Babu magani ko allurar rigakafi da aka tabbatar don magance cutar.
Ana gudanar da bincike na kasa da kasa kan alluran rigakafi da magungunan COVID-19 ta hukumomi, kungiyoyin malamai da masu bincike a masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da "Taraitaccen Gwajin" don nazarin tasirin kwayoyi huɗu na yau da kullun da ake zaton za su iya magance cutar.
Babu allurar rigakafi, amma kamfanoni daban-daban suna gwada allurai daban-daban.
Ana amfani da binciken da aka yi a SARS-CoV SARS-CoV da SARS-CoV-2 saboda duka biyun suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin jikin mutum.
Ana gudanar da bincike kan alluran rigakafi guda uku.
Da farko, masu bincike suna son samar da cikakken rigakafin cutar.
Ana amfani da kwayar cutar, ko dai ba ta aiki ko kuma ta mutu, don farkawa da tsarin rigakafin mutum don gano sabon kamuwa da COVID-19.
Mataki na biyu shi ne amfani da kwayoyin halitta, wanda shine tsarin da ke nufin samar da allurar rigakafi wanda ke ba da damar gano ƙwayoyin cutar.
Game da SARS-CoV-2, binciken ya mai da hankali kan ƙaho mai ƙusa wanda ke taimakawa kwayar cutar ta shiga cikin abubuwan ACE2.
Hanyar ta uku ita ce ta ƙwayoyin halitta (DNA ko RNA, sabon tsarin yin allurar rigakafi).
Ana buƙatar gwada inganci da inganci na allurar rigakafi na wannan nau'in da ake bincike a kai. A ranar 16 ga Maris, 2020, masu sa kai huɗu a Seattle sun fara gwajin allurar.
An ba da shawarar ƙara rigakafin jiki a matsayin ingantaccen hanyar yin allurar SARS-COV-2, amma har yanzu akwai matsala.
A watan Afrilu na shekarar 2020, an yi bincike kan alluran rigakafi sama da 300.
An yi gwaji guda bakwai a kan magungunan da aka yarda su yi maganin zazzabin cizon sauro, ciki har da guda hudu na hydroxychloroquine ko chloroquine.
Binciken kasar Sin na mai da hankali kan magungunan da ke magance cututtukan cuta na yau da kullun, tare da gwaji na III na tara akan remdesivir, a cikin ƙasashe da yawa daban-daban saboda rahoton da za a fitar a ƙarshen Afrilu.
A watan Afrilu na 2020, akwai gwajin gwaji na yau da kullun na magungunan COVID-19. Yawancin magungunan da aka saba amfani da su don magance cututtukan cututtukan cuta suna cikin gwajin gwaji don magance COVID-19, waɗanda suka haɗa da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a hade da interferon beta.
A watan Afrilu na 2020, akwai alamun cewa remdesivir yana da tasiri.
Marasa lafiya da aka yi musu magani da remdesivir sun nuna rashin jin daɗi.
Ana gudanar da gwaje-gwaje na III a Amurka, Kanada da Italiya. Chloroquine, wanda aka yi amfani da shi a matsayin magani na Malaria, an yi nazari a watan Fabrairun 2020, kuma an sami sakamako na asali.
Amma, ana gayyatar mutane su yi irin wannan bincike.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun ba da shawarar yin amfani da chloroquine.
Sai dai Cibiyar Kula da Cututtuka ta Wuhan, a lokacin da ta ba da shawarar yin amfani da gram 1 a rana, ta nuna cewa ninka wannan adadin zai iya haifar da matsaloli masu tsanani na rashin lafiya da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin wucin gadi ga likitocin da ke kula da marasa lafiya na COVID-19 don amfani da hydroxychloroquine da chloroquine a asirce. A cikin jagorar aji na 7 sun haɗa da amfani da interferon, ribavirin ko umifenovir don magance COVID-19.
Bayanai na asali sun nuna cewa ana buƙatar ribavirin mai yawa don magance SARS-CoV-2 wanda ba ya shiga cikin kwayoyin halitta.
Hakanan ana iya amfani da nitzoxanide don ƙwayoyin cuta na jiki waɗanda aka shigo da su daga baya bayan an gano ƙarancin adadin SARS-CoV-2. Binciken ya nuna cewa ana buƙatar maganin farko na mai amfani da nau'in 2 (TMPRSS2) don shigar da SARS-CoV-2 ta hanyar mai karɓar ACE2.
Bincike akan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba ya nuna manyan ƙuntatawa ga likitoci don amfani da maganin ba tare da ƙarin bincike ba. Oseltamivir ba ya fitar da SARS-CoV-2 ba sai dai idan ya shiga cikin jiki ba tare da wani aiki da aka sani ba wajen magance COVID-19.
Cytokine na iya haifar da matsaloli yayin da COVID-19 ya fara zama mai tsanani.
Akwai hujja cewa hydroxychloroquine na iya hana cytokines. Hukumar Lafiya ta kasar Sin ta amince da Tocilizumab a cikin magunguna masu amfani bayan karamin bincike.
Ana gudanar da gwajin mataki na 2 a Italiya wanda ya haɗa da gwajin ƙasa bayan an sami sakamako mai kyau a cikin mutanen da ke fama da cutar.
Ana yin gwajin jini na jini na jini don gano jini, don ganin ci gaban jini, wanda ake tsammanin yana haifar da wasu cututtuka.
A shekara ta 2017, FDA ta amince da amfani da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar ta hanyar maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar ta CAR T.
Har zuwa yau, babu wata alama da ta nuna cewa tocilizumab yana da tasiri wajen magance CRS.
Ana gudanar da bincike kan samar da rigakafin jiki mai tsabta da ƙarancin ƙarfi ga mutanen da suka tsira daga COVID-19 waɗanda suke buƙatar su a matsayin hanyar da ba a yi amfani da allurar rigakafi ba.
An gwada wannan hanyar akan SARS amma ba ta da tasiri.
Tsarin hana kwayar cutar shine tsarin da aka yi tunaninsa inda masu tsaron jikin mutum zasu iya haɗa kai don magance SARS-CoV-2.
Amma, ana iya amfani da wasu hanyoyi, kamar su tsawaita ko kuma ƙara tsarin rigakafi.
Ana yin wasu hanyoyin da za a iya amfani da su wajen magance cutar ta hanyar amfani da magungunan jiki, kamar su magungunan da aka yi a dakin gwaje-gwaje.
Dole ne a kara samar da jini, wanda ya fito ne daga masu arziki da kuma masu yaki da cutar, don samun saurin shiga jiki.
Cutar coronavirus, nau'in cututtuka ne kawai tare da alamomi tara.
Li Wenliang, likita a asibitin Wuhan na tsakiya, ya kamu da cutar COVID-19 kuma ya mutu bayan da aka sanar da barkewar cutar.
